
<html lang="en"     class="pb-page"  data-request-id="fda93953-bf40-4aa7-b196-f0282fd3a0e8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2005.48.issue-15;article:article:10.1021/jm058205b;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Structure−Activity Relationships of Pyrazine-Pyridine Biheteroaryls as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors" /></meta><meta name="dc.Creator" content="Gee-Hong  Kuo,*" /></meta><meta name="dc.Creator" content="Catherine  Prouty," /></meta><meta name="dc.Creator" content="Aihua  Wang," /></meta><meta name="dc.Creator" content="Stuart  Emanuel," /></meta><meta name="dc.Creator" content="Alan  DeAngelis," /></meta><meta name="dc.Creator" content="Yan  Zhang," /></meta><meta name="dc.Creator" content="Fengbin  Song," /></meta><meta name="dc.Creator" content="Lawrence  Beall," /></meta><meta name="dc.Creator" content="Peter J.  Connolly," /></meta><meta name="dc.Creator" content="Prahba  Karnachi," /></meta><meta name="dc.Creator" content="Xin  Chen," /></meta><meta name="dc.Creator" content="Robert H.  Gruninger," /></meta><meta name="dc.Creator" content="Jan  Sechler," /></meta><meta name="dc.Creator" content="Angel  Fuentes-Pesquera," /></meta><meta name="dc.Creator" content="Steven A.  Middleton," /></meta><meta name="dc.Creator" content="Linda  Jolliffe, and" /></meta><meta name="dc.Creator" content="William V.  Murray" /></meta><meta name="dc.Description" content="There is much evidence that direct inhibition of the kinase activity of vascular endothelial growth factor receptor-2 (VEGFR-2) will result in the reduction of angiogenesis and the suppression of t..." /></meta><meta name="Description" content="There is much evidence that direct inhibition of the kinase activity of vascular endothelial growth factor receptor-2 (VEGFR-2) will result in the reduction of angiogenesis and the suppression of t..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="June 24, 2005" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm058205b" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-48-15-4892" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(05)08205-1" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2005 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm058205b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm058205b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm058205b" /></link>
        
    
    

<title>Synthesis and Structure−Activity Relationships of Pyrazine-Pyridine Biheteroaryls as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm058205b" /></meta><meta property="og:title" content="Synthesis and Structure−Activity Relationships of Pyrazine-Pyridine Biheteroaryls as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bn00001.jpeg" /></meta><meta property="og:description" content=" There is much evidence that direct inhibition of the kinase activity of vascular endothelial growth factor receptor-2 (VEGFR-2) will result in the reduction of angiogenesis and the suppression of tumor growth. Palladium-catalyzed C−C bond, C−N bond formation reactions were used to assemble various pyrazine-pyridine biheteroaryls as potent VEGFR-2 inhibitors. Among them, 4-{5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol (39) and N-{5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N‘,N‘-dimethyl-ethane-1,2-diamine (41) exhibited the highest kinase selectivity against fibroblast growth factor receptor kinase, platelet-derived growth factor receptor kinase, and glycogen synthase kinase-3. All of these compounds showed good cellular potency to inhibit VEGF-stimulated proliferation of human umbilical vein endothelial cells (HUVEC) but with modest effects on the unstimulated growth of HUVEC. The low inhibition of these compounds to the growth of tumor cell lines, such as HeLa, HCT-116, and A375 further confirms that these VEGFR-2 inhibitors are not cytotoxic agents. The in vivo antitumor activity of 39 and 41 were demonstrated in the A375 human melanoma xenograft nude mice model. Molecular modeling (QSAR analysis) was conducted in an attempt to rationalize the observed structure−activity relationship.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm058205b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm058205b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm058205b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm058205b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm058205b&amp;href=/doi/10.1021/jm058205b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2005</span><span class="cit-fg-volume">, 48</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 4892-4909</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/48/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm050182d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm050221l" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Structure−Activity Relationships of Pyrazine-Pyridine Biheteroaryls as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gee-Hong++Kuo">Gee-Hong Kuo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Prouty">Catherine Prouty</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aihua++Wang">Aihua Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart++Emanuel">Stuart Emanuel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++DeAngelis">Alan DeAngelis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Zhang">Yan Zhang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fengbin++Song">Fengbin Song</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence++Beall">Lawrence Beall</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Connolly">Peter J. Connolly</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prahba++Karnachi">Prahba Karnachi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Chen">Xin Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+H.++Gruninger">Robert H. Gruninger</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Sechler">Jan Sechler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angel++Fuentes-Pesquera">Angel Fuentes-Pesquera</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+A.++Middleton">Steven A. Middleton</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linda++Jolliffe">Linda Jolliffe</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+V.++Murray">William V. Murray</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm058205b&amp;href=/doi/10.1021%2Fjm058205b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2005</span></span><span class="cit-volume">, 48</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 4892–4909</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 24, 2005</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 March 2005</li><li><span class="item_label"><b>Published</b> online</span>24 June 2005</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 July 2005</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm058205b" title="DOI URL">https://doi.org/10.1021/jm058205b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2005 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4892%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGee-Hong%2BKuo%252C%2BCatherine%2BProuty%252C%2BAihua%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D48%26issueNum%3D15%26contentID%3Djm058205b%26title%3DSynthesis%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BPyrazine-Pyridine%2BBiheteroaryls%2Bas%2BNovel%252C%2BPotent%252C%2Band%2BSelective%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4909%26publicationDate%3DJuly%2B2005">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm058205b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1800</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm058205b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Structure−Activity Relationships of Pyrazine-Pyridine Biheteroaryls as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gee-Hong&quot;,&quot;last_name&quot;:&quot;Kuo&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Prouty&quot;},{&quot;first_name&quot;:&quot;Aihua&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;Emanuel&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;DeAngelis&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Fengbin&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;Beall&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Connolly&quot;},{&quot;first_name&quot;:&quot;Prahba&quot;,&quot;last_name&quot;:&quot;Karnachi&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;H. Gruninger&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Sechler&quot;},{&quot;first_name&quot;:&quot;Angel&quot;,&quot;last_name&quot;:&quot;Fuentes-Pesquera&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;A. Middleton&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;Jolliffe&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;V. Murray&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2005&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;48&quot;,&quot;pages&quot;:&quot;4892-4909&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm058205b&quot;},&quot;abstract&quot;:&quot;There is much evidence that direct inhibition of the kinase activity of vascular endothelial growth factor receptor-2 (VEGFR-2) will result in the reduction of angiogenesis and the suppression of tumor growth. Palladium-catalyzed C−C bond, C−N bond formation reactions were used to assemble various pyrazine-pyridine biheteroaryls as potent VEGFR-2 inhibitors. Among them, 4-{5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol (39) and N-{5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-N‘,N‘-dimethyl-ethane-1,2-diamine (41) exhibited the highest kinase selectivity against fibroblast growth factor receptor kinase, platelet-derived growth factor receptor kinase, and glycogen synthase kinase-3. All of these compounds showed good cellular potency to inhibit VEGF-stimulated proliferation of human umbilical vein endothelial cells (HUVEC) but with modest effects on the unstimulated growth of HUVEC. The low inhibition of these compounds to the growth of tumor cell lines, such as HeLa, HCT-116&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm058205b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058205b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm058205b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058205b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm058205b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058205b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm058205b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm058205b&amp;href=/doi/10.1021/jm058205b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm058205b" /></input><a href="/doi/pdf/10.1021/jm058205b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (484 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm058205b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm058205b%26sid%3Dliteratum%253Aachs%26pmid%3D16033269%26genre%3Darticle%26aulast%3DKuo%26date%3D2005%26atitle%3DSynthesis%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BPyrazine-Pyridine%2BBiheteroaryls%2Bas%2BNovel%252C%2BPotent%252C%2Band%2BSelective%2BVascular%2BEndothelial%2BGrowth%2BFactor%2BReceptor-2%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D48%26issue%3D15%26spage%3D4892%26epage%3D4909%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/48/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There is much evidence that direct inhibition of the kinase activity of vascular endothelial growth factor receptor-2 (VEGFR-2) will result in the reduction of angiogenesis and the suppression of tumor growth. Palladium-catalyzed C−C bond, C−N bond formation reactions were used to assemble various pyrazine-pyridine biheteroaryls as potent VEGFR-2 inhibitors. Among them, 4-{5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol (<b>39</b>) and <i>N</i>-{5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-<i>N</i>‘,<i>N</i>‘-dimethyl-ethane-1,2-diamine (<b>41</b>) exhibited the highest kinase selectivity against fibroblast growth factor receptor kinase, platelet-derived growth factor receptor kinase, and glycogen synthase kinase-3. All of these compounds showed good cellular potency to inhibit VEGF-stimulated proliferation of human umbilical vein endothelial cells (HUVEC) but with modest effects on the unstimulated growth of HUVEC. The low inhibition of these compounds to the growth of tumor cell lines, such as HeLa, HCT-116, and A375 further confirms that these VEGFR-2 inhibitors are not cytotoxic agents. The in vivo antitumor activity of <b>39</b> and <b>41</b> were demonstrated in the A375 human melanoma xenograft nude mice model. Molecular modeling (QSAR analysis) was conducted in an attempt to rationalize the observed structure−activity relationship. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm058205bAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Tel:  908-704-4330. Fax:  908-203-8109. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="bbdcd0ced4fbcbc9dfcec895d1d5d195d8d4d695">[email protected]</a></p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Angiogenesis, the formation of new capillaries from preexisting blood vessels,<sup><a onclick="showRef(event, 'jm058205bb00001'); return false;" href="javascript:void(0);" class="ref jm058205bb00001">1</a></sup> is a necessary process for organ development during embryogenesis and is critical for the female reproductive cycle, inflammation, and wound healing in the adult.<sup><a onclick="showRef(event, 'jm058205bb00002'); return false;" href="javascript:void(0);" class="ref jm058205bb00002">2</a></sup> Pathological angiogenesis is associated with disease states such as cancer,<sup><a onclick="showRef(event, 'jm058205bb00003'); return false;" href="javascript:void(0);" class="ref jm058205bb00003">3</a></sup> diabetic retinopathy,<sup><a onclick="showRef(event, 'jm058205bb00004'); return false;" href="javascript:void(0);" class="ref jm058205bb00004">4</a></sup> rheumatoid arthritis,<sup><a onclick="showRef(event, 'jm058205bb00005'); return false;" href="javascript:void(0);" class="ref jm058205bb00005">5</a></sup> endometriosis,<sup><a onclick="showRef(event, 'jm058205bb00006'); return false;" href="javascript:void(0);" class="ref jm058205bb00006">6</a></sup> and psoriasis.<sup><a onclick="showRef(event, 'jm058205bb00007'); return false;" href="javascript:void(0);" class="ref jm058205bb00007">7</a></sup> Solid tumors, in particular, are dependent on angiogenesis to grow beyond a certain critical size by inducing new capillaries sprouting from existing blood vessels to secure their nutrition, oxygen supply, and waste removal.<sup><a onclick="showRef(event, 'jm058205bb00008'); return false;" href="javascript:void(0);" class="ref jm058205bb00008">3,8</a></sup> In addition, angiogenesis also promotes metastasis of tumor cells to other sites.<sup><a onclick="showRef(event, 'jm058205bb00009'); return false;" href="javascript:void(0);" class="ref jm058205bb00009">9</a></sup></div><div class="NLM_p">The new vessel growth and maturation are highly complex and coordinated processes, requiring the stimulation by a number of growth factors,<sup><a onclick="showRef(event, 'jm058205bb00010'); return false;" href="javascript:void(0);" class="ref jm058205bb00010">10</a></sup> but vascular endothelial growth factor (VEGF) signaling often represents a critical rate-limiting step in physiological angiogenesis and pathological angiogenesis.<sup><a onclick="showRef(event, 'jm058205bb00011'); return false;" href="javascript:void(0);" class="ref jm058205bb00011">11</a></sup> The biological effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 (Flt-1)<sup><a onclick="showRef(event, 'jm058205bb00012'); return false;" href="javascript:void(0);" class="ref jm058205bb00012">12</a></sup> and VEGFR-2 [also known as kinase domain region (KDR) or Flk-1].<sup><a onclick="showRef(event, 'jm058205bb00013'); return false;" href="javascript:void(0);" class="ref jm058205bb00013">13</a></sup> While the precise function of VEGFR-1 is still under debate,<sup><a onclick="showRef(event, 'jm058205bb00014'); return false;" href="javascript:void(0);" class="ref jm058205bb00014">14</a></sup> there is much evidence that VEGFR-2 is the major mediator of vascular endothelial cell (EC) mitogenesis and survival, as well as angiogenesis and microvascular permeability.<sup>14</sup> Therefore, it is expected that direct inhibition of the kinase activity of VEGFR-2 will result in the reduction of angiogenesis and the suppression of tumor growth. Furthermore, inhibition of VEGFR-2 targeting the genetically more stable host ECs instead of labile tumor tissues may decrease the chance of resistance development.<sup><a onclick="showRef(event, 'jm058205bb00015'); return false;" href="javascript:void(0);" class="ref jm058205bb00015">15</a></sup></div><div class="NLM_p">A number of VEGF inhibitors are currently undergoing clinical trials in advanced stage for the treatment of cancer, including a humanized monoclonal antibody to VEGF (bevacizumab/rhuMab VEGF),<sup><a onclick="showRef(event, 'jm058205bb00016'); return false;" href="javascript:void(0);" class="ref jm058205bb00016">16</a></sup> an anti-VEGFR-2 antibody,<sup><a onclick="showRef(event, 'jm058205bb00017'); return false;" href="javascript:void(0);" class="ref jm058205bb00017">17</a></sup> a soluble VEGF receptor,<sup><a onclick="showRef(event, 'jm058205bb00018'); return false;" href="javascript:void(0);" class="ref jm058205bb00018">18</a></sup> and several small-molecule VEGFR-2 inhibitors (PTK787/vatalanib <b>80</b>,<sup><a onclick="showRef(event, 'jm058205bb00019'); return false;" href="javascript:void(0);" class="ref jm058205bb00019">19</a></sup> SU-11248 <b>81</b>,<sup><a onclick="showRef(event, 'jm058205bb00020'); return false;" href="javascript:void(0);" class="ref jm058205bb00020">20</a></sup> SU-6668 <b>82</b>,<sup><a onclick="showRef(event, 'jm058205bb00021'); return false;" href="javascript:void(0);" class="ref jm058205bb00021">21</a></sup> and ZD-6474 <b>83</b>,<sup><a onclick="showRef(event, 'jm058205bb00022'); return false;" href="javascript:void(0);" class="ref jm058205bb00022">22</a></sup> Scheme 1<a data-tab="pane-pcw-Figures" href="#jm058205bh00001" id="" class=" internalNav"></a>). Among them, bevacizumab in combination with chemotherapy<sup><a onclick="showRef(event, 'jm058205bb00023'); return false;" href="javascript:void(0);" class="ref jm058205bb00023">16,23</a></sup> was accepted by FDA in 2003 for the treatment of first-line metastatic colorectal cancer. This first proof-of-concept example will certainly warrant the development of many more small-molecule VEGF inhibitors<sup><a onclick="showRef(event, 'jm058205bb00024'); return false;" href="javascript:void(0);" class="ref jm058205bb00024">24</a></sup> for anti-angiogenesis therapy. <div id="_i4"><figure id="jm058205bh00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Scheme 1  </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">In an attempt to identify a potent and selective cyclin-dependent kinase-1 (CDK1) inhibitor, we unexpectedly discovered a pyrazine-pyridine scaffold, with 1,3-substitution-orientation at both upper and lower rings (Scheme 1, Targets I), exhibiting high inhibitory potency at VEGFR-2.<sup><a onclick="showRef(event, 'jm058205bb00025'); return false;" href="javascript:void(0);" class="ref jm058205bb00025">25</a></sup> This article describes our continued efforts in the structure−activity relationships (SAR) studies and toward the identification of pyrazine-pyridine biheteroaryls as potent and selective VEGFR-2 inhibitors. The in vivo antitumor activity in mice model was also demonstrated. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a name="jm004801504893" id="jm004801504893"></a>The 3,3‘-disubstituted pyrazine-pyridine targets II (Scheme 1) were assembled based upon three key steps:  (1) a palladium-catalyzed Stille reaction<sup><a onclick="showRef(event, 'jm058205bb00026'); return false;" href="javascript:void(0);" class="ref jm058205bb00026">26</a></sup> to form the C−C bond that connected the pyrazine ring and pyridine ring, (2) a palladium-catalyzed cross-coupling reaction to form the C−N bond<sup>27a</sup> or C−O bond<sup>27b</sup> that installed the substituent on the pyrazine ring, (3) a Curtius rearrangement<sup>28</sup> to form the C−N bond that introduced the substituent on the pyridine ring. </div><div class="NLM_p">For example, a Stille coupling reaction of organo-stannane <b>2</b> with 2,6-dichloropyrazine catalyzed by Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub><sup>29</sup> gave <b>3</b> (Scheme 2<a data-tab="pane-pcw-Figures" href="#jm058205bh00002" id="" class=" internalNav"></a>). The organo-stannane <b>2</b> was prepared by the palladium-catalyzed transformation from the organo-bromide <b>1</b>.<sup>30</sup> The palladium-catalyzed amination reaction of <b>3</b> with 3-chloroaniline in the presence of DPPF<sup>31</sup> as the ligand generated <b>4</b>. Boc-protection, base hydrolysis, followed by Curtius rearrangement provided <b>6.</b> Alkylation of <b>6</b> with (3-bromopropoxy)-<i>t-</i>butyl-dimethylsilane, followed by TFA deprotection, gave the first target molecule <b>7</b> (Scheme 2, Table 1<a class="ref showTableEvent internalNav" data-ID="jm058205bt00001" href="#jm058205bt00001"></a>). Replacing 3-chloroaniline with 3-fluoroaniline (3-methoxyaniline or 2-chloroaniline), following the same procedure as in the preparation of <b>7</b> gave <b>11</b><a name="jm004801504894" id="jm004801504894"></a> (<b>15 </b>or<b> 19</b>). On the other hand, alkylation of <b>6</b> with 4-(3-chloropropyl)pyridine followed by TFA deprotection gave target molecule <b>20</b> (Scheme 2, Table 1). The pyridine analogues, <b>24</b> and <b>28</b>, were both prepared in the similar way as that of <b>20</b>. Meanwhile, alkylation of <b>6 </b>with diverse halides, followed by TFA deprotection, provided target molecules <b>38</b>−<b>41 </b>and <b>50</b>−<b>62</b> (Scheme 2, Table 2<a class="ref showTableEvent internalNav" data-ID="jm058205bt00002" href="#jm058205bt00002"></a>). <div id="_i7"><figure id="jm058205bh00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00002.jpeg" id="_i8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) [(<i>n</i>-Bu)<sub>3</sub>Sn]<sub>2</sub>, Pd(OAc)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, 100 °C; (ii) 2,6-dichloropyrazine, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, LiCl, 100 °C; (iii) substituted aniline, Pd<sub>2</sub>(dba)<sub>3</sub>, DPPF, Cs<sub>2</sub>CO<sub>3</sub>, 110 °C; (iv) (a) Boc<sub>2</sub>O, DMAP, (b) NaOH, 0−20 °C; (v) DPPA, Et<sub>3</sub>N, <i>t-</i>BuOH, 65−100 °C; (vi) (a) X(CH<sub>2</sub>)<i><sub>n</sub></i>R<sup>1</sup>, Cs<sub>2</sub>CO<sub>3</sub>, 70 °C, (b) TFA.  </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm058205bt00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Binding Affinities at CDK1 and VEGFR-2<i><sup>a</sup></i><sup></sup><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bu00001a.gif" alt="" id="_i9" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50 </sub>± SEM<i><sup>b</sup></i><sup></sup> (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">N</td><td class="colsep2 rowsep2">Y</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">CDK1</td><td class="colsep2 rowsep2">VEGFR-2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.084 ± 0.014 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>11</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">3-F </td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.168 ± 0.002 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>15</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">3-OCH<sub>3</sub></td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.740 ± 0.070 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">2-Cl </td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">1.010 ± 0.300 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">4-pyridine </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.076 ± 0.024 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">4-Cl </td><td class="colsep2 rowsep2">4-pyridine </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">1.0 ± 0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">3,4-Cl<sub>2</sub></td><td class="colsep2 rowsep2">4-pyridine </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.189 ± 0.080 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32</b></td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">1.05 ± 0.18 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>36</b></td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">3-Cl </td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Assay details were described in Experimental Section.<i><sup>b</sup></i><sup></sup> SEM:  standard error mean.</p></div></div><div class="NLM_table-wrap" id="jm058205bt00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Binding Affinities at CDK1 and VEGFR-2<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bu00002a.gif" alt="" id="_i10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Assay details were described in Experimental Section.  </p></div></div></div><div class="NLM_p">The palladium-catalyzed amination of <b>3</b> with benzylamine was conducted using the same reaction conditions as with substituted anilines to give <b>29</b> in 28% yield (Scheme 3<a data-tab="pane-pcw-Figures" href="#jm058205bh00003" id="" class=" internalNav"></a>). Boc-protection, base hydrolysis, followed by Curtius rearrangement, alkylation, and deprotection gave the target molecule <b>32 </b>(Scheme 3, Table 1). Under the same palladium-catalyzed reaction conditions, C−O bond formation between <b>3</b> and 3-chlorophenol was accomplished to give <b>33</b> in modest yield (27%). Following the same reaction sequence as for the preparation of <b>32</b>, diaryl-ether analogue <b>36</b> was obtained (Scheme 3, Table 1). <div id="_i11"><figure id="jm058205bh00003" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00003.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Benzylamine (or 3-chlorophenol), Pd<sub>2</sub>(dba)<sub>3</sub>, DPPF, Cs<sub>2</sub>CO<sub>3</sub>, 110 °C; (ii) (a) Boc<sub>2</sub>O, DMAP, (b) NaOH, 0−20 °C (or NaOH, 0−20 °C); (iii) DPPA, Et<sub>3</sub>N, <i>t-</i>BuOH, 65−100 °C; (iv) (a) Br(CH<sub>2</sub>)<sub>3</sub>OTBS, Cs<sub>2</sub>CO<sub>3</sub>, 70 °C, (b) TFA.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The syntheses of amide and reversed-amide series were shown in Scheme 4<a data-tab="pane-pcw-Figures" href="#jm058205bh00004" id="" class=" internalNav"></a>. HATU-promoted amide bond formation of <b>5</b> with various amines gave <b>42 </b>and <b>43</b> (Scheme 4, Table 2). Alkylation of <b>6</b> with substituted acetyl chlorides followed by TFA deprotection generated target molecules <b>44</b>−<b>49</b> (Scheme 4, Table 2). <div id="_i13"><figure id="jm058205bh00004" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00004.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (a) NH<sub>2</sub>(CH<sub>2</sub>)<i><sub>n</sub></i>R, DIPA, HATU, 20 °C, (b) TFA; (ii) (a) 60% NaH, R<sup>1</sup>COCl, 20 °C, (b) TFA.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">The synthesis of the fluoro-pyridine <b>70</b> was shown in Scheme 5<a data-tab="pane-pcw-Figures" href="#jm058205bh00005" id="" class=" internalNav"></a>. Bromination followed by Curtius rearrangement of pyridine <b>63</b> gave <b>64</b>. Alkylation of <b>64</b> gave <b>65</b>, and reaction of <b>65</b> with NOBF<sub>4</sub> gave 3-bromo-2-fluoro-pyridine <b>66</b> in 62% yield. Converting the bromide <b>66</b> to the organo-stannane <b>67</b> followed by Stille coupling of <b>67</b> with <b>68</b> afforded <b>69</b>. Removal of the Cbz-, Boc-, and TBDPS-protecting groups of <b>69</b> gave the fluoro-pyridine <b>70</b>. The synthesis of the chloro-pyridine <b>76</b> was shown in Scheme 6<a data-tab="pane-pcw-Figures" href="#jm058205bh00006" id="" class=" internalNav"></a>. Bromination of <b>71</b> followed by reaction with POCl<sub>3</sub> gave <b>72</b>. Curtius rearrangement of <b>72 </b>gave <b>73</b>; alkylation of <b>73</b> followed by palladium-catalyzed transformation gave organo-stannane <b>75</b>. Stille coupling of <b>75</b> with <b>68</b> gave the target molecule <b>76</b>. The amino-pyridine <b>79</b> was prepared with a method similar to that of <b>70</b> as shown in Scheme 5. <div id="_i15"><figure id="jm058205bh00005" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00005.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (a) Br<sub>2</sub>, H<sub>2</sub>O, (b) DPPA, Et<sub>3</sub>N, PhCH<sub>2</sub>OH; (ii) Br(CH<sub>2</sub>)<sub>3</sub>OTBDPS, Cs<sub>2</sub>CO<sub>3</sub>; (iii) NOBF<sub>4</sub>; (iv) Pd(PPh<sub>3</sub>)<sub>4</sub>, Me<sub>6</sub>Sn<sub>2</sub>, LiCl, BHT; (v) <b>68</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, LiCl; (vi) (a) H<sub>2</sub>, 10%Pd/C, (b) TFA, CH<sub>3</sub>SO<sub>3</sub>H.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058205bh00006" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00006.jpeg" id="_i17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (a) Br<sub>2</sub>, H<sub>2</sub>O, (b) POCl<sub>3</sub>, quinoline; (ii) DPPA, Et<sub>3</sub>N, <i>t</i>-BuOH; (iii) Br(CH<sub>2</sub>)<sub>3</sub>OH, Cs<sub>2</sub>CO<sub>3</sub>; (iv) Pd(PPh<sub>3</sub>)<sub>4</sub>, Me<sub>6</sub>Sn<sub>2</sub>, LiCl, BHT; (v) <b>68</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, LiCl.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Lead Optimization.</b> With 3-chloroanilino-pyrazine-pyridine-biheteroaryl <b>7</b><sup>25</sup> as the VEGFR-2 lead molecule in hand (IC<sub>50</sub> = 0.084 μM, Table 1), we first examined the binding affinities of other substituents at the upper-right position. While a smaller 3-fluoroanilino-pyrazine <b>11</b> (IC<sub>50</sub> = 0.168 μM) reduced the binding affinity about 2-fold, the sterically bulkier 3-methoxyanilino-pyrazine <b>15</b> (IC<sub>50</sub> = 0.74 μM) decreased the binding affinity almost 10-fold. Replacing the 3-chloroaniline of <b>7</b> with 2-chloroaniline reduced the potency about 12-fold (<b>19</b>, IC<sub>50</sub> = 1.01 μM). In a parallel study, we found out that replacing the hydroxyl group in the lower side chain of <b>7</b> with a 4-pyridine ring gave compound <b>20</b> with comparable potency (IC<sub>50</sub> = 0.076 μM). We thus synthesized two other analogues in compound <b>20</b> series in <a name="jm004801504895" id="jm004801504895"></a> comparison to compound <b>7</b> series. Replacing the 3-chloroaniline of <b>20</b> with 4-chloroaniline reduced the potency about 13-fold (<b>24</b>, IC<sub>50</sub> = 1.0 μM). On the other hand, replacement of the 3-chloroaniline of <b>20</b> with 3,4-dichloroaniline only decreased the potency about 2-fold (<b>28</b>, IC<sub>50</sub> = 0.189 μM). These examples suggested that 3-chloro-substitution seems to be highly favorable to the binding affinity. In addition, replacement of the 3-chloroaniline of <b>7</b> with a benzylamine group also resulted in 13-fold lower potency (<b>32</b>, IC<sub>50</sub> = 1.05 μM). Converting the 3-chloroaniline of <b>7</b> to a 3-chlorophenol moiety totally abolished the potency (<b>36</b>, IC<sub>50</sub> >10 μM). These two examples further demonstrated the important contributions of 3-chloroaniline in the upper-right position to the inhibitory potency at VEGFR-2. Meanwhile, all of these compounds showed poor inhibition at CDK1 (IC<sub>50</sub> >10 μM). </div><div class="NLM_p">We next turned our attentions to the binding affinities of substituents at the lower-right position. Removal of the hydroxypropyl side chain of <b>7</b> gave <b>37</b> with 14-fold reduced potency (<b>37</b>, IC<sub>50</sub> = 1.16 μM, Table 2). Shortening the three-carbon side chain of <b>7</b> to a two-carbon side chain gave a 3-fold less potent compound (<b>38</b>, IC<sub>50</sub> = 0.275 μM). Extending the three-carbon side chain to a four-carbon-chain provided a slightly more potent analogue (<b>39</b>, IC<sub>50</sub> = 0.063 μM). Replacing the hydroxyl group of <b>7</b> with a dimethylamino group generated <b>40</b> with moderately lower potency (<b>40</b>, IC<sub>50</sub> = 0.135 μM). Interestingly, shortening the three-carbon side chain of dimethylamino compound <b>40 </b>to a two-carbon-chain analogue regained some of the potency (<b>41</b>, IC<sub>50</sub> = 0.105 μM). </div><div class="NLM_p">With no dramatic improvement in potency observed in amino side chain series (<b>38</b>−<b>41</b>), we decided to <a name="jm004801504896" id="jm004801504896"></a> explore the potency of the amide side chain series. Insertion of a carbonyl group between the biheteroaryl and the amino side chain of <b>41</b> or <b>7</b> gave the corresponding amide <b>42</b> (IC<sub>50</sub> = 4.3 μM) or amide <b>43</b> (IC<sub>50</sub> = 2.38 μM). The 41- and 28-fold decreased potencies of amide <b>42 </b>(versus amine <b>41</b>) and amide <b>43</b> (versus amine <b>7</b>) might suggest the importance of a direct attachment of a NH moiety of the side chain to the biheteroaryl to the binding affinity. </div><div class="NLM_p">Upon the basis of these observations, we felt the reversed-amide side chain series, with direct attachment of the NH moiety to the biheteroaryl, might be still worthy of investigation. We thus replaced one of the methylene units of <b>38</b> with a carbonyl group to generate reversed-amide <b>44</b>. Indeed, no dramatic loss of potency of <b>44</b> (IC<sub>50</sub> = 0.346 μM) was observed when compared to the amine <b>38</b> (IC<sub>50</sub> = 0.275 μM). Increasing the length of the side chain of <b>44</b> by adding one methylene unit to the hydroxyl end gave compound <b>45</b> (IC<sub>50</sub> = 0.303 μM) with slightly better potency. Further increasing the chain length of <b>45</b> by adding another methylene unit to the center of the side chain gave compound <b>46</b> (IC<sub>50</sub> = 0.593 μM) with 2-fold lower potency. We next examined the impact of an additional aromatic ring on the binding affinity. Replacement of the methoxy group of <b>45</b> with the benzyloxy group totally abolished the potency (<b>47</b>, IC<sub>50</sub> >10 μM). Shortening the chain length by removing one methylene or two methylene units did not restore any potency (<b>48</b> and <b>49</b>, IC<sub>50</sub> >10 μM). It seems that the installation of a phenyl group was detrimental to the binding affinity. </div><div class="NLM_p">Since lower potencies were observed in both the amide and the reversed-amide series, we decided to revisit the amine side chain series. Incorporation of piperazine, morpholine, piperidine, and tetrahydropyran heterocycles to the side chain provided compounds <b>50</b>−<b>54</b> with IC<sub>50</sub>'s ranging from 0.123 to 0.399 μM. On the other hand, we were pleased to find out that the incorporation of pyridine, pyrazole, and triazole heteroaryls to the side chain led to compounds <b>20</b> and <b>56</b>−<b>58</b> with good potency (<b>20</b>, IC<sub>50</sub> = 0.076 μM; <b>56</b>, IC<sub>50</sub> = 0.076 μM; <b>57</b>, IC<sub>50</sub> = 0.094 μM; <b>58</b>, IC<sub>50</sub> = 0.067 μM), although the four-carbon-chain analogue (<b>55</b>, IC<sub>50</sub> = 0.266 μM) was less favorable than the three-carbon-chain analogue (<b>20</b>, IC<sub>50</sub> = 0.076 μM). These results were particularly surprising considering the detrimental effect of phenyl incorporation in reversed-amide series, as shown in <b>47</b>−<b>49</b> (IC<sub>50</sub> >10 μM). To confirm that the poor potencies of <b>47</b>−<b>49</b> were due to the phenyl group but not to the reversed-amide moiety, we synthesized compounds <b>59</b> and <b>60</b>. Indeed, the poor potency of <b>59</b> (IC<sub>50</sub> = 2.277 μM) and <b>60</b> (IC<sub>50</sub> >10 μM) in the amine series further demonstrated that the phenyl ring, but not the heteroaryl ring, was unfavorable to the inhibition at VEGFR-2. Replacement of the hydroxyl group of <b>7</b> with carboxyl or carboxyamide gave <b>61</b> (IC<sub>50</sub> = 0.568 μM) or <b>62</b> (IC<sub>50</sub> = 0.61 μM) with 7-fold lower potency. All of the compounds prepared in Table 2 exhibit poor potency against CDK1. </div><div class="NLM_p last">Up to this point, our studies suggested that the NH unit of the lower side chain is critical to the binding affinity and might, potentially, serve as a hydrogen-bond donor site. Therefore, we attempted to adjust the hydrogen-bond donor capability of the NH moiety and thus the binding affinity of the molecule by increasing or decreasing the electron density in the pyridine ring. However, installation of an electron-withdrawing fluorine atom in the pyridine ring at the para position relative to the amino side chain gave compound <b>70</b> with 3-fold lower potency (IC<sub>50</sub> = 0.251 μM, Table 3<a class="ref showTableEvent internalNav" data-ID="jm058205bt00003" href="#jm058205bt00003"></a>) than compound <b>7</b> (IC<sub>50</sub> = 0.084 μM). Incorporation of an electron-donating amino group even further reduced the inhibitory potency to micromolar range (<b>79</b>, IC<sub>50</sub> = 1.36 μM). Replacement of the fluorine atom with an “electron neutral” but sterically bulkier chlorine atom totally abolished the potency (<b>76</b>, IC<sub>50</sub> >10 μM). It appears that the hydrogen atom may still be the most favorable atom at this position. <div class="NLM_table-wrap" id="jm058205bt00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Binding Affinities at CDK1 and VEGFR-2<i><sup>a</sup></i><sup></sup><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bu00003a.gif" alt="" id="_i19" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="2">IC<sub>50</sub> ± SEM (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd</td><td class="colsep2 rowsep2">R</td><td class="colsep2 rowsep2">CDK1</td><td class="colsep2 rowsep2">VEGFR-2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>70</b></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.251 ± 0.110 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>76</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>79</b></td><td class="colsep2 rowsep2">NH<sub>2</sub></td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">1.36 ± 0.65</td></tr></tbody></table></div></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Kinase Selectivity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We next examined the selectivity of the most potent compounds in each subseries against a representative panel of kinases (Table 4<a class="ref showTableEvent internalNav" data-ID="jm058205bt00004" href="#jm058205bt00004"></a>). First, in the hydroxyalkyl-amino series, while the three-carbon-chain biheteroaryl <b>7</b> (VEGFR-2, IC<sub>50</sub> = 0.084 μM) showed very modest selectivity (2−6-fold) against fibroblast growth factor receptor kinase (FGFR-2, IC<sub>50</sub> = 0.21 μM), platelet-derived growth factor receptor kinase (PDGF-R, IC<sub>50</sub> = 0.36 μM), and glycogen synthase kinase-3 (GSK-3, IC<sub>50</sub> = 0.478 μM), it exhibited more than 1 order of magnitude of selectivity against epidermal growth factor receptor (EGFR, IC<sub>50</sub> = 1.36 μM) and insulin-R kinase (IC<sub>50</sub> = 1.69 μM). On the other hand, the four-carbon-chain analogue <b>39</b> (VEGFR-2, IC<sub>50</sub> = 0.063 μM) exhibited more than 1 order of magnitude of selectivity <a name="jm004801504897" id="jm004801504897"></a> against FGFR-2 (IC<sub>50</sub> = 2.36 μM), PDGF-R (IC<sub>50</sub> = 2.8 μM), and GSK-3 (IC<sub>50</sub> = 4.02 μM), while it displayed more than 2 orders of magnitude of selectivity against EGFR (IC<sub>50</sub> = 7.4 μM) and insulin-R kinase (IC<sub>50</sub> >10 μM). Meanwhile, both compound <b>7 </b>and compound<b> 39</b> exhibited at least 2 orders of magnitude of selectivity against calmodulin kinase 2, casein kinase-1 or -2, CDK1, CDK4, mitogen-activated protein kinase (MAPK), protein kinase A (PKA), PKCβ2, and PKCγ (IC<sub>50</sub> >10 μM). <div class="NLM_table-wrap" id="jm058205bt00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  IC<sub>50</sub> (μM) at Selected Kinase Assays<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">kinase assay</td><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2"><b>56</b></td><td class="colsep2 rowsep2"><b>57</b></td><td class="colsep2 rowsep2"><b>58</b></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">VEGFR-2 </td><td class="colsep2 rowsep2">0.084 </td><td class="colsep2 rowsep2">0.063 </td><td class="colsep2 rowsep2">0.105 </td><td class="colsep2 rowsep2">0.076 </td><td class="colsep2 rowsep2">0.094 </td><td class="colsep2 rowsep2">0.067 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">calmodulin kinase-2 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">casein kinase-1 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">5.6 </td><td class="colsep2 rowsep2">6.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">casein kinase-2 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">8.1 </td><td class="colsep2 rowsep2">7.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">CDK1 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">CDK4 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">ND<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">EGFR </td><td class="colsep2 rowsep2">1.36 </td><td class="colsep2 rowsep2">7.4 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">FGFR-2 </td><td class="colsep2 rowsep2">0.21 </td><td class="colsep2 rowsep2">2.36 </td><td class="colsep2 rowsep2">1.40 </td><td class="colsep2 rowsep2">0.293 </td><td class="colsep2 rowsep2">0.326 </td><td class="colsep2 rowsep2">0.153 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">GSK-3 </td><td class="colsep2 rowsep2">0.478 </td><td class="colsep2 rowsep2">4.02 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.318 </td><td class="colsep2 rowsep2">0.606 </td><td class="colsep2 rowsep2">0.196 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">insulin R kinase </td><td class="colsep2 rowsep2">1.69 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">MAPK </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PDGF-R </td><td class="colsep2 rowsep2">0.36 </td><td class="colsep2 rowsep2">2.8 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">0.876 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">0.725 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKA </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKCβ2 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">ND </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PKCγ </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">3.96 </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">ND </td><td class="colsep2 rowsep2">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Assay details were described in Experimental Section. IC<sub>50</sub> values were reported as the average of at least two separate determinations.<i><sup>b</sup></i><sup></sup> ND:<sup></sup>IC<sub>50</sub> not determined because less than 50% inhibition was observed at 10 μM concentration of the compounds tested.</p></div></div></div><div class="NLM_p">Second, in the dimethylaminoalkyl-amino series, the two-carbon-chain biheteroaryl <b>41</b> (VEGFR-2, IC<sub>50</sub> = 0.105 μM) showed more than 1 order of magnitude of selectivity against FGFR-2 (IC<sub>50</sub> = 1.4 μM) and PKCγ (IC<sub>50</sub> = 3.96 μM), meanwhile, it displayed at least 2 orders of magnitude of selectivity against the remaining 12 kinases (IC<sub>50</sub> >10 μM). Third, in the six-membered heteroarylalkyl-amino series, the three-carbon-chain biheteroaryl <b>56</b> (VEGFR-2, IC<sub>50</sub> = 0.076 μM) exhibited very modest selectivity (4−12-fold) against FGFR-2 (IC<sub>50</sub> = 0.293 μM), GSK-3 (IC<sub>50</sub> = 0.318 μM), and PDGF-R (IC<sub>50</sub> = 0.876 μM), while it displayed at least 2 orders of magnitude of selectivity against the remaining 11 kinases (IC<sub>50</sub> > 10 μM). Fourth, in the five-membered heteroarylalkyl-amino series, both of the three-carbon-chain biheteroaryls <b>57</b> and <b>58</b> exhibited very modest selectivity (2−18-fold) against FGFR-2, GSK-3, and PDGF-R, while both compounds displayed a more than 60-fold selectivity against casein kinase-1 and -2. Meanwhile, both compounds exhibited at least 2 orders of magnitude of selectivity against the remaining nine kinases (Table 4). </div><div class="NLM_p last">FGFR-2 and PDGF-R have been implicated indirectly in inducing VEGF secretion and hence angiogenesis.<sup>32</sup> ST1-571 (Gleevec) is a potent PDGF-R inhibitor and a v-Abl inhibitor. It has been approved recently for the treatment of chronic myeloid leukemia and KIT-positive metastatic malignant gastrointestinal stromal tumors and is under investigation in the treatment of glioblastomas, which exploits its PDGFR inhibitory activity.<sup>33</sup> Therefore, although we were targeting the VEGFR inhibition, the very modest selectivity of several of these compounds against FGFR-2 and PDGF-R may not be undesirable. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Cellular Selectivity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52151" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52151" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cellular activity of the compound was tested for its ability to inhibit VEGF-stimulated proliferation of human umbilical vein endothelial cells (HUVEC). In hydroxyalkyl-amino series, while the three-carbon-chain biheteroaryl <b>7</b> exhibited submicromolar cellular potency (IC<sub>50</sub> = 0.164 μM, Table 5<a class="ref showTableEvent internalNav" data-ID="jm058205bt00005" href="#jm058205bt00005"></a>) for inhibiting VEGF-stimulated proliferation, it only displayed a modest effect on the unstimulated growth of HUVEC (IC<sub>50</sub> = 1.68 μM). The 10-fold difference in potency of compound <b>7</b> for inhibition of VEGF-stimulated versus unstimulated growth of HUVEC may suggest its specificity of action through inhibition of VEGFR signal transduction. Meanwhile, the four-carbon-chain analogue <b>39</b> also exhibited high cellular potency (IC<sub>50</sub> = 0.063 μM) for inhibiting VEGF-stimulated proliferation, and therefore it displayed around 20-fold of selectivity against unstimulated growth of HUVEC (IC<sub>50</sub> = 1.17 μM). Interestingly, compound <b>39</b> demonstrated consistently higher cellular selectivity and higher kinase selectivity than compound <b>7</b>. In addition, both compound <b>7</b> and compound <b>39</b> displayed very minimal inhibition of proliferation in two normal human cell types, human aortic smooth muscle cells (HASMC, IC<sub>50</sub> = 3.87 μM for <b>7</b> and IC<sub>50</sub> = 3.23 μM for <b>39</b>), and MRC5 lung fibroblasts (IC<sub>50</sub> = 6.6 μM for <b>7</b> and IC<sub>50</sub> = 3.61 μM for <b>39</b>). These data further indicate the high cellular selectivity of both compound<b> 7 </b>and compound <b>39 </b>in VEGF-mediated processes. <div class="NLM_table-wrap" id="jm058205bt00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  IC<sub>50</sub> for Inhibition of Cell Proliferation<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="6">IC<sub>50</sub> (μM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cell line</td><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2"><b>56</b></td><td class="colsep2 rowsep2"><b>57</b></td><td class="colsep2 rowsep2"><b>58</b></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">VEGF-stimulated HUVEC </td><td class="colsep2 rowsep2">0.164 ± 0.033 </td><td class="colsep2 rowsep2">0.063 ± 0.033 </td><td class="colsep2 rowsep2">0.059 ± 0.005 </td><td class="colsep2 rowsep2">0.086 ± 0.008 </td><td class="colsep2 rowsep2">0.120 ± 0.027 </td><td class="colsep2 rowsep2">0.057 ± 0.014 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">HUVEC </td><td class="colsep2 rowsep2">1.68 ± 0.15 </td><td class="colsep2 rowsep2">1.17 ± 0.37 </td><td class="colsep2 rowsep2">0.877 ± 0.056 </td><td class="colsep2 rowsep2">1.67 ± 0.16 </td><td class="colsep2 rowsep2">1.39 ± 0.33 </td><td class="colsep2 rowsep2">1.07 ± 0.05 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">HASMC </td><td class="colsep2 rowsep2">3.87 ± 0.17 </td><td class="colsep2 rowsep2">3.23 ± 0.16 </td><td class="colsep2 rowsep2">2.77 ± 0.06 </td><td class="colsep2 rowsep2">6.15 ± 0.31 </td><td class="colsep2 rowsep2">3.00 ± 0.08 </td><td class="colsep2 rowsep2">2.98 ± 0.12 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">MRC5 </td><td class="colsep2 rowsep2">6.60 ± 0.11 </td><td class="colsep2 rowsep2">3.61 ± 0.15 </td><td class="colsep2 rowsep2">2.91 ± 0.10 </td><td class="colsep2 rowsep2">3.38 ± 0.09 </td><td class="colsep2 rowsep2">3.61 ± 0.35 </td><td class="colsep2 rowsep2">6.72 ± 0.09 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">HeLa </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">5.56 ± 0.62 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">3.06 ± 0.44 </td><td class="colsep2 rowsep2">3.50 ± 0.16 </td><td class="colsep2 rowsep2">6.06 ± 0.13 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">HCT-116 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">8.58 ± 0.67 </td><td class="colsep2 rowsep2">5.05 ± 0.06 </td><td class="colsep2 rowsep2">5.24 ± 0.19 </td><td class="colsep2 rowsep2">>10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">A375 </td><td class="colsep2 rowsep2">>10 </td><td class="colsep2 rowsep2">6.08 ± 0.48 </td><td class="colsep2 rowsep2">3.72 ± 0.87 </td><td class="colsep2 rowsep2">2.96 ± 0.05 </td><td class="colsep2 rowsep2">2.84 ± 0.01 </td><td class="colsep2 rowsep2">5.16 ± 0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Assay details were described in Experimental Section.</p></div></div></div><div class="NLM_p">Consistently, dimethylamino-biheteroaryl <b>41</b> and pyridine-biheteroaryl <b>56</b> displayed good cellular potency for inhibiting VEGF-stimulated HUVEC proliferation (IC<sub>50</sub> = 0.059 μM for <b>41</b> and IC<sub>50</sub> = 0.086 μM for <b>56</b>), while they maintained the lower potencies for inhibiting unstimulated growth of cell lines (IC<sub>50</sub> ranging from 0.877 to 6.15 μM). Therefore, both compound <b>41</b> and <b>56</b> displayed more than 15-fold of cellular selectivity in general. Similarly, the pyrazole-biheteroaryl <b>57</b> and triazole-biheteroaryl <b>58</b> also exhibited higher cellular potencies for inhibiting VEGF-stimulated HUVEC proliferation (IC<sub>50</sub> = 0.120 μM for <b>57</b> and IC<sub>50</sub> = 0.057 μM for <b>58</b>) versus unstimulated growth of cell lines (IC<sub>50</sub> ranging from 1.07 μM to >10 μM, Table 5). </div><div class="NLM_p last">The ability of all of these compounds to inhibit the proliferation of cells derived from carcinomas originating from various tissues such as HeLa (cervical adenocarcinoma), HCT-116 (colon carcinoma) and A375 (malignant melanoma) was also examined. The low inhibition of the growth of these tumor cell lines (IC<sub>50</sub> ranging from 2.84 μM to >10 μM, Table 5) further confirms that these VEGFR inhibitors do not exhibit general cytotoxic antiproliferative activity as would occur through inhibition of growth regulatory kinases such as CDK1 inhibitors. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">In Vivo Antitumor Activity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The antitumor activity of representative compounds<sup>34a</sup><b>39</b> and <b>41</b> were evaluated against A375 human melanoma xenografts growing in nude mice,<sup>34b</sup> and the result is shown in Table 6<a class="ref showTableEvent internalNav" data-ID="jm058205bt00006" href="#jm058205bt00006"></a>, while the percent remaining survival plot is shown in Figure 2<a data-tab="pane-pcw-Figures" href="#jm058205bf00001" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm058205bf00002" id="" class=" internalNav"></a>. Control groups <a name="jm004801504898" id="jm004801504898"></a> included a no treatment tumor growth control group (10 mice, group 1), and a vehicle control group (6 mice, group 2). In addition, dacarbazine (DTIC), a cancer chemotherapy drug used in the treatment of melanoma patients, was given i.p. at 90 mg/kg on a qd × 5 schedule to another group of mice as a positive-control group (group 3).<sup>34c</sup> Compound <b>39</b> or <b>41</b> was administered i.p. at either 10 mg/kg (group 4 or group 6) or 75 mg/kg (group 5 or group 7) on a qd × 30 schedule to two groups of mice. The tumor growth delay method was used in this study. Each animal was euthanized when its A375 neoplasm reached a size of 2.0 g. Mean day of survival (MDS) values were calculated for all groups. The MDS value of 29.2 days calculated from the compound <b>39</b>-treated animal group (75 mg/kg, group 5) is significant differently from the vehicle-control group (MDS = 20.6 days, <i>p</i> = 0.05) and represents a 41.7% (<i>p</i> = 0.05) survival increase. Similarly, the MDS value of 28.9 days calculated from the compound <b>41</b>-treated animal group (75 mg/kg, group 7) represents a 40.3% survival increase. In comparison, the MDS value of 24.5 days was obtained from the DTIC-treated animal group (group 3). All of these treatments with compound <b>39 </b>or <b>41</b> were well tolerated; no animal deaths or weight losses were recorded. Therefore, it may be possible to administer higher dose of <b>39</b> or <b>41</b> to increase its moderate efficacy if desired. <div id="_i23"><figure id="jm058205bf00001" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00001.jpeg" id="_i24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 (a) Illustration of the alignment of 32 compounds in the ATP-binding site of VEGFR-2. The ligands and the key residues that act as their hydorgen-bond partners are represented in the tube model, while the protein is represented in the carton model. The hydrogen bonds are indicated by the yellow dotted lines. The connolly water-accessible surface of binding site is represented as meshes. (Atom color scheme:  hydrogen in white; oxygen in red; nitrogen in blue; chlorine in dark green; carbon on ligands in orange; and carbon on proteins in gray.) (b) Correlation plot of the calculated pIC<sub>50</sub> values from eq 1 versus the experimental pIC<sub>50</sub> values. The dotted line represents the best fitting line between them.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm058205bf00002" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00002.jpeg" id="_i25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Compounds <b>39</b> and <b>41</b> delay tumor growth and increase survival in an A375 melanoma tumor xenograft model. Compounds were administered to nude mice IP at 75 mg/kg, and tumor growth was measured. Percent remaining refers to the number of animals remaining in the study with a tumor size under 2 g. Animals with a tumor size over 2 g were removed from the study but do not represent treatment-related deaths. Control animals were treated with vehicle alone (▪). Dacarbazine (DTIC) was administered at 90 mg/kg on a qd × 5 schedule (red solid circles). Compound <b>39</b> (blue open triangles) and compound <b>41</b> (green open squares) were administered on a QD x 30 schedule, and the experiment was ended on day 60.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm058205bt00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  In Vivo A375 Treatment Response Summary<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">group</td><td class="colsep2 rowsep2"><i>n</i></td><td class="colsep2 rowsep2">agent</td><td class="colsep2 rowsep2">mg/kg</td><td class="colsep2 rowsep2">MDS ± SEM (<i>n</i>) when reach 2.0 g</td><td class="colsep2 rowsep2">no death </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">growth control </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">20.6 ± 1.4 (10) </td><td class="colsep2 rowsep2">0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2">1.5% Pluronic F108 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">20.6 ± 2.1 (6) </td><td class="colsep2 rowsep2">0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2">1.5% Pluronic F108 and DTIC </td><td class="colsep2 rowsep2">90 </td><td class="colsep2 rowsep2">24.5 ± 1.6 (6) </td><td class="colsep2 rowsep2">0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">4 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">24.0 ± 1.2 (6) </td><td class="colsep2 rowsep2">0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">5 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">75 </td><td class="colsep2 rowsep2">29.2 ± 2.9 (6) </td><td class="colsep2 rowsep2">0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">22.4 ± 1.2 (6) </td><td class="colsep2 rowsep2">0 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">7 </td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2">75 </td><td class="colsep2 rowsep2">28.9 ± 2.3 (6) </td><td class="colsep2 rowsep2">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Assay details were described in the Experimental Section.</p></div></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Molecular Modeling Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A QSAR analysis was conducted in an attempt to rationalize the observed structure−activity data. On the basis of the previously developed model of VEGFR-2 in complex with <b>7</b>,<sup>25</sup> all the 32 compounds with IC<sub>50</sub> values less than 10 μM in Tables 1−3 were docked into the ATP-binding site of VEGFR-2, using the docking program Glide.<sup>39</sup> The favorable docking poses were then used to develop QSAR models. The binding poses were finally predicted as those leading to the best QSAR model (see Experimental Section. Computational Details). Their alignment in the binding pocket is illustrated in Figure 1a. Generally, they all adopt a unique hydrogen-bond pattern to interact with VEGFR-2:  one hydrogen bond between the pyridine nitrogen <a name="jm004801504899" id="jm004801504899"></a> and the backbone amide nitrogen of Cys919 at the so-called hinge region and the other between the anilino nitrogen and the side chain carboxylate group of Asp1046. In addition, some compounds with a polar group on their aliphatic side chains may pick up some hydrogen-bond interactions with Asn923. </div><div class="NLM_p">The QSAR analysis was carried out with the GlideScore<sup>40</sup> components. GlideScore is a popular empirical scoring function that estimates binding affinity as the sum of multiple empirical terms. The relative contribution of each term can be determined by fitting to the known experimental data of binding affinity. By retraining them in our data set of 32 compounds, the following regression model was obtained as optimal using five GlideScore components.<a class="ref internalNav" href="#jm058205be00001" aria-label=""></a><span class="NLM_disp-formula" id="jm058205be00001"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205be00001.gif" alt="" id="_i27" /></img></span> in which <i>n</i> = 32, rmsd = 0.160, <i>r</i><sup>2</sup> = 0.894, <i>q</i><sup>2</sup> = 0.851. </div><div class="NLM_p">Here, Lipo represents the lipophilic contact term that counts the favorable hydrophobic−hydrophobic matches between the ligand and the receptor. BuryP is the penalty term that counts the unfavorable mismatches of polar or charged groups in a hydrophobic binding pocket. It actually provides a way to take into account the solvation effect in binding. vdW and Coul represent the contributions from the van der Waals and Coulomb interaction energies between the ligand and the receptor, respectively. Site is the reward term that considers polar but non-hydrogen-bonding atoms found in a hydrophobic pocket. The other GlideScore components were discarded because their inclusion actually made the model worse. </div><div class="NLM_p">For 32 compounds, eq 1 produces a conventional correlation coefficient <i>r</i><sup>2</sup> of 0.894 and a leave-one-out cross-validated correlation coefficient <i>q</i><sup>2</sup> of 0.851. The root-mean-square deviation (rmsd) is 0.160. These values clearly indicate this model as a statistically significant and stable model. The <i>r</i><sup>2</sup> value of 0.894 also indicates that this model can explain approximately 89.4% of the internal variance observed in the experimental pIC50 data. The calculated and the experimental pIC<sub>50</sub> values are listed in Table 7<a class="ref showTableEvent internalNav" data-ID="jm058205bt00007" href="#jm058205bt00007"></a> and plotted in Figure 1b. <div class="NLM_table-wrap" id="jm058205bt00007"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 7.  Experimental and Calculated pIC<sub>50</sub> Values, with the Values of the Five GlideScore Components Used in the Final QSAR Model</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="5">GlideScore components</td><td class="colsep2 rowsep2" colspan="2">pIC<sub>50</sub></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compound</td><td class="colsep2 rowsep2">Lipo</td><td class="colsep2 rowsep2">BuryP</td><td class="colsep2 rowsep2">vdW</td><td class="colsep2 rowsep2">Coul</td><td class="colsep2 rowsep2">Site</td><td class="colsep2 rowsep2">expt</td><td class="colsep2 rowsep2">calc </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>7</b></td><td class="colsep2 rowsep2">−2.48 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−34.85 </td><td class="colsep2 rowsep2">−15.73 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">7.08 </td><td class="colsep2 rowsep2">6.96 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>11</b></td><td class="colsep2 rowsep2">−2.46 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−33.87 </td><td class="colsep2 rowsep2">−14.98 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.77 </td><td class="colsep2 rowsep2">6.70 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>15</b></td><td class="colsep2 rowsep2">−2.47 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−33.61 </td><td class="colsep2 rowsep2">−12.75 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.13 </td><td class="colsep2 rowsep2">6.36 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2">−2.51 </td><td class="colsep2 rowsep2">−0.90 </td><td class="colsep2 rowsep2">−33.78 </td><td class="colsep2 rowsep2">−11.24 </td><td class="colsep2 rowsep2">−0.09 </td><td class="colsep2 rowsep2">6.00 </td><td class="colsep2 rowsep2">5.94 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b></td><td class="colsep2 rowsep2">−2.75 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−40.04 </td><td class="colsep2 rowsep2">−11.54 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">7.12 </td><td class="colsep2 rowsep2">6.86 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">−2.90 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−39.92 </td><td class="colsep2 rowsep2">−7.38 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.00 </td><td class="colsep2 rowsep2">5.87 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2">−3.24 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−45.42 </td><td class="colsep2 rowsep2">−11.13 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.72 </td><td class="colsep2 rowsep2">6.48 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32</b></td><td class="colsep2 rowsep2">−2.61 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−33.86 </td><td class="colsep2 rowsep2">−14.76 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">5.98 </td><td class="colsep2 rowsep2">6.17 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">−2.25 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−31.67 </td><td class="colsep2 rowsep2">−7.16 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">5.94 </td><td class="colsep2 rowsep2">6.02 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38</b></td><td class="colsep2 rowsep2">−2.48 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−35.41 </td><td class="colsep2 rowsep2">−9.62 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.56 </td><td class="colsep2 rowsep2">6.43 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">−2.57 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−36.34 </td><td class="colsep2 rowsep2">−15.22 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">7.20 </td><td class="colsep2 rowsep2">6.96 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>40</b></td><td class="colsep2 rowsep2">−2.62 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−36.64 </td><td class="colsep2 rowsep2">−13.76 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.87 </td><td class="colsep2 rowsep2">6.71 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2">−2.59 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−36.78 </td><td class="colsep2 rowsep2">−12.64 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.98 </td><td class="colsep2 rowsep2">6.72 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>42</b></td><td class="colsep2 rowsep2">−2.48 </td><td class="colsep2 rowsep2">0.20 </td><td class="colsep2 rowsep2">−37.73 </td><td class="colsep2 rowsep2">−10.51 </td><td class="colsep2 rowsep2">−0.40 </td><td class="colsep2 rowsep2">5.37 </td><td class="colsep2 rowsep2">5.38 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>43</b></td><td class="colsep2 rowsep2">−2.53 </td><td class="colsep2 rowsep2">0.20 </td><td class="colsep2 rowsep2">−40.08 </td><td class="colsep2 rowsep2">−10.00 </td><td class="colsep2 rowsep2">−0.46 </td><td class="colsep2 rowsep2">5.62 </td><td class="colsep2 rowsep2">5.61 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>44</b></td><td class="colsep2 rowsep2">−2.45 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−37.03 </td><td class="colsep2 rowsep2">−12.36 </td><td class="colsep2 rowsep2">−0.45 </td><td class="colsep2 rowsep2">6.46 </td><td class="colsep2 rowsep2">6.37 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>45</b></td><td class="colsep2 rowsep2">−2.46 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−37.71 </td><td class="colsep2 rowsep2">−10.71 </td><td class="colsep2 rowsep2">−0.44 </td><td class="colsep2 rowsep2">6.52 </td><td class="colsep2 rowsep2">6.35 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46</b></td><td class="colsep2 rowsep2">−2.51 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−38.69 </td><td class="colsep2 rowsep2">−10.81 </td><td class="colsep2 rowsep2">−0.46 </td><td class="colsep2 rowsep2">6.23 </td><td class="colsep2 rowsep2">6.39 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b></td><td class="colsep2 rowsep2">−2.74 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−39.84 </td><td class="colsep2 rowsep2">−12.07 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.63 </td><td class="colsep2 rowsep2">6.90 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>51</b></td><td class="colsep2 rowsep2">−2.75 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−39.84 </td><td class="colsep2 rowsep2">−11.96 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.91 </td><td class="colsep2 rowsep2">6.86 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52</b></td><td class="colsep2 rowsep2">−2.73 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−40.07 </td><td class="colsep2 rowsep2">−10.78 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.74 </td><td class="colsep2 rowsep2">6.85 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>53</b></td><td class="colsep2 rowsep2">−2.79 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−39.37 </td><td class="colsep2 rowsep2">−12.34 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.40 </td><td class="colsep2 rowsep2">6.65 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>54</b></td><td class="colsep2 rowsep2">−2.83 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−38.80 </td><td class="colsep2 rowsep2">−10.68 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.41 </td><td class="colsep2 rowsep2">6.20 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>55</b></td><td class="colsep2 rowsep2">−2.92 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−40.89 </td><td class="colsep2 rowsep2">−14.10 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.58 </td><td class="colsep2 rowsep2">6.77 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>56</b></td><td class="colsep2 rowsep2">−2.67 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−39.89 </td><td class="colsep2 rowsep2">−13.16 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">7.12 </td><td class="colsep2 rowsep2">7.27 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>57</b></td><td class="colsep2 rowsep2">−2.66 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−39.80 </td><td class="colsep2 rowsep2">−11.96 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">7.03 </td><td class="colsep2 rowsep2">7.15 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>58</b></td><td class="colsep2 rowsep2">−2.57 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−38.90 </td><td class="colsep2 rowsep2">−11.98 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">7.17 </td><td class="colsep2 rowsep2">7.24 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>59</b></td><td class="colsep2 rowsep2">−3.30 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−43.64 </td><td class="colsep2 rowsep2">−10.33 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">5.64 </td><td class="colsep2 rowsep2">5.76 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>61</b></td><td class="colsep2 rowsep2">−2.58 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−35.96 </td><td class="colsep2 rowsep2">−9.72 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.24 </td><td class="colsep2 rowsep2">6.24 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>62</b></td><td class="colsep2 rowsep2">−2.73 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−39.73 </td><td class="colsep2 rowsep2">−6.69 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">6.21 </td><td class="colsep2 rowsep2">6.32 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>70</b></td><td class="colsep2 rowsep2">−2.38 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−35.60 </td><td class="colsep2 rowsep2">−13.21 </td><td class="colsep2 rowsep2">−0.33 </td><td class="colsep2 rowsep2">6.60 </td><td class="colsep2 rowsep2">6.58 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>79</b></td><td class="colsep2 rowsep2">−2.53 </td><td class="colsep2 rowsep2">0.00 </td><td class="colsep2 rowsep2">−35.37 </td><td class="colsep2 rowsep2">−14.02 </td><td class="colsep2 rowsep2">−0.38 </td><td class="colsep2 rowsep2">5.87 </td><td class="colsep2 rowsep2">6.01</td></tr></tbody></table></div></div></div><div class="NLM_p last">The two major contributions are from the Lipo and vdW terms. They count 32.7 and 32.1% to the information content of this model, respectively. These numbers indicate that the complementary shape contacts between the ligand and the receptor, especially the hydrophobic−hydrophobic contacts, are the major differential force behind the VEGFR-2 binding of this series of compounds. Interestingly, the hydrogen-bond interaction term does not appear in the final model, although it obviously plays an important role in determining the binding poses of these compounds. This fact indicates that the optional hydrogen bonds with Asn923 are not directly involved in determining the variance of binding affinities within this series. Instead, they may contribute by influencing the binding poses of these compounds. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Using palladium-catalyzed C−C bond, C−N bond formation reactions as the key methods, SAR studies of the pyrazine-pyridine lead were conducted. These efforts resulted in the identification of several potent VEGFR-2 inhibitors with various degrees of kinase selectivity. Among them, compound <b>39</b> and compound <b>41</b> exhibited the highest kinase selectivity, while compound <b>7</b> and compounds <b>56</b>−<b>58 </b>displayed modest selectivity against FGFR-2, PDGF-R, and GSK-3. All of these compounds showed high cellular potency to inhibit VEGF-stimulated proliferation of HUVEC. Meanwhile, they all displayed modest effect on the unstimulated growth of HUVEC and very minimal inhibition of proliferation of two normal human cell types, HASMC and MRC5. The low inhibition of these compounds to the growth of tumor cell lines, such as HeLa, HCT-116, and A375 further confirms that these VEGFR-2 inhibitors are not cytotoxic agents. The in vivo antitumor activity of compounds <b>39</b> and <b>41</b> was demonstrated in the A375 human melanoma xenograft nude mice model. Molecular modeling (QSAR analysis) was conducted in an attempt to rationalize the observed SAR. The high VEGFR-2 inhibitory potency, good kinase selectivity profile, and good cellular potency and selectivity demonstrated in vivo antitumor activity may potentially render these compounds as valuable pharmacological tools in elucidating the complex roles of VEGF signaling pathways and the potential utility for anti-angiogenesis therapy. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Chemistry.</b><sup>1</sup>H NMR spectra were measured on a Bruker AC<b>-</b>300 (300 MHz) spectrometer using tetramethylsilane as an internal standard. Elemental analyses were obtained by <a name="jm004801504900" id="jm004801504900"></a> Quantitative Technologies Inc. (Whitehouse, New Jersey), and the results were within 0.4% of the calculated values unless otherwise mentioned. Melting points were determined in open capillary tubes with a Thomas-Hoover apparatus and were uncorrected. The optical rotation was measured at 25 °C with an Autopol III polarimeter. Electrospray mass spectra (MS-ES) were recorded on a Hewlett-Packard 59987A spectrometer. High-resolution mass spectra (HRMS) were obtained on a Micromass Autospec. E. spectrometer. The term DMAP refers to (dimethylamino)pyridine, TFA refers to trifluoroacetic acid, NMP refers to 1-methyl-2-pyrrolidinone, DPPF refers to 1,1‘-bis(diphenylphosphino)ferrocene, Pd<sub>2</sub>(dba)<sub>3</sub> refers to tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct, and DPPA refers to diphenylphosphoryl azide. </div><div class="NLM_p"><b>5-Tributylstannanyl-nicotinic Acid Ethyl Ester 2.</b> A mixture of 5-bromonicotinate <b>1</b> (25 g, 108.7 mmol), bis(tributyltin) (63.05 g, 108.7 mmol), palladium acetate (1.1 g, 4.89 mmol), tri-<i>o</i>-tolylphosphine (8.6 g, 28.26 mmol), and triethylamine (21.96 g, 217.4 mmol) in acetonitrile (350 mL) was stirred at 95−100 °C for 22 h under nitrogen. The cooled reaction mixture was filtered through Celite. Then the Celite was washed with more acetonitrile, and the combined acetonitrile was concentrated under a vacuum. The residue was diluted with a suitable solvent, such as dichloromethane, washed with aqueous sodium carbonate and concentrated. The residue was further diluted with hexane. The solid was filtered off, and the filtrate was concentrated. The product was purified by column chromatography (twice, SiO<sub>2</sub>, dichloromethane/hexane as solvent) to give 19.09 g (40%) of <b>2</b> as a light orange oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.11 (brs, 1 H), 8.74 (brs, 1 H), 8.35 (brs, 1 H), 4.41 (q, <i>J</i> = 6.9 Hz, 2 H), 1.72−1.05 (m, 21 H), 0.89 (t, <i>J</i> = 7.2 Hz, 9 H); MS (ES) <i>m</i>/<i>z</i>:  442 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>5-(6-Chloro-pyrazine-2-yl)-nicotinic Acid Ethyl Ester 3.</b> A mixture of <b>2</b> (10 g, 22.7 mmol), 2,6-dichloropyrazine (6.76 g, 45.4 mmol), dichloro-bis(triphenylphosphine)palladium (797 mg, 1.14 mmol), and LiCl (4.77 g, 113.5 mmol) in anhydrous toluene (85 mL) was stirred at 100 °C for 23 h under nitrogen. The cooled reaction mixture was concentrated under a vacuum. Aqueous sodium carbonate was added to the residue and stirred for 10 min and extracted with dichloromethane (3×). The combined dichloromethane solution was filtered through Celite, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The product was purified by column chromatography (EtOAc/hexane as solvent) to give 3.56 g (60%) of <b>3 </b>as an off-white solid:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.43 (brs, 1 H), 9.35 (brs, 1 H), 9.05 (s, 1 H), 8.91 (s, 1 H), 8.64 (s, 1 H), 4.48 (q, <i>J</i> = 7.3 Hz, 2 H), 1.47 (t, <i>J</i> = 7.2 Hz, 3 H); MS (ES) <i>m</i>/<i>z</i>:  264 (M+H<sup>+</sup>). Anal. (C<sub>12</sub>H<sub>10</sub>N<sub>3</sub>O<sub>2</sub>Cl) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 4, 8, 12, 16, 21, and 25. </b>5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-nicotinic acid ethyl ester <b>4</b>. A mixture of <b>3 </b>(24.3 g, 92.4 mmol), 3-chloroaniline (16.6 g, 129 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (2.39 g, 2.31 mmol), DPPF (4.1 g, 7.4 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (60.2 g, 185 mmol) in anhydrous dioxane (230 mL) was stirred at 110 °C for 46 h under nitrogen. Dichloromethane (100 mL) was added to the cooled reaction mixture. The mixture was then filtered through Celite, the Celite cake was washed with more dichloromethane, and the combined filtrate was concentrated to give a yellow-brown solid. Small amounts of dichloromethane was added, the solid was collected through filtration, and the filtrate was concentrated. The solid collected was recrystallized from EtOAc/hexane to give 21.83 g (67%) of compound <b>4 </b>as a yellow solid:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.44 (brs, 1 H), 9.31 (brs, 1 H), 8.90 (s, 1 H), 8.57 (s, 1 H), 8.26 (s, 1 H), 7.72 (s, 1 H), 7.44 (d, <i>J</i> = 8.1 Hz, 1 H), 7.31 (t, <i>J</i> = 8.0 Hz, 1 H), 7.08 (d, <i>J</i> = 8.0 Hz, 1 H), 7.04 (s, 1 H), 4.48 (q, <i>J</i> = 7.2 Hz, 2 H), 1.46 (t, <i>J</i> = 7.0 Hz, 3 H); MS (ES) <i>m</i>/<i>z</i>:  355 (M + H<sup>+</sup>). Anal. (C<sub>18</sub>H<sub>15</sub>N<sub>4</sub>O<sub>2</sub>Cl) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 5, 9, 13, 17, 22, and 26. </b><b>5-{6-[</b><b><i>tert</i></b><b>-Butoxycarbonyl-(3-chloro-phenyl)-amino]-pyrazin-2-yl}-nicotinic Acid 5.</b> A mixture of <b>4 </b>(21.83 g, 61.7 mmol), Boc<sub>2</sub>O (26.9 g, 123 mmol), and DMAP (3 g, cat.) in dichloromethane (500 mL) was stirred at 20 °C for 4 h. The reaction mixture was concentrated, and the product was purified by column chromatography (EtOAc/hexane as solvent) to give 26.7 g (95%) of <b>Boc-4 </b>as yellowish oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.22 (d, <i>J</i> = 2.0 Hz, 1 H), 9.15 (d, <i>J</i> = 2.2 Hz, 1 H), 9.10 (s, 1 H), 8.84 (s, 1 H), 8.64 (t, <i>J</i> = 2.1 Hz, 1 H), 7.35 (m, 3 H), 7.18 (brd, <i>J</i> = 7.3 Hz, 1 H), 4.44 (q, <i>J</i> = 7.1 Hz, 2 H), 1.50 (s, 9 H), 1.44 (t, <i>J</i> = 7.1 Hz, 3 H); MS (ES) <i>m</i>/<i>z</i>:  455 (M + H<sup>+</sup>). </div><div class="NLM_p">Compound <b>Boc-4 </b>(32.2 g, 71 mmol) was dissolved in methanol (200 mL) and stirred for 10 min and then cooled to 0 °C. A NaOH<sub>(aq)</sub> (1 N, 118 mL) solution was added slowly, and the mixture was stirred at 0 °C for 20 min and then stirred at 20 °C for another 18 h. Glacial acetic acid (95 mL) was added to the reaction mixture at 0 °C slowly followed by the addition of water (350 mL). A yellow solid was formed. The yellow solid was collected through filtration, washed with water (5×), dried in a vacuum oven overnight to give 28.3 g (94%) of the carboxylic acid <b>5 </b>as a yellow solid:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.27 (d, <i>J</i> = 1.9 Hz, 1 H), 9.22 (s, 1 H), 9.09 (d, <i>J</i> = 1.6 Hz, 1 H), 9.03 (s, 1 H), 8.65 (brs, 1 H), 7.52−7.31 (m, 4 H), 1.44 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  425 (M−H<sup>+</sup>). Anal. (C<sub>21</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>Cl) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 6, 10, 14, 18, 23, and 27. </b><b>[6-(5-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-pyridin-3-yl)-pyrazin-2-yl]-(3-chloro-phenyl)-carbamic </b><b>Acid </b><b><i>tert</i></b><b>-Butyl Ester 6.</b> A mixture of the carboxylic acid <b>5 </b>(28.3 g, 66.5 mmol), DPPA (21.95 g, 80 mmol), triethylamine (13.43 g, 133 mmol), <i>t</i>-BuOH (280 mL) in toluene (200 mL) was stirred under nitrogen at 70 °C for 30 min and then stirred at 100 °C for 4 h. The reaction mixture was concentrated under a vacuum. The product was purified by column chromatography (EtOAc/hexane as solvent) to give 29.28 g (89%) of <b>6 </b>as a yellowish foam:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1 H), 8.80 (s, 1 H), 8.67 (d, <i>J</i> = 1.7 Hz, 1 H), 8.49 (d, <i>J</i> = 2.4 Hz, 1 H), 8.41 (brs, 1 H), 7.29 (m, 3 H), 7.17 (d, <i>J</i> = 7.5 Hz, 1 H), 7.08 (s, 1 H), 1.54 (s, 9 H), 1.49 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  498 (M + H<sup>+</sup>). Anal. (C<sub>25</sub>H<sub>28</sub>N<sub>5</sub>O<sub>4</sub>Cl) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 7, 11, 15, and 19. </b><b>3-[[5-[6-[(3-chlorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol 7.</b> A mixture of <b>6 </b>(3 g, 6 mmol), (3-bromopropoxy)-<i>tert</i>-butyl-dimethylsilane (2.28 g, 9 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (5.9 g, 18 mmol) in DMF (60 mL) was stirred at 70 °C under nitrogen for 36 h. The reaction mixture was diluted with water, extracted with ether (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The product was purified by column chromatography (EtOAc/hexane as solvent) to give 3.04 g of the silylated product as an orange oil. The silylated product was dissolved in TFA (30 mL) and stirred at 20 °C for 1 h before it was concentrated. An ammonium hydroxide solution was added to the residue until the pH was about 10−11, water was added, and a yellow solid was formed. The yellow solid was collected through filtration, washed with water, and dried under a vacuum. The yellow solid was recrystallized from CH<sub>3</sub>OH/EtOAc to give 1.25 g (59%) of <b>7</b> as a light yellow solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.45 (s, 1 H), 8.41 (d, <i>J</i> = 1.6 Hz, 1 H), 8.12 (brs, 2 H), 8.00 (d, <i>J</i> = 2.7 Hz, 1 H), 7.66 (brs, 1 H), 7.55 (d, <i>J</i> = 8.3 Hz, 1 H), 7.30 (t, <i>J</i> = 8.1 Hz, 1 H), 6.99 (d, <i>J</i> = 7.9 Hz, 1 H), 3.72 (t, <i>J</i> = 6.3 Hz, 2 H), 3.33 (t, <i>J</i> = 6.8 Hz, 2 H), 1.91 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  356 (M + H<sup>+</sup>). Anal. (C<sub>18</sub>H<sub>18</sub>N<sub>5</sub>OCl·0.5 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>5-[6-(3-Fluoro-phenylamino)-pyrazin-2-yl]-nicotinic Acid Ethyl Ester 8. </b>Replacing 3-chloroaniline with 3-fluoroaniline and following the same procedure as in the preparation of <b>4</b> gave <b>8</b> as a yellow solid:  80% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.42 (d, <i>J</i> = 2.2 Hz, 1 H), 9.30 (d, <i>J</i> = 2.0 Hz, 1 H), 8.91 (t, <i>J</i> = 2.1 Hz, 1 H), 8.58 (s, 1 H), 8.26 (s, 1 H), 7.54 (d, <i>J</i> = 10.9 Hz, 1 H), 7.38−7.24 (m, 1 H), 6.91 (s, 1 H), 6.83 (t, <i>J</i> = 8.1 Hz, 1 H), 4.48 (q, <i>J</i> = 7.1 Hz, 2 H), 1.46 (t, <i>J</i> = 7.1 Hz, 3 H); MS (ES) <i>m</i>/<i>z</i>:  339 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>5-{6-[</b><b><i>tert</i></b><b>-Butoxycarbonyl-(3-fluoro-phenyl)-amino]-pyrazin-2-yl}-nicotinic Acid 9.</b> Replacing <b>4</b> with <b>8</b> and following the same procedure as in the preparation of <b>5</b> gave <b>9</b> as a yellow solid:  67% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.29 (brs, 1 H), 9.20 (brs, 1 H), 9.13 (brs, 1 H), 8.86 (brs, 1 H), <a name="jm004801504901" id="jm004801504901"></a> 8.73 (brs, 1 H), 7.44−7.27 (m, 1 H), 7.07−6.91 (m, 3 H), 1.50 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  409 (M − H<sup>+</sup>). </div><div class="NLM_p"><b>[6-(5-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-pyridin-3-yl)-pyrazin-2-yl]-(3-fluoro-phenyl)-carbamic </b><b>Acid </b><b><i>tert</i></b><b>-Butyl Ester 10.</b> Replacing <b>5</b> with <b>9</b> and following the same procedure as in the preparation of <b>6</b> gave <b>10</b> as a yellowish gum:  31% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1 H), 8.80 (s, 1 H), 8.68 (d, <i>J</i> = 1.9 Hz, 1 H), 8.46 (d, <i>J</i> = 2.5 Hz, 1 H), 8.38 (brs, 1 H), 7.41−7.27 (m, 1 H), 7.06−7.01 (m, 3 H), 6.58 (brs, 1 H), 1.54 (s, 9 H), 1.49 (s, 9 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>25</sub>H<sub>29</sub>N<sub>5</sub>O<sub>4</sub>F 482.2204, found 482.2204. </div><div class="NLM_p"><b>3-[[5-[6-[(3-Fluorophenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol 11. </b>Replacing <b>6</b> with <b>10</b> and following the same procedure as in the preparation of <b>7</b> gave <b>11</b> as a yellow solid:  27% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.46 (s, 1 H), 8.43 (d, <i>J</i> = 1.8 Hz, 1 H), 8.13 (brs, 1 H), 8.01 (d, <i>J</i> = 2.7 Hz, 1 H), 7.90 (dt, <i>J</i> = 12.1, 2.1 Hz, 1 H), 7.68 (t, <i>J</i> = 2.1 Hz, 1 H), 7.42−7.28 (m, 2 H), 6.73 (t, <i>J</i> = 8.3 Hz, 1 H), 3.72 (t, <i>J</i> = 6.2 Hz, 2 H), 3.31 (m, 2 H), 1.91 (m, 2 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>18</sub>H<sub>19</sub>N<sub>5</sub>OF 340.1574, found 340.1586. </div><div class="NLM_p"><b>5-[6-(3-Methoxy-phenylamino)-pyrazin-2-yl]-nicotinic Acid Ethyl Ester 12. </b>Replacing 3-chloroaniline with 3-methoxyaniline and following the same procedure as in the preparation of <b>4</b> gave <b>12</b> as a yellow solid:  65% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.42 (d, <i>J</i> = 2.1 Hz, 1 H), 9.28 (d, <i>J</i> = 2.0 Hz, 1 H), 8.89 (t, <i>J</i> = 2.1 Hz, 1 H), 8.53 (s, 1 H), 8.27 (s, 1 H), 7.3−7.27 (m, 2 H), 7.05 (dd, <i>J</i> = 7.9, 1.3 Hz, 1 H), 6.78 (brs, 1 H), 6.69 (brd, <i>J</i> = 7.6 Hz, 1 H), 4.48 (q, <i>J</i> = 7.1 Hz, 2 H), 3.85 (s, 3 H), 1.56 (t, <i>J</i> = 7.1 Hz, 3 H); Anal. (C<sub>19</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>5-{6-[</b><b><i>tert</i></b><b>-Butoxycarbonyl-(3-methoxy-phenyl)-amino]-pyrazin-2-yl}-nicotinic Acid 13.</b> Replacing <b>4</b> with <b>12</b> and following the same procedure as in the preparation of <b>5</b> gave <b>13</b> as a yellow solid:  71% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 9.16 (d, <i>J</i> = 2.2 Hz, 1 H), 9.11 (d, <i>J</i> = 1.9 Hz, 1 H), 9.04 (s, 1 H), 8.98 (s, 1 H), 8.82 (t, <i>J</i> = 2.1 Hz, 1 H), 7.35 (t, <i>J</i> = 8.0 Hz, 1 H), 6.96−6.85 (m, 3 H), 3.81 (s, 3 H), 1.48 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  421 (M − H<sup>+</sup>). Anal. (C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>0<sub>5</sub>·0.3 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>[6-(5-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-pyridin-3-yl)-pyrazin-2-yl]-(3-methoxy-phenyl)-carbamic </b><b>Acid </b><b><i>tert</i></b><b>-Butyl Ester 14.</b> Replacing <b>5</b> with <b>13</b> and following the same procedure as in the preparation of <b>6</b> gave <b>14</b> as a yellowish gum:  75% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.91 (s, 1 H), 8.78 (s, 1 H), 8.71 (d, <i>J</i> = 1.9 Hz, 1 H), 8.49 (d, <i>J</i> = 2.5 Hz, 1 H), 8.38 (brs, 1 H), 7.31 (t, <i>J</i> = 8.2 Hz, 1 H), 6.87−6.82 (m, 3 H), 6.63 (brs, 1 H), 3.81 (s, 3 H), 1.54 (s, 9 H), 1.49 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  494 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>3-[[5-[6-[(3-Methoxyphenyl)amino]pyrazinyl]-3-pyridinyl]amino]-1-propanol 15. </b>Replacing <b>6</b> with <b>14</b> and following the same procedure as in the preparation of <b>7</b> gave <b>15</b> as a yellow solid:  10% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.44 (d, <i>J</i> = 1.6 Hz, 1 H), 8.39 (s, 1 H), 8.10 (s, 1 H), 8.00 (d, <i>J</i> = 2.8 Hz, 1 H), 7.67 (brs, 1 H), 7.65 (brs, 1 H), 7.23−7.20 (m, 2 H), 6.62−6.58 (m, 1 H), 3.81 (s, 3 H), 3.72 (t, <i>J</i> = 6.2 Hz, 2 H) 3.31 (m, 2 H), 1.90 (m, 2 H); Anal. (C<sub>19</sub>H<sub>21</sub>N<sub>5</sub>0<sub>2</sub>·0.5 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>5-[6-(2-Chloro-phenylamino)-pyrazin-2-yl]-nicotinic Acid Ethyl Ester 16. </b>Replacing 3-chloroaniline with 2-chloroaniline and following the same procedure as in the preparation of <b>4</b> gave <b>16</b> as a solid:  69% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.44 (d, <i>J</i> = 3.0 Hz, 1 H), 9.30 (d, <i>J</i> = 3.0 Hz, 1 H), 8.89 (s, 1 H), 8.60 (s, 1 H), 8.37 (d, <i>J</i> = 9.0, 1 H), 8.29 (s, 1 H), 7.47 (d, <i>J</i> = 9.0, 1 H), 7.35 (dd, <i>J</i> = 9.0, 6.0 Hz, 1 H), 7.14 (brs, 1 H), 7.06 (dd, <i>J</i> = 9.0, 6.0 Hz, 1 H), 4.48 (q, <i>J</i> = 6.0 Hz, 2 H), 1.46 (t, <i>J</i> = 6.0 Hz, 3 H); MS (ES) <i>m</i>/<i>z</i>:  355 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>5-{6-[</b><b><i>tert</i></b><b>-Butoxycarbonyl-(2-chloro-phenyl)-amino]-pyrazin-2-yl}-nicotinic Acid 17.</b> Replacing <b>4</b> with <b>16</b> and following the same procedure as in the preparation of <b>5</b> gave <b>17</b> as a solid:  64% yield as a mixture of two inseparable compounds (<b>17</b> and <b>des-Boc-17) </b>in 7:3 ratio; MS (ES) <i>m</i>/<i>z</i>:  427 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>[6-(5-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-pyridin-3-yl)-pyrazin-2-yl]-(2-chloro-phenyl)-carbamic </b><b>acid </b><b><i>tert</i></b><b>-butyl Ester 18.</b> Replacing <b>5</b> with <b>17</b> and following the same procedure as in the preparation of <b>6</b> gave <b>18</b>:  50% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.28 (s, 1 H), 8.74 (s, 1 H), 8.59 (d, <i>J</i> = 3 Hz, 1 H), 8.47 (d, <i>J</i> = 3.0 Hz, 1 H), 8.30 (brs, 1 H), 7.49 (dd, <i>J</i> = 9.0, 3.0 Hz, 1 H), 7.40−7.25 (m, 3 H), 6.98 (s, 1 H), 1.54 (s, 9 H), 1.47 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  498 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>3-{5-[6-(2-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol 19. </b>Replacing <b>6</b> with <b>18</b> and following the same procedure as in the preparation of <b>7</b> gave <b>19</b> as a solid:  61% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.45 (s, 1 H), 8.36 (s, 1 H), 8.22 (s, 1 H), 8.17 (dd, <i>J</i> = 9.0, 3.0 Hz, 1 H), 7.97 (s, 1 H), 7.59 (s, 1 H), 7.47 (dd, <i>J</i> = 9.0, 3.0 Hz, 1 H), 7.34 (dd, <i>J</i> = 6.0, 6.0, 3.0 Hz, 1 H), 7.10 (ddd, <i>J</i> = 6.0, 6.0, 3.0 Hz, 1 H), 3.70 (t, <i>J</i> = 6.0 Hz, 2 H), 3.27 (t, <i>J</i> = 6.0 Hz, 2 H), 1.87 (t, <i>J</i> = 6.0 Hz, 2 H); MS (ES) <i>m</i>/<i>z</i>:  356 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>General Procedure for the Synthesis of 20, 24, and 28. </b>(3-Chloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine 20. A mixture of <b>6 </b>(0.1 g, 0.2 mmol), 4-(3-chloropropyl)pyridine<sup>35</sup> (0.047 g, 0.3 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.197 g, 0.6 mmol) in DMF (4 mL) was stirred at 70 °C under nitrogen for 20 h. The reaction mixture was diluted with water, extracted with ether (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The product was purified by column chromatography (EtOAc/MeOH as solvent) to give 0.074 g of product as an oil. The oil was dissolved in TFA (2.0 mL) and stirred at 20 °C for 2 h before concentrated. Ammonium hydroxide solution was added to the residue until the pH was about 10−11. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. Product was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH as solvent) to give 0.045 g (91%) of <b>20 </b>as a yellow solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.42 (m, 4 H), 8.12 (s, 2 H), 7.99 (s, 1 H), 7.65 (s, 1 H), 7.48 (m, 1 H), 7.34 (s, 2 H), 7.25 (t, <i>J</i> = 8.0 Hz, 1 H), 6.97 (d, <i>J</i> = 6.7 Hz, 1 H), 3.30 (m, 2 H), 2.83 (m, 2 H), 2.03 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  417 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>23</sub>H<sub>22</sub>ClN<sub>6</sub> 417.1594, found 417.1605. </div><div class="NLM_p"><b>5-[6-(4-Chloro-phenylamino)-pyrazin-2-yl]-nicotinic Acid Ethyl Ester 21. </b>Replacing 3-chloroaniline with 4-chloroaniline and following the same procedure as in the preparation of <b>4</b> gave <b>21</b> as a yellow solid:  56% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.40 (d, <i>J</i> = 2.1 Hz, 1 H), 9.29 (d, <i>J</i> = 1.9 Hz, 1 H), 8.87 (t, <i>J</i> = 2.0 Hz, 1 H), 8.55 (s, 1 H), 8.22 (s, 1 H), 7.52 (d, <i>J</i> = 8.7 Hz, 2 H), 7.35 (d, <i>J</i> = 8.7 Hz, 2 H), 6.71 (s, 1 H), 4.47 (q, <i>J</i> = 7.1 Hz, 2 H), 1.44 (t, <i>J</i> = 7.1 Hz, 3 H); MS (ES) <i>m</i>/<i>z</i>:  355 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>5-{6-[</b><b><i>tert</i></b><b>-Butoxycarbonyl-(4-chloro-phenyl)-amino]-pyrazin-2-yl}-nicotinic Acid 22.</b> Replacing <b>4</b> with <b>21</b> and following the same procedure as in the preparation of <b>5</b> gave <b>22</b> as a yellow solid:  94% yield; MS (ES) <i>m</i>/<i>z</i>:  427 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>[6-(5-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-pyridin-3-yl)-pyrazin-2-yl]-(4-chloro-phenyl)-carbamic </b><b>Acid </b><b><i>tert</i></b><b>-Butyl Ester 23.</b> Replacing <b>5</b> with <b>22</b> and following the same procedure as in the preparation of <b>6</b> gave <b>23</b> as a foam:  55% yield:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.02 (s, 1 H), 8.78 (s, 1 H), 8.68 (d, <i>J</i> = 1.8 Hz, 1 H), 8.44 (d, <i>J</i> = 2.4 Hz, 2 H), 7.38 (d, <i>J</i> = 8.7 Hz, 2 H), 7.22 (d, <i>J</i> = 8.7 Hz, 2 H), 6.56 (brs, 1 H), 1.55 (s, 9 H), 1.48 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  498 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>(4-Chloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine </b><b>24</b>. Replacing <b>6</b> with <b>23</b> and following the same procedure as in the preparation of <b>20</b> gave <b>24</b> as a light yellow solid:  79% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.39 (m, 4 H), 8.10 (s, 1 H), 7.98 (s, 1 H), 7.77 (m, 2 H), 7.61 (s, 1 H), 7.33 (d, <i>J</i> = 6.1 Hz, 2 H), 7.27 (dd, <i>J</i> = 6.9, 2.1 Hz, 2 H), 3.25 (t, <i>J</i> = 6.8 Hz, 2 H), 2.84 (t, <i>J</i> = 7.6 Hz, 2 H), 2.04 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  417 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>23</sub>H<sub>23</sub>ClN<sub>6</sub> 417.1594, found 417.1588. </div><div class="NLM_p"><b>5-[6-(3,4-Dichloro-phenylamino)-pyrazin-2-yl]-nicotinic Acid Ethyl Ester 25. </b>Replacing 3-chloroaniline with 3,4-dichloroaniline and following the same procedure as in the preparation of <b>4</b> gave <b>25</b> as a yellow solid:  24% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.15 (d, <i>J</i> = 1.9 Hz, 1 H), 9.06 (d, <i>J</i> = 2.1 Hz, 1 H), 8.53 (s, 1 H), 8.45 (s, 1 H), 8.07 (m, 1 H), 7.50 (m, 1 H), 7.40 (m, 1 H), 7.21 (dd, <i>J</i> = 8.7, 1.5 Hz, 1 H), 4.45 (q, <i>J</i> = 7.1 Hz, 2 H), 1.44 (t, <i>J</i> = 7.1 Hz, 3 H); MS (ES) <i>m</i>/<i>z</i>:  389 (M + H<sup>+</sup>). </div><div class="NLM_p"><a name="jm004801504902" id="jm004801504902"></a><b>5-{6-[</b><b><i>tert</i></b><b>-Butoxycarbonyl-(3,4-dichloro-phenyl)-amino]-pyrazin-2-yl}-nicotinic Acid 26.</b> Replacing <b>4</b> with <b>25</b> and following the same procedure as in the preparation of <b>5</b> gave <b>26</b> as a yellow solid:  90% yield; MS (ES) <i>m</i>/<i>z</i>:  461 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>[6-(5-</b><b><i>tert</i></b><b>-Butoxycarbonylamino-pyridin-3-yl)-pyrazin-2-yl]-(3,4-dichloro-phenyl)-carbamic </b><b>acid </b><b><i>tert</i></b><b>-butyl ester 27.</b> Replacing <b>5</b> with <b>26</b> and following the same procedure as in the preparation of <b>6</b> gave <b>27</b> as a foam:  23% yield:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1 H), 8.81 (s, 1 H), 8.69 (brs, 1 H), 8.45 (brs, 2 H), 7.49 (d, <i>J</i> = 8.6 Hz, 1 H), 7.40 (d, <i>J</i> = 2.4 Hz, 1 H), 7.16 (dd, <i>J</i> = 8.6 2.4 Hz, 1 H), 6.59 (brs, 1 H), 1.54 (s, 9 H), 1.49 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  532 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>(3,4-Dichloro-phenyl)-{6-[5-(3-pyridin-4-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine </b><b>28.</b> Replacing <b>6</b> with <b>27</b> and following the same procedure as in the preparation of <b>20</b> gave <b>28</b> as a light yellow solid:  29% yield:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.97 (s, 1 H), 8.62 (s, 1 H), 8.46 (s, 2 H), 8.34 (d, <i>J</i> = 2.1 Hz, 1 H), 8.23 (s, 1 H), 8.08 (s, 1 H), 7.58 (m, 3 H), 7.31 (m, 2 H), 3.18 (m, 2 H), 2.76 (t, <i>J</i> = 7.7 Hz, 2 H), 1.93 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  451 (M+H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>23</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>6</sub> 451.1196, found 451.1205. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 29 and 33. 5-(6-Benzylamino-pyrazin-2-yl)-nicotinic </b><b>Acid Ethyl Ester 29.</b> A mixture of <b>3 </b>(320 mg, 1.22 mmol), benzylamine (144 mg, 1.34 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (32 mg, 0.03 mmol), DPPF (54 mg, 0.096 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (795 mg, 2.44 mmol) in anhydrous dioxane (3.6 mL) was stirred at 110 °C for 39 h under nitrogen. The cooled reaction mixture was concentrated and purified by column chromatography to give 130 mg (28%) of <b>29</b> as a green oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.35 (d, <i>J</i> = 2.2 Hz, 1 H), 9.25 (d, <i>J</i> = 2.0 Hz, 1 H), 8.84 (t, <i>J</i> = 2.0 Hz, 1 H), 8.37 (s, 1 H), 7.94 (s, 1 H), 7.43−7.38 (m, 5 H), 5.13 (m, 1 H), 4.68 (d, <i>J</i> = 5.7 Hz, 2 H), 4.46 (q, <i>J</i> = 7.2 Hz, 2 H), 1.45 (t, <i>J</i> = 7.2 Hz, 3 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>19</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub> 335.1508, found 335.1515. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 30 and 34. </b><b>5-[6-(Benzyl-</b><b><i>tert</i></b><b>-butoxycarbonyl-amino)-pyrazin-2-yl]-nicotinic Acid 30.</b> A mixture of <b>29</b> (220 mg, 1.658 mmol), Boc<sub>2</sub>O (431 mg, 1.98 mmol), and DMAP (30 mg, cat.) in dichloromethane (4.1 mL) was stirred at 20 °C for 4 days. The reaction mixture was concentrated, and the product was purified by column chromatography (EtOAc/hexane as solvent) to give 195 mg (68%) of <b>Boc-29</b> as a white solid:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.27 (dd, <i>J</i> = 7.9, 2.2 Hz, 2 H), 9.22 (s, 1 H), 8.78 (t, <i>J</i> = 2.1 Hz, 1 H), 8.74 (s, 1 H), 7.35−7.21 (m, 5 H), 5.30 (s, 2 H), 4.46 (q, <i>J</i> = 7.1 Hz, 2 H), 1.50 (s, 9 H), 1.43 (t, <i>J</i> = 7.1 Hz, 3 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>24</sub>H<sub>27</sub>N<sub>4</sub>O<sub>4</sub> 435.2032, found 435.2058. </div><div class="NLM_p">A mixture of <b>Boc-29</b> (195 mg, 0.449 mmol) was dissolved in methanol (4.4 mL) and stirred for 10 min then cooled to 0 °C. NaOH<sub>(aq)</sub> (1 N, 0.94 mL) was added slowly, and the mixture was stirred at 0 °C for 10 min and then stirred at 20 °C for another 18 h. Glacial acetic acid (0.8 mL) was added to the reaction mixture at 0 °C slowly followed by the addition of water (3 mL). A solid was formed and was collected by filtration, washed with water (5×), and dried in a vacuum over overnight to give 399 mg (80%) of <b>30</b> as a white solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 9.29 (d, <i>J</i> = 2.0 Hz, 1 H), 9.17 (s, 1 H), 9.15 (d, <i>J</i> = 1.6 Hz, 1 H), 8.94 (t, <i>J</i> = 2.1 Hz, 1 H), 8.90 (s, 1 H), 7.42−7.19 (m, 5 H), 5.30 (s, 2 H), 1.50 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  405 (M − H<sup>+</sup>); Anal. (C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>0<sub>4</sub>·0.4 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 31 and 35. </b><b>Benzyl-[6-(5-</b><b><i>tert</i></b><b>-butoxycarboylamino-pyridin-3-yl)-pyrazin-2-yl]-carbamic acid </b><b><i>tert</i></b><b>-butyl </b><b>Ester 31.</b> A mixture of <b>30</b> (128 mg, 0.315 mmol), DPPA (104 mg, 0.38 mmol), triethylamine (64 mg, 0.68 mmol), and <i>t</i>-BuOH (1.33 mL) in toluene (0.95 mL) was stirred under nitrogen at 70 °C for 30 min and then at 100 °C for 19 h. The reaction mixture was concentrated under a vacuum. The product was purified by column chromatography (EtOAc/hexane as solvent) to give 89 mg (59%) of <b>31</b> as a white solid:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.13 (s, 1 H), 8.81 (d, <i>J</i> = 1.8 Hz, 1 H), 8.69 (s, 1 H), 8.55 (d, <i>J</i> = 2.4 Hz, 1 H), 8.38 (brs, 1 H), 7.35−7.21 (m, 5 H), 6.56 (brs, 1 H), 5.28 (s, 2 H), 1.55 (s, 9 H), 1.50 (s, 9 H); MS (ES) <i>m</i>/<i>z</i> 478 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>General Procedure for the Synthesis of 32 and 36. </b><b>3-[5-(6-Benzylamino-pyrazin-2-yl)-pyridin-3-yl-amino]-propan-1-ol 32.</b> A mixture of <b>31</b> (83 mg, 0.174 mmol), (3-bromopropoxy)-<i>tert</i>-butyl-dimethylsilane (66 mg, 0.26 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (170 mg, 0.522 mmol) in DMF (2.1 mL) was stirred at 70 °C under nitrogen for 3 days. The reaction mixture was diluted with water, extracted with dichloromethane (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The product was purified by column chromatography (EtOAc/hexane as solvent) to give 54 mg of the silylated product as an orange oil. The silylated product was dissolved in TFA (0.6 mL) and stirred at 20 °C for 4 h before it was concentrated. An ammonium hydroxide solution was added to the residue until the pH was about 10−11, and a greenish solid was formed. The greenish solid was collected by filtration, washed with water, and dried under a vacuum. The greenish solid was recrystallized from CH<sub>3</sub>OH/EtOAc to give 10 mg (17% two steps) of <b>32</b> as a light greenish solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.30 (s, 1 H), 8.15 (s, 1 H), 7.93 (brs, 1 H), 7.86 (s, 1 H), 7.54 (s, 1 H), 7.42−7.20 (m, 5 H), 4.64 (s, 2 H), 3.70 (t, <i>J</i> = 6.1 Hz, 2 H), 3.24 (t, <i>J</i> = 6.6 Hz, 2 H), 1.86 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  336 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>19</sub>H<sub>22</sub>N<sub>5</sub>O 336.1824, found 336.1817. </div><div class="NLM_p"><b>5-[6-(3-Chloro-phenoxy)-pyrazin-2-yl]-nicotinic Acid Ethyl Ester 33.</b> Replacing benzylamine with 3-chlorophenol and following the same procedure as in the preparation of <b>29</b> gave <b>33</b> as a solid:  27% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.26 (brs, 2 H), 8.85 (s, 1 H), 8.73 (t, <i>J</i> = 2.1 Hz, 1 H), 8.46 (s, 1 H), 7.39 (t, <i>J</i> = 8.4 Hz, 1 H), 7.30−7.25 (m, 2 H), 7.16 (brd, <i>J</i> = 8.2 Hz, 1 H), 4.44 (q, <i>J</i> = 7.1 Hz, 2 H), 1.43 (t, <i>J</i> = 7.1 Hz, 3 H); Anal. (C<sub>18</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>5-[6-(3-Chloro-phenoxy)-pyrazin-2-yl]-nicotinic Acid 34.</b> Replacing <b>29</b> with <b>33</b> and following the same procedure as in the preparation of <b>30</b> gave <b>34</b> as a solid:  85% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 9.23 (s, 1 H), 9.14 (s, 1 H), 9.00 (s, 1 H), 8.85 (t, <i>J</i> = 2.1 Hz, 1 H), 8.50 (s, 1 H), 7.47 (t, <i>J</i> = 8.1 Hz, 1 H), 7.39−7.23 (m, 3 H); MS (ES) <i>m</i>/<i>z</i>:  326 (M − H<sup>+</sup>); Anal. (C<sub>16</sub>H<sub>10</sub>ClN<sub>3</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>{5-[6-(3-Chloro-phenoxy)-pyrazin-2-yl]-pyridin-3-yl}-carbamic Acid </b><b><i>tert</i></b><b>-Butyl Ester 35.</b> Replacing <b>30</b> with <b>34</b> and following the same procedure as in the preparation of <b>31</b> gave <b>35</b> as a solid:  40% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.81 (s, 1 H), 8.78 (d, <i>J</i> = 1.9 Hz, 1 H), 8.51 (d, <i>J</i> = 2.5 Hz, 1 H), 8.44 (brs, 1 H), 8.40 (s, 1 H), 7.39 (t, <i>J</i> = 8.2 Hz, 1 H), 7.27−7.24 (m, 1 H), 7.17 (d, <i>J</i> = 7.6 Hz, 1 H), 6.57 (brs, 2 H), 1.54 (s, 9 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>20</sub>H<sub>19</sub>ClN<sub>4</sub>O<sub>3</sub> 399.1224, found 399.1241. </div><div class="NLM_p"><b>3-{5-[6-(3-Chloro-phenoxy)-pyrazin-2-yl]-pyridin-3-yl-amino}-propan-1-ol 36.</b> Replacing <b>31</b> with <b>35</b> and following the same procedure as in the preparation of <b>32</b> gave <b>36</b> as a solid:  33% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.87 (s, 1 H), 8.4 (s, 1 H), 8.28 (s, 1 H), 7.96 (d, <i>J</i> = 2.7 Hz, 1 H), 7.49−7.21 (m, 5 H), 3.67 (t, <i>J</i> = 6.3 Hz, 2 H), 3.20 (t, <i>J</i> = 6.9 Hz, 2 H), 1.82 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  357 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>18</sub>H<sub>18</sub>ClN<sub>4</sub>O<sub>2</sub> 357.1118, found 357.1120. </div><div class="NLM_p"><b>[6-(5-Amino-pyridin-3-yl)-pyrazin-2-yl]-(3-chloro-phenyl)-amine 37.</b> Compound <b>6 </b>(100 mg, 0.2 mmol) was dissolved in TFA (2 mL) and stirred at 20 °C for 2 h before it was concentrated. An ammonium hydroxide solution was added to the residue until the pH was about 10−11, water was added and a yellow solid was formed. The yellow solid was collected through filtration, washed with water, and dried under a vacuum to give 54 mg (91%) of <b>37</b> as a light yellow solid:  MS (ES) <i>m</i>/<i>z</i>:  298 (M + H<sup>+</sup>). Anal. (C<sub>15</sub>H<sub>12</sub>ClN<sub>5</sub>) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 38</b><b>−</b><b>41. </b><b>2-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-ethanol 38.</b> A mixture of <b>6 </b>(0.1 g, 0.2 mmol), (2-bromoethoxy)-<i>tert</i>-butyl-dimethylsilane (0.07 g, 0.3 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.197 g, 0.6 mmol) in DMF (4 mL) was stirred at 70 °C under nitrogen for 22 h. The reaction mixture was diluted with water, extracted with ether (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The product was purified by column chromatography (EtOAc/hexane as solvent) to give 0.05 g of the <a name="jm004801504903" id="jm004801504903"></a> silylated product as an oil. The silylated product was dissolved in TFA (1.5 mL) and stirred at 20 °C for 2 h before it was concentrated. An ammonium hydroxide solution was added to the residue until the pH was about 10−11, and a yellow solid was formed. The yellow solid was collected through filtration, washed with water, and dried under a vacuum to give 0.029 g (43%) of <b>38 </b>as a light yellow solid:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.87 (s, 1 H), 8.59 (s, 1 H), 8.46 (s, 1 H), 8.22 (s, 1 H), 8.12 (m, 2 H), 7.61 (d, <i>J</i> = 8.2 Hz, 1 H), 7.52 (s, 1H), 7.37 (t, <i>J</i> = 8.1 Hz, 1 H), 7.03 (d, <i>J</i> = 7.8 Hz, 1 H), 6.10 (t, <i>J</i> = 5.3 Hz, 1 H), 4.79 (t, <i>J</i> = 5.3 Hz, 1 H), 3.63 (m, 2 H), 3.25 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  342 (M+H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>17</sub>H<sub>16</sub>ClN<sub>5</sub>O 342.1122, found 342.1128. </div><div class="NLM_p"><b>4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butan-1-ol 39. </b>Replacing (2-bromoethoxy)-<i>tert</i>-butyl-dimethylsilane with (4-bromobutoxy)-<i>tert</i>-butyl-dimethylsilane and following the same procedure as in the preparation of <b>38</b> gave <b>39</b> as a light yellow solid:  64% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (s, 1 H), 8.60 (s, 1 H), 8.45 (s, 1 H), 8.20 (m, 2 H), 8.08 (d, <i>J</i> = 2.5 Hz, 1 H), 7.56 (d, <i>J</i> = 8.2 Hz, 1 H), 7.48 (s, 1H), 7.36 (t, <i>J</i> = 8.0 Hz, 1 H), 7.03 (dd, <i>J</i> = 7.7, 1.4 Hz, 1 H), 6.12 (t, <i>J</i> = 5.2 Hz, 1 H), 4.45 (t, <i>J</i> = 5.1 Hz, 1 H), 3.44 (q, <i>J</i> = 6.1 Hz, 2 H), 3.15 (q, <i>J</i> = 6.2 Hz, 2 H), 1.59 (m, 4 H); MS (ES) <i>m</i>/<i>z</i>:  370 (M + H<sup>+</sup>). Anal. (C<sub>19</sub>H<sub>20</sub>ClN<sub>5</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-</b><b><i>N</i></b>‘<b>,</b><b><i>N</i></b>‘<b>-dimethyl-propane-1,3-di</b><b>amine 40.</b> Replacing (2-bromoethoxy)-<i>tert</i>-butyl-dimethylsilane with 3-chloro-<i>N</i>,<i>N</i>-dimethylamine and following the same procedure as in the preparation of <b>38</b> gave <b>40</b> as a light yellow solid:  43% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.42 (m, 2 H), 8.16 (t, <i>J</i> = 2.0 Hz, 1 H), 8.10 (s, 1 H), 8.00 (d, <i>J</i> = 2.6 Hz, 1 H), 7.63 (t, <i>J</i> = 2.0 Hz, 1 H), 7.48 (dd, <i>J</i> = 7.5, 1.2 Hz, 1 H), 7.28 (t, <i>J</i> = 8.0 Hz, 1 H), 6.98 (dd, <i>J</i> = 7.2, 1.1 Hz, 1 H), 3.27 (m, 2 H), 2.54 (brt, <i>J</i> = 7.5 Hz, 2 H), 2.30 (s, 6 H), 1.88 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  383 (M + H<sup>+</sup>). Anal. (C<sub>20</sub>H<sub>23</sub>N<sub>6</sub>OCl·0.9 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-</b><b><i>N</i></b>‘<b>,</b><b><i>N</i></b>‘<b>-dimethyl-ethane-1,2-dia</b><b>mine 41.</b> Replacing (2-bromoethoxy)-<i>tert</i>-butyl-dimethylsilane with 2-dimethylaminoethyl chloride hydrochloride and following the same procedure as in the preparation of <b>38</b> gave <b>41</b> as a light yellow solid:  41% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.44 (m, 2 H), 8.13 (m, 2 H), 8.02 (d, <i>J</i> = 2.7 Hz, 1 H), 7.65 (m, 1 H), 7.52 (dd, <i>J</i> = 2.0, 0.9 Hz, 1 H), 7.29 (t, <i>J</i> = 8.0 Hz, 1 H), 7.00 (dd, <i>J</i> = 2.0, 0.9 Hz, 1 H), 3.36 (t, <i>J</i> = 6.5 Hz, 2 H), 2.64 (t, <i>J</i> = 6.5 Hz, 2 H), 2.32 (s, 6 H); MS (ES) <i>m</i>/<i>z</i>:  369 (M + H<sup>+</sup>). Anal. (C<sub>19</sub>H<sub>21</sub>ClN<sub>6</sub>) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 42 and 43. </b><b>5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-</b><b><i>N</i></b><b>-(2</b><b>-(dimethylamino)-</b><b>ethyl)-nicotinamide 42.</b> A mixture compound <b>5 </b>(0.05 g, 0.12 mmol), <i>N</i>,<i>N</i>-dimethylethylenediamine (0.01 g, 0.12 mmol), diisopropylethylamine (0.06 g, 0.47 mmol), and HATU (0.045 g, 0.12 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was stirred at 20 °C under N<sub>2</sub> for 2 days. Solvent was removed, and the product was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/acetic acid as solvent) to give 0.02 g of product. The above product was dissolved in TFA (1.0 mL) and stirred at 20 °C for 1 h before concentration. An ammonium hydroxide solution was added to the residue until the pH was about 10−11, and a yellow solid was formed. The yellow solid was collected through filtration, washed with water, and dried under a vacuum to give 0.005 g (11%) of <b>42 </b>as a yellow solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 9.39 (s, 1 H), 9.06 (s, 1 H), 8.91 (s, 1 H), 8.59 (s, 1 H), 8.19 (s, 1 H), 8.07 (s, 1 H), 7.59 (d, <i>J</i> = 8.3 Hz, 1 H), 7.32 (t, <i>J</i> = 8.1 Hz, 1 H), 7.02 (d, <i>J</i> = 7.8 Hz, 1 H), 3.60 (t, <i>J</i> = 6.7 Hz, 2 H), 2.63 (t, <i>J</i> = 6.7 Hz, 2 H), 2.34 (s, 6 H); MS (ES) <i>m</i>/<i>z</i>:  397 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>20</sub>H<sub>21</sub>ClN<sub>6</sub>O 397.1543, found 397.1555. </div><div class="NLM_p"><b>5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-</b><b><i>N</i></b><b>-(3-hydroxy-propyl)-nicotinamide 43.</b> Replacing <i>N</i>,<i>N</i>-dimethylethylenediamine with 3-amino-1-propanol and following the same procedure as in the preparation of <b>42</b> gave <b>43</b> as a light yellow solid:  41% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 9.38 (d, <i>J</i> = 2.0 Hz, 1 H), 9.02 (d, <i>J</i> = 2.0 Hz, 1 H), 8.86 (t, <i>J</i> = 2.0 Hz, 1 H), 8.58 (s, 1 H), 8.19 (s, 1 H), 8.06 (t, <i>J</i> = 2.0 Hz, 1 H), 7.59 (dd, <i>J</i> = 8.2, 1.3 Hz, 1 H), 7.31 (t, <i>J</i> = 8.0 Hz, 1 H), 7.02 (dd, <i>J</i> = 7.9, 1.1 Hz, 1 H), 3.68 (t, <i>J</i> = 6.2 Hz, 2 H), 3.55 (m, 2 H), 1.88 (t, <i>J</i> = 6.6 Hz, 2 H); MS (ES) <i>m</i>/<i>z</i>:  384 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>19</sub>H<sub>19</sub>ClN<sub>5</sub>O<sub>2</sub> 384.1218, found 384.1227. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 44</b><b>−</b><b>49. </b><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-hydroxy-acetamide 44.</b> A mixture of compound<b> 6</b> (250 mg, 0.5 mmol) and 60% NaH (150 mg, 3.5 mmol) in THF (9 mL) was stirred under nitrogen at 20 °C for 0.5 h before acetoxyacetyl chloride (478 mg, 3.5 mmol) was added. The reaction was stirred at reflux for 18 h and cooled to room temperature. Water was added, and the reaction mixture was extracted with ethyl acetate. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated, and purified by column chromatography (EtOAc/acetone as solvent) to give 70 mg of the Boc-protected amide as an oil. The Boc-protected amide was stirred in dichloromethane (1.3 mL) and TFA (0.42 mL) at 20 °C for 60 h before concentrated. Ammonium hydroxide solution was added to the residue until the pH was about 10−11 and was then extracted with ethyl acetate. The ethyl acetate layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and then concentrated under a vacuum and purified by column chromatography (EtOAc/acetone as solvent) to give 26 mg (13%) of <b>acetyl</b>-<b>44</b> as an off-white solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.91 (brs, 1 H), 8.75 (brs, 2 H), 8.42 (brs, 1 H), 8.10 (brs, 1 H), 7.83−7.56 (m, 2 H), 7.28 (m, 1 H), 6.96 (m, 1 H), 4.85 (s, 2 H), 2.21 (s, 3 H); MS (ES) <i>m</i>/<i>z</i>:  398 (M + 1<sup>+</sup>). </div><div class="NLM_p">A mixture of <b>acetyl-44 </b>(26 mg, 0.065 mmol), K<sub>2</sub>CO<sub>3</sub> (5.4 mg, 0.04 mmol), H<sub>2</sub>O (0.1 mL), and methanol (3.4 mL) was heated at reflux for 1 min. Crystals were recovered by filtration and purified by recrystallization from methanol to give 5 mg (22%) of <b>44 </b>as an off-white solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 10.10 (s, 1 H), 9.89 (s, 1 H), 8.98−8.88 (m, 3 H), 8.60 (s, 1 H), 8.26 (s, 1 H), 7.89−7.86 (m, 2 H), 7.40 (t, <i>J</i> = 8.2 Hz, 1 H), 7.04 (d, <i>J</i> = 7.2 Hz, 1 H), 5.81 (m, 1 H), 4.08 (d, <i>J</i> = 5.5 Hz, 2 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>17</sub>H<sub>14</sub>ClN<sub>5</sub>O<sub>2</sub> 356.0914, found 356.0927. </div><div class="NLM_p"><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-methoxy-acetamide 45.</b> Replacing acetoxyacetyl chloride with methoxyacetyl chloride and following the same procedure as in the preparation of <b>44</b> gave <b>45</b> as a yellow solid:  21% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.98 (s, 1 H), 8.86 (brs, 2 H), 8.48 (s, 1 H), 8.15 (s, 1 H), 7.92 (s, 1 H), 7.72 (d, <i>J</i> = 8.1 Hz, 1 H), 7.32 (t, <i>J</i> = 8.0 Hz, 1 H), 6.99 (d, <i>J</i> = 7.8 Hz, 1 H), 4.11 (s, 2 H), 3.52 (s, 3 H); MS (ES) <i>m</i>/<i>z</i>:  370 (M + H<sup>+</sup>). </div><div class="NLM_p"><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-3-methoxy-propionamide 46.</b> Replacing acetoxyacetyl chloride with 3-methoxypropanoyl chloride and following the same procedure as in the preparation of <b>44</b> gave <b>46</b> as an off-white solid:  26% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.35 (s, 1 H), 9.89 (s, 1 H), 8.96 (s, 1 H), 8.81 (s, 1 H), 8.78 (s, 1 H), 8.60 (s, 1 H), 8.26 (s, 1 H), 7.88 (brs, 1 H), 7.84 (brs, 1 H), 7.40 (t, <i>J</i> = 8.1 Hz, 1 H), 7.04 (dd, <i>J</i> = 7.8, 1.1 Hz, 1 H), 3.66 (t, <i>J</i> = 6.1 Hz, 2 H), 3.26 (s, 3 H), 2.63 (t, <i>J</i> = 6.1 Hz, 2 H); Anal. (C<sub>19</sub>H<sub>18</sub>ClN<sub>5</sub>O<sub>2</sub>·0.2 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-benzyloxy-acetamide 47.</b> Replacing acetoxyacetyl chloride with benzyloxyacetyl chloride and following the same procedure as in the preparation of <b>44</b> gave <b>47</b> as an off-white solid:  22% yield; <sup>1</sup>H NMR (300 MHz, -DMSO-<i>d</i><sub>6</sub>) δ 10.21 (s, 1 H), 9.89 (s, 1 H), 8.99 (d, <i>J</i> = 1.7 Hz, 1 H), 8.86 (brs, 1 H), 8.61 (s, 1 H), 8.27 (s, 1 H), 7.90 (brs, 1 H), 7.86 (d, <i>J</i> = 8.1 Hz, 1 H), 7.45−7.30 (m, 6 H), 7.03 (d, <i>J</i> = 9.4 Hz, 1 H), 4.67 (s, 2 H), 4.18 (s, 2 H); Anal. (C<sub>24</sub>H<sub>20</sub>ClN<sub>5</sub>O<sub>2</sub>·0.2 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-2-phenoxy-acetamide 48.</b> Replacing acetoxyacetyl chloride with phenoxyacetyl chloride and following the same procedure as in the preparation of <b>44</b> gave <b>48</b> as an off-white solid:  23% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (s, 1 H), 9.89 (s, 1 H), 9.00 (d, <i>J</i> = 1.6 Hz, 1 H), 8.86 (brs, 2 H), 8.62 (s, 1 H), 8.26 (s, 1 H), 7.87 (s, 1 H), 7.84 (s, 1 H), 7.34 (t, <i>J</i> = <a name="jm004801504904" id="jm004801504904"></a> 7.6 Hz, 3 H), 7.07−6.97 (m, 4 H), 4.79 (s, 2 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>23</sub>H<sub>18</sub>ClN<sub>5</sub>O<sub>2</sub> 432.1227, found 432.1238. </div><div class="NLM_p"><b><i>N</i></b><b>-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-yl}-4</b><b>-(dimethylamino)-</b><b>benzamide </b><b>49.</b> Replacing acetoxyacetyl chloride with 4-dimethylaminobenzoyl chloride and following the same procedure as in the preparation of <b>44</b> gave <b>49</b> as an off-white solid:  49% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97 (m, 3 H), 8.63 (s, 1 H), 8.27 (s, 1 H), 7.96 (m, 3 H), 7.92 (s, 1 H), 7.84 (dd, <i>J</i> = 8.2, 1.3 Hz, 1 H), 7.41 (t, <i>J</i> = 8.0 Hz, 1 H), 7.04 (dd, <i>J</i> = 7.9, 1.4 Hz, 1 H), 6.79 (d, <i>J</i> = 9.0 Hz, 2 H), 3.02 (s, 6 H); MS (ES) <i>m</i>/<i>z</i>:  445 (M + H<sup>+</sup>). Anal. (C<sub>24</sub>H<sub>21</sub>N<sub>6</sub>OCl·1.15 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>General Procedure for the Synthesis of 50</b><b>−</b><b>62. </b><b><i>N</i></b><b>-(3-Chlorophenyl)-6-[5-[[3-(1-piperazinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine 50.</b> 1-(3-Chloropropyl)-piperazine hydrochloride (1 g, 4.1 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and treated with Boc<sub>2</sub>O (1.78 g, 8.2 mmol), DMAP (cat.), and Et<sub>3</sub>N (2.06 g, 20 mol). The reaction mixture was stirred at room temperature for 5 h and then refluxed overnight. The solvent was removed under a vacuum, and the product was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH as solvent) to give 1 g (93%) of 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.60 (t, <i>J</i> = 6.5 Hz, 2 H), 3.42 (t, <i>J</i> = 5.0 Hz, 4 H), 2.48 (t, <i>J</i> = 6.9 Hz, 2 H), 2.38 (t, <i>J</i> = 5.0 Hz, 4 H), 1.94 (m, 2 H), 1.46 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  263 (M + H<sup>+</sup>). </div><div class="NLM_p">A mixture of compound<b> 6 </b>(0.1 g, 0.2 mmol), 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester (0.079 g, 0.3 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.197 g, 0.6 mmol) in DMF (4 mL) was stirred at 70 °C under nitrogen for 20 h. The reaction mixture was diluted with water, extracted with ether (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The product was purified by column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH as solvent) to give 0.192 g of product as an oil. The oil was dissolved in TFA (2.0 mL) and stirred at 20 °C for 2 h before concentrated. Ammonium hydroxide solution was added to the residue until the pH was about 10−11, and a yellow solid was formed. The yellow solid was collected through filtration, washed with water, and dried under a vacuum to give 0.072 g (65%) of<b> 50</b> as a yellow solid:  <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (m, 2 H), 8.18 (d, <i>J</i> = 2.0 Hz, 1 H), 8.11 (s, 1 H), 8.00 (d, <i>J</i> = 2.5 Hz, 1 H), 7.65 (s, 1 H), 7.49 (brd, <i>J</i> = 8.0 Hz, 1 H), 7.29 (t, <i>J</i> = 8.0 Hz, 1 H), 6.99 (d, <i>J</i> = 7.0 Hz, 1 H), 3.30 (m, 2 H), 2.86 (m, 4 H), 2.51 (m, 6 H), 1.88 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  424 (M + H<sup>+</sup>). Anal. (C<sub>22</sub>H<sub>26</sub>N<sub>7</sub>Cl·0.9 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(3-Chlorophenyl)</b><b>-</b><b>(6-{5-[3-(4-methyl-piperazin-1-yl)-propylamino]-pyridin-3-yl}-pyrazin-2-</b><b>yl)-amine</b><b>51. </b>Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 1-(3-chloropropyl)-4-methylpiperazine dihydrochloride and following the same procedure as in the preparation of <b>50</b> gave <b>51</b> as a solid:  61% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.51 (s, 2 H), 8.16 (s, 1 H), 7.90 (t, <i>J</i> = 2.0 Hz, 1 H), 7.50 (t, <i>J</i> = 1.9 Hz, 1 H), 7.30 (m, 2 H), 7.06 (m, 1 H), 6.73 (s, 1 H), 5.42 (brs, 1 H), 3.33 (t, <i>J</i> = 5.3 Hz, 2 H), 2.55 (t, <i>J</i> = 6.3 Hz, 8 H), 2.30 (s, 3 H), 1.87 (m, 2 H), 1.66 (m, 2 H); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>23</sub>H<sub>29</sub>ClN<sub>7</sub> 438.2173, found 438.2180. </div><div class="NLM_p"><b><i>N</i></b><b>-[5-[6-[(3-Chlorophenyl)amino]pyrazinyl]-3-pyridinyl]-4-morpholinepropanamine 52.</b> Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with morpholinopropyl chloride and following the same procedure as in the preparation of <b>50</b> gave <b>52</b> as an off-white solid:  62% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 1 H), 8.39 (d, <i>J</i> = 1.5 Hz, 1 H), 8.16 (d, <i>J</i> = 1.9 Hz, 1 H), 8.09 (s, 1 H), 7.99 (d, <i>J</i> = 2.3 Hz, 1 H), 7.64 (s, 1 H), 7.47 (d, <i>J</i> = 7.8. Hz, 1 H), 7.27 (t, <i>J</i> = 8.0 Hz, 1 H), 6.98 (d, <i>J</i> = 7.9 Hz, 1 H), 3.66 (m, 4 H), 3.28 (m, 2 H), 2.49 (m, 6 H), 1.85 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  425 (M + H<sup>+</sup>). Anal. (C<sub>22</sub>H<sub>25</sub>N<sub>6</sub>OCl·0.55 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(3-Chlorophenyl)-{6-[5-(3-piperidin-1-yl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine </b><b>53. </b>Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 1-(3-chloropropyl)piperidine and following the same procedure as in the preparation of <b>50</b> gave <b>53</b> as a light yellow solid:  83% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.46 (s, 1 H), 8.42 (s, 1 H), 8.16 (s, 1 H), 8.11 (s, 1 H), 8.00 (s, 1 H), 7.65 (s, 1 H), 7.49 (d, <i>J</i> = 9.0 Hz, 1 H), 7.29 (t, <i>J</i> = 8.0 Hz, 1 H), 6.99 (d, <i>J</i> = 8.0 Hz, 1 H) 3.28 (m, 2 H), 2.57 (m, 6 H), 1.90 (m, 2 H), 1.63 (m, 4 H), 1.49 (d, <i>J</i> = 4.4 Hz, 2 H); MS (ES) <i>m</i>/<i>z</i>:  423 (M + H<sup>+</sup>). Anal. (C<sub>23</sub>H<sub>27</sub>N<sub>6</sub>Cl·0.7 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Chlorophenyl)-6-[5-[[(tetrahydro-2</b><b><i>H</i></b><b>-pyran-4-yl)methyl]amino]-3-pyridinyl]-2-pyrazi</b><b>namine 54.</b> Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with tetrahydropyranyl-4-methanesulfonate ester<sup>36</sup> and following the same procedure as in the preparation of <b>50</b> gave <b>54</b> as an off-white solid:  83% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.53 (m, 2 H), 8.17 (s, 1 H), 8.10 (d, <i>J</i> = 2.6 Hz, 1 H), 7.90 (brs, 1 H), 7.53 (t, <i>J</i> = 2.2 Hz, 1 H), 7.29 (m, 2 H), 7.07 (m, 1 H), 6.69 (s, 1 H), 4.02 (dd, <i>J</i> = 11.3, 4.3 Hz, 2 H), 3.92 (brs, 1 H), 3.40 (td, <i>J</i> = 11.9, 1.8 Hz, 2 H), 3.17 (t, <i>J</i> = 6.0 Hz, 2 H), 1.90 (m, 1 H), 1.74 (brd, <i>J</i> = 12.8 Hz, 2 H), 1.42 (qd, <i>J</i> = 12.2, 4.2 Hz, 2 H); MS (ES) <i>m</i>/<i>z</i>:  396 (M + H<sup>+</sup>). Anal. (C<sub>21</sub>H<sub>22</sub>N<sub>5</sub>ClO·0.2 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Chlorophenyl)-6-[5-[[4-(4-pyridinyl)butyl]amino]-3-pyridinyl]-2-pyrazinamine 55.</b> Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 4-(4-pyridinyl)butyl chloride<sup>37</sup> and following the same procedure as in the preparation of <b>50</b> gave <b>55</b> as a light yellow solid:  74% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.52 (m, 4 H), 8.17 (s, 1 H), 8.09 (d, <i>J</i> = 2.3 Hz, 1 H), 7.92 (s, 1 H), 7.50 (s, 1 H), 7.28 (s, 1 H), 7.12 (d, <i>J</i> = 5.4 Hz, 2 H), 7.06 (m, 1 H), 6.83 (s, 1 H), 3.81 (brs, 1 H), 3.26 (q, <i>J</i> = 5.9 Hz, 2 H), 2.69 (t, <i>J</i> = 7.0 Hz, 2 H), 1.77 (m, 4 H); MS (ES) <i>m</i>/<i>z</i>:  431 (M + H<sup>+</sup>). Anal. (C<sub>24</sub>H<sub>23</sub>N<sub>6</sub>Cl·0.3 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Chlorophenyl)-6-[5-[[3-(3-pyridinyl)propyl]amino]-3-pyridinyl]-2-pyrazinamine 56.</b> Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 3-(3-chloropropyl)pyridine<sup>35</sup> and following the same procedure as in the preparation of <b>50</b> gave <b>56</b> as a yellow solid:  78% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.55 (m, 4 H), 8.24 (s, 1 H), 8.07 (s, 1 H), 7.81 (m, 2 H), 7.54 (m, 2 H), 7.27 (m, 2 H), 7.06 (d, <i>J</i> = 7.1 Hz, 1 H), 3.95 (m, 1 H), 3.28 (m, 2 H), 2.80 (t, <i>J </i>= 7.3 Hz, 2 H), 2.05 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  417 (M + H<sup>+</sup>). Anal. (C<sub>23</sub>H<sub>21</sub>N<sub>6</sub>Cl·0.7 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Chlorophenyl)-6-[5-[[3-(1</b><b><i>H</i></b><b>-pyrazol-1-yl)propyl]amino]-3-pyridinyl]-2-pyrazinamine </b><b>57.</b> 1-Bromo-3-chloropropane (11.3 g, 72 mmol) was added dropwise to a vigorously stirred ice-cooled mixture of pyrazole (5.0 g, 73 mmol), K<sub>2</sub>CO<sub>3</sub> (10.0 g, 73 mmol), and acetone (95 mL). After 3 h, the cooling bath was removed, and the reaction mixture was stirred at 20 ° C for 5 days and then filtered. The filtrate was concentrated, and product was purified by column chromatography (using EtOAc/hexane as solvent) to give 3.3 g (31%) of 1-(3-chloro-propyl)-1<i>H</i>-pyrazole as a clear oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.52 (d, <i>J</i> = 1.5 Hz, 1 H), 7.42 (d, <i>J</i> = 2.1 Hz, 1 H), 6.24 (t, <i>J</i> = 2.0 Hz, 1 H), 4.32 (t, <i>J</i> = 6.4 Hz, 2 H), 3.45 (t, <i>J</i> = 6.0 Hz, 2 H), 2.32 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  145 (M + H<sup>+</sup>). </div><div class="NLM_p">Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 1-(3-chloro-propyl)-1<i>H</i>-pyrazole and following the same procedure as in the preparation of <b>50</b> gave <b>57</b> as an off-white solid:  90% yield; <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 8.43 (s, 2 H), 8.10 (d, <i>J</i> = 7.9 Hz, 2 H), 7.98 (s, 1 H), 7.60 (m, 4 H), 7.27 (t, <i>J</i> = 8.0 Hz, 1 H), 6.98 (d, <i>J</i> = 7.9 Hz, 1 H), 6.26 (s, 1 H), 4.31 (t, <i>J</i> = 6.7 Hz, 2 H), 3.19 (t, <i>J</i> = 6.7 Hz, 2 H), 2.19 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  406 (M + H<sup>+</sup>). Anal. (C<sub>21</sub>H<sub>20</sub>N<sub>7</sub>Cl·0.3 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-Chlorophenyl)-6-[5-[[3-(1</b><b><i>H</i></b><b>-1,2,4-triazol-1-yl)propyl]amino]-3-pyridinyl]-2-pyrazinam</b><b>ine 58.</b> 1-Bromo-3-chloropropane (11.3 g, 72 mmol) was added dropwise under N<sub>2</sub> to a vigorously stirred ice-cooled mixture of 1,2,4-triazole (5.0 g, 72 mmol), K<sub>2</sub>CO<sub>3</sub> (10.0 g, 73 mmol), and acetone (95 mL). After 3 h, the cooling bath was removed, and the reaction mixture stirred at 20 ° C for 5 days and then filtered. The filtrate was concentrated, and the product was purified by column chromatography (EtOAc/hexane as solvent) to give 7.1 g (68%) of 1-(3-chloro-propyl)-1<i>H</i>-[1,2,4]triazole as a clear oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1 H), 7.96 (s, 1 H), 4.38 <a name="jm004801504905" id="jm004801504905"></a> (t, <i>J</i> = 6.4 Hz, 2 H), 3.48 (t, <i>J</i> = 6.0 Hz, 2 H), 2.35 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  146 (M + H<sup>+</sup>). </div><div class="NLM_p">Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 1-(3-chloro-propyl)-1<i>H</i>-[1,2,4]triazole and following the same procedure as in the preparation of <b>50</b> gave <b>58</b> as a yellow solid:  86% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (s, 1 H), 8.59 (s, 1 H), 8.52 (s, 1 H), 8.47 (s, 1 H), 8.23 (s, 1 H), 8.12 (t, <i>J</i> = 1.9 Hz, 1 H), 8.08 (d, <i>J</i> = 2.6 Hz, 1 H), 7.96 (s, 1 H), 7.59 (d, <i>J</i> = 9.5 Hz, 1 H), 7.47 (s, 1 H), 7.33 (t, <i>J</i> = 8.1 Hz, 1 H), 7.02 (dd, <i>J</i> = 7.7, 1.6 Hz, 1 H), 6.23 (t, <i>J</i> = 5.5 Hz, 1 H), 4.33 (t, <i>J</i> = 6.9 Hz, 1 H), 3.15 (m, 2 H), 2.12 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  407 (M + H<sup>+</sup>). Anal. (C<sub>20</sub>H<sub>19</sub>N<sub>8</sub>Cl·0.4 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(3-Chloro-phenyl)-{6-[5-(3-phenyl-propylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine 59. </b>Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 1-chloro-3-phenylpropane and following the same procedure as in the preparation of <b>50</b> gave <b>59</b> as an off-white solid:  47% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (s, 1 H), 8.58 (s, 1 H), 8.45 (brs, 1 H), 8.22 (s, 1 H), 8.16 (s, 1 H), 8.09 (brs, 1 H), 7.56 (d, <i>J</i> = 8.0 Hz, 1 H), 7.47 (s, 1 H), 7.26 (m, 6 H), 7.02 (d, <i>J</i> = 7.9 Hz, 1 H), 6.19 (t, <i>J</i> = 5.5 Hz, 1 H), 3.17 (m, 2 H), 2.72 (t, <i>J</i> = 7.4 Hz, 2 H), 1.89 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  416 (M + H<sup>+</sup>). Anal. (C<sub>24</sub>H<sub>22</sub>N<sub>5</sub>Cl·0.1 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(3-Chloro-phenyl)-{6-[5-(2-phenoxy-ethylamino)-pyridin-3-yl]-pyrazin-2-yl}-amine 60. </b>Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with beta-bromophenetole and following the same procedure as in the preparation of <b>50</b> gave <b>60</b> as a yellow solid:  68% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (s, 1 H), 8.61 (s, 1 H), 8.49 (s, 1 H), 8.23 (s, 1 H), 8.14 (s, 1 H), 7.66 (m, 2 H), 7.31 (m, 3 H), 6.98 (m, 4 H), 6.39 (brs, 1 H), 4.19 (t, <i>J</i> = 5.2 Hz, 2 H), 3.59 (d, <i>J</i> = 5.3 Hz, 2 H); MS (ES) <i>m</i>/<i>z</i>:  418 (M + H<sup>+</sup>). Anal. (C<sub>23</sub>H<sub>20</sub>N<sub>5</sub>ClO·0.2 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-butyric acid 61. </b>4-Chlorobutyryl chloride (14.1 g, 100 mmol) was added over 15 min to a cooled mixture of pyridine (7.91 g, 100 mmol) and <i>t</i>-BuOH (10.52 g, 125 mmol). The mixture was stirred at room temperature for 18 h. 10% Sulfuric acid (50 mL) was added, and the oil that was formed was separated. The aqueous layer was extracted with ether (30 mL), and the ether extract was combined with the oil. The combined organic layer was washed with water and dried (Na<sub>2</sub>SO<sub>4</sub>) to give 8.9 g (50%) of 4-chloro-butyric acid <i>tert</i>-butyl ester:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 3.58 (t, <i>J</i> = 6.4 Hz, 2 H), 2.40 (t, <i>J</i> = 7.2 Hz, 2 H), 2.04 (m, 2 H), 1.45 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  179 (M+H<sup>+</sup>). </div><div class="NLM_p">Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 4-chloro-butyric acid <i>tert</i>-butyl ester and following the same procedure as in the preparation of <b>50</b> gave <b>61</b> as a yellow solid:  27% yield; <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (brs, 1 H), 9.85 (s, 1 H), 8.60 (s, 1 H), 8.46 (s, 1 H), 8.22 (s, 1 H), 8.15 (s, 1 H), 8.08 (s, 1 H), 7.59 (d, <i>J</i> = 9.3 Hz, 1 H), 7.51 (s, 1 H), 7.36 (t, <i>J</i> = 8.1 Hz, 1 H), 7.03 (d, <i>J</i> = 7.8 Hz, 1 H), 6.19 (m, 1 H), 3.14 (q, <i>J</i> = 6.2 Hz, 2 H), 2.36 (t, <i>J</i> = 7.2 Hz, 2 H), 1.83 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  384 (M+H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>19</sub>H<sub>19</sub>ClN<sub>5</sub>O<sub>2</sub> 384.1227, found 384.1234. </div><div class="NLM_p"><b>4-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-1-piperidin-1-yl-butan-1</b><b>-one 62.</b> Replacing 4-(3-chloropropyl)-piperazine-1-carboxylic acid <i>tert</i>-butyl ester with 1-(4-chloro-1-oxobutyl)-piperidine and following the same procedure as in the preparation of <b>50</b> gave <b>62</b> as a yellow solid:  47% yield; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.51 (s, 2 H), 8.17 (s, 1 H), 8.09 (d, <i>J</i> = 2.7 Hz, 1 H), 7.87 (t, <i>J</i> = 2.0 Hz, 1 H), 7.54 (t, <i>J</i> = 2.2 Hz, 1 H), 7.31 (m, 2 H), 7.05 (dd, <i>J</i> = 3.4, 1.5 Hz, 1 H), 6.73 (s, 1 H), 4.45 (brs, 1 H), 3.56 (t, <i>J</i> = 5.9 Hz, 2 H), 3.38 (t, <i>J</i> = 5.4 Hz, 2 H), 3.32 (q, <i>J</i> = 6.7 Hz, 2 H), 2.48 (t, <i>J</i> = 6.7 Hz, 2 H), 2.05 (m, 2 H), 1.53 (m, 6 H); MS (ES) <i>m</i>/<i>z</i>:  451 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>24</sub>H<sub>27</sub>ClN<sub>6</sub>O 451.2017, found 451.2013. </div><div class="NLM_p"><b>(6-Amino-5-bromo-pyridin-3-yl)-carbamic Acid Benzyl Ester 64.</b> Bromine (2.3 mL, 44.6 mmol) was added dropwise to a suspension of the 6-aminonicotinic acid <b>63</b> (5.08 g, 36.8 mmol) in water (20 mL) at 4 °C. After the completion of the addition, the cooling bath was removed, and the reaction mixture was stirred at room temperature for 4.5 h. Saturated Na<sub>2</sub>S<sub>2</sub>O<sub>5</sub> was added slowly to the stirred mixture. The solid was collected through filtration, washed with water, and dried under a vacuum overnight to give 9.30 g of 6-amino-5-bromonicotinic acid along with 3,5-dibromo-2-aminopyridine in an ∼1:1 ratio as a greenish solid; MS (ES) <i>m</i>/<i>z</i>:  217 (M + H<sup>+</sup>). </div><div class="NLM_p">A mixture of the solid (4.00 g) containing 6-amino-5-bromonicotinic acid, DPPA (6.08 g, 22.1 mmol), triethylamine (2.80 g, 27.7 mmol), benzyl alcohol (3.8 mL, 36.8 mmol), and toluene (50 mL) was heated at 70 °C for 1 h and then at 100 °C for 1 h. After concentration of the sample, the reaction mixture was purified by flash chromatography (EtOAc/hexane as solvent) to give 1.31 g (26% in two steps) of compound <b>64</b> as a yellow solid:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.99 (brs, 1 H), 7.91(d, <i>J</i> = 2.3 Hz, 1 H), 7.39−7.34 (m, 5 H), 6.50 (brs, 1 H), 5.19 (s, 2 H), 4.79 (brs, 2 H); MS (ES) <i>m</i>/<i>z</i>:  324 (M + H<sup>+</sup>). Anal. (C<sub>13</sub>H<sub>12</sub>BrN<sub>3</sub>O<sub>2</sub><b>.</b>0.1 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(6-Amino-5-bromo-pyridin-3-yl)-[3-(</b><b><i>tert</i></b><b>-butyl-diphenyl-silanyloxy)-propyl]-carbamic</b><b>Acid </b><b>Benzyl Ester 65.</b> A mixture of compound <b>64</b> (685 mg, 2.13 mmol), (3-bromopropoxy)-<i>tert</i>-butyldiphenylsilane (965 mg, 2.56 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.04 g, 3.19 mmol) in dry DMF (20 mL) was heated at 70 °C for 3 h. The reaction mixture was concentrated and purified by column chromatography (EtOAc/hexane as solvent) to give 1.06 g (81%) of compound <b>65</b> as a yellow oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.88 (brs, 1 H), 7.61−7.58 (m, 5 H), 7.51 (brs, 1 H), 7.41−7.30 (m, 10 H), 5.12 (s, 2 H), 4.93 (s, 2 H), 3.74 (t, <i>J</i> = 7.4 Hz, 2 H), 3.65 (t, <i>J</i> = 6.0 Hz, 2 H), 1.82−1.73 (m, 2 H), 1.00 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  620 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>(5-Bromo-6-fluoro-pyridin-3-yl)-[3-(</b><b><i>tert</i></b><b>-butyl-diphenyl-silanyloxy)-propyl]-carbamic Acid </b><b>Benzyl Ester 66.</b> Nitrosonium tetrafluoroborate (170 mg, 1.45 mmol) was added to the solution of compound <b>65</b> (680 mg, 1.10 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) at 4 °C. After 1 h at 4 °C, more NOBF<sub>4</sub> (50 mg, 0.43 mmol) was added followed by the same amount of NOBF<sub>4</sub> (50 mg, 0.43 mmol) after another 1 h. After stirring of the sample for total 3 h at 4 °C, water was added. The aqueous solution was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried, concentrated, and flash chromatographed (EtOAc/hexane) to give 425 mg (62%) of compound <b>66</b> as a yellow oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.24 (d, <i>J</i> = 2.3 Hz, 1 H), 7.84 (brs, 1 H), 7.59−7.56 (m, 5 H), 7.45−7.27 (m, 10 H), 5.15 (s, 2 H), 3.83 (m, 2 H), 3.65 (t, <i>J</i> = 5.9 Hz, 2 H), 1.79 (m, 2 H), 1.00 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  645 (M + Na<sup>+</sup>). Anal. (C<sub>32</sub>H<sub>34</sub>BrFN<sub>2</sub>O<sub>3</sub>Si<b>.</b>0.50 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>[6-(5-{Benzyloxycarbonyl-[3-(</b><b><i>tert</i></b><b>-butyl-diphenyl-silanyloxy)-propyl]-amino}-2-fluoro-pyrid</b><b>in-3-yl)-pyrazin-2-yl]-(3-chloro-phenyl)-carbamic Acid </b><b><i>tert</i></b><b>-Butyl Ester 69.</b> A mixture of compound <b>66</b> (405 mg, 0.652 mmol), bis(trimethyltin) (427 mg, 1.30 mmol), tetrakis(triphenylphosphine) palladium (76 mg, 0.066 mmol), LiCl (110 mg, 2.59 mmol), and 2,6-di-<i>tert</i>-butyl-4-methylphenol (6 mg, 0.03 mmol) in anhydrous 1,4-dioxane (10 mL) was refluxed at 100 °C for 4.5 h under nitrogen. After the solvent was removed under reduced pressure, the mixture was purified by flash chromatography (EtOAc/hexane as solvent) to give 375 mg (82%) of <b>67</b> as a clear oil:  <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1 H), 7.59−7.57 (m, 5 H), 7.53 (s, 1 H), 7.44−7.27 (m, 10 H), 5.14 (s, 2 H), 3.84 (t, <i>J</i> = 7.5 Hz, 2 H), 3.66 (t, <i>J</i> = 5.8 Hz, 2 H), 1.82 (m, 2 H), 0.98 (s, 9 H), 0.38 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  729 (M + Na<sup>+</sup>). </div><div class="NLM_p">A mixture of compound <b>67</b> (370 mg, 0.525 mmol), <i>N</i>-(<i>tert</i>-butoxycarbonyl)-<i>N</i>-(3-chlorophenyl)-2-amino-6-chloropyrazine <b>68</b> (200 mg, 0.588 mmol), dichlorobis-(triphenylphosphine)palladium (74 mg, 0.11 mmol), and LiCl (89 mg, 2.10 mmol) in anhydrous toluene (5 mL) was stirred at 100 °C for 19 h under nitrogen. After the solvent was removed under reduced pressure, the residue was purified by flash chromatography (EtOAc/hexane as solvent) to give 140 mg (32%) of <b>69 </b>as a yellow solid:  <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.15 (s, 1 H), 8.94 (d, <i>J</i> = 1.6 Hz, 1 H), 8.06 (s, 1 H), 7.89 (brs, 1 H), <a name="jm004801504906" id="jm004801504906"></a> 7.59−7.52 (m, 5 H), 7.41−7.20 (m, 13 H), 7.06−7.04 (m, 1 H), 5.13 (s, 2 H), 3.78 (t, <i>J</i> = 7.3 Hz, 2 H), 3.62 (t, <i>J</i> = 5.9 Hz, 2 H), 1.76−1.70 (m, 2 H), 1.48 (s, 9 H), 0.95 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  868 (M + Na<sup>+</sup>). </div><div class="NLM_p"><b>3-{5-[6-(3-Chloro-phenylamino)-pyrazin-2-yl]-6-fluoro-pyridin-3-ylamino}-propan-1-ol 70.</b> The mixture of compound <b>69</b> (100 mg, 0.118 mmol), 10% Pd/C (100 mg), EtOH (9 mL), and EtOAc (3 mL) was hydrogenated under 22 psi for 46 h at room temperature. After the solvents were removed under reduced pressure, the residue was purified by flash chromatography (ethyl acetate/hexane as solvent) to give 55 mg (65%) of the <b>des-Cbz</b>-<b>69</b> compound as a yellow oil. Anal. (C<sub>39</sub>H<sub>43</sub>ClFN<sub>5</sub>O<sub>3</sub>Si·0.30 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p">A solution of the <b>des-Cbz</b>-<b>69</b> (68 mg, 0.096 mmol), TFA (1 mL), and CH<sub>3</sub>SO<sub>3</sub>H (3 drops) was stirred at room temperature for 5 h and then concentrated. A saturated NH<sub>4</sub>OH solution was added to the residue until the mixture was made basic followed by the addition of water. The precipitated solid was collected through filtration, washed with water, and dried under a vacuum. The product was purified by flash chromatography on silica gel (using EtOAc/MeOH as the solvent) to provide 30 mg (84%) of <b>70</b> as a yellow solid:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.90 (s, 1 H), 8.42 (s, 1 H), 8.25 (s, 1 H), 8.05 (s, 1 H), 7.64 (s, 1 H), 7.62 (s, 2 H), 7.36 (t, <i>J</i> = 8.1 Hz, 1 H), 7.03 (d, <i>J</i> = 7.8 Hz, 1 H), 6.02 (brs, 1 H), 4.52 (brs, 1 H), 3.54 (t, <i>J</i> = 5.9 Hz, 2 H), 3.17 (m, 2 H), 1.76 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  374 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>18</sub>H<sub>17</sub>ClFN<sub>5</sub>O 374.1184, found 374.1179. </div><div class="NLM_p"><b>5-Bromo-6-chloro-nicotinic Acid 72.</b> Bromine (4.2 mL, 81.4 mmol) was added dropwise to the suspension of 6-hydroxynicotinic acid <b>71</b> (8.00 g, 57.6 mmol) in water (30 mL) at 4 °C. After the addition was completed, the cooling bath was removed, and the reaction mixture was stirred at room temperature for 4 h. Saturated Na<sub>2</sub>S<sub>2</sub>O<sub>5</sub> was added slowly to the stirred mixture until the brown mixture became white. The solid was collected through filtration, washed with water, and dried under a vacuum overnight to give 12.17 g (97%) of 6-hydroxy-5-bromonicotinic acid as an off-white solid:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.95 (brs, 1 H), 12.55 (brs, 1 H), 8.16 (s, 1 H), 8.04 (s, 1 H). </div><div class="NLM_p">Quinoline (1.0 mL, 8.47 mmol) was slowly added to the solution of POCl<sub>3</sub> (2.0 mL, 21.5 mmol), followed by 6-hydroxy-5-bromonicotinic acid (3.92 g, 18.0 mmol) at room temperature. After the sample was heated at 120 °C for 2 h, the reaction was quenched by addition of water dropwise at ∼100 °C. After the mixture was cooled at 4 °C for a few hours, the solid was collected through filtration, washed with water, and dried under a vacuum overnight to give 3.68 g (87%) of <b>72</b> as an off-white solid:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.86 (s, 1 H), 8.55 (s, 1 H); MS (ES) <i>m</i>/<i>z</i>:  236 (M − H<sup>+</sup>). </div><div class="NLM_p"><b>(5-Bromo-6-chloro-pyridin-3-yl)-carbamic Acid </b><b><i>tert</i></b><b>-Butyl Ester 73.</b> A mixture of <b>72 </b>(2.00 g, 8.46 mmol), DPPA (3.49 g, 12.7 mmol), triethylamine (2.56 g, 25.3 mmol), <i>t</i>-BuOH (18 mL), and toluene (20 mL) was heated at 65 °C for 3 h and then at 100 °C for 1.5 h. After the solvent was removed under reduced pressure, the reaction mixture was purified by flash chromatography (EtOAc/hexane as solvent) to give 3.04 g of <b>73</b> as an off-white solid:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.36 (s, 1 H), 8.19 (d, <i>J</i> = 2.3 Hz, 1 H), 7.01 (brs, 1 H), 1.52 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  309 (M+H<sup>+</sup>). Anal. (C<sub>10</sub>H<sub>12</sub>BrClN<sub>2</sub>O<sub>2</sub>) C, H, N. </div><div class="NLM_p"><b>(5-Bromo-6-chloro-pyridin-3-yl)</b><b>-</b><b>(3-hydroxy-propyl)-carbamic Acid </b><b><i>tert</i></b><b>-Butyl Ester 74.</b> A mixture of compound <b>73</b> (710 mg, 2.31 mmol), 3-bromo-1-propanol (400 mg, 2.88 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.13 g, 3.47 mmol) in dry CH<sub>3</sub>CN (10 mL) was heated at 65 °C for 17 h. The reaction mixture was concentrated and purified by column chromatography (EtOAc/hexane as solvent) to give 255 mg (30%) of <b>74</b> as a clear oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.22 (d, <i>J</i> = 2.4 Hz, 1 H), 7.84 (d, <i>J</i> = 2.3 Hz, 1 H), 3.80 (t, <i>J</i> = 6.5 Hz, 2 H), 3.67 (m, 2 H), 1.74 (m, 2 H), 1.44 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  389 (M + Na<sup>+</sup>). </div><div class="NLM_p"><b>(6-Chloro-5-trimethylstannanyl-pyridin-3-yl)</b><b>-</b><b>(3-hydroxy-propyl)-carbamic Acid </b><b><i>tert</i></b><b>-Butyl </b><b>Ester 75.</b> A mixture of <b>74</b> (145 mg, 0.396 mmol), bis(trimethyltin) (260 mg, 0.794 mmol), tetrakis(triphenylphosphine) palladium (46 mg, 0.040 mmol), LiCl (68 mg, 1.6 mmol), and 2,6-di-<i>tert</i>-butyl-4-methylphenol (4 mg, 0.02 mmol) in anhydrous 1,4-dioxane (5 mL) was refluxed at 100 °C for 3 h under nitrogen. After the solvent was removed under reduced pressure, the residue was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/EtOAc as solvent) to give 149 mg (84%) of <b>75</b> as a clear oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 2.9 Hz, 1 H), 7.50 (d, <i>J</i> = 2.9 Hz, 1 H), 3.79 (t, <i>J</i> = 6.3 Hz, 2 H), 3.67 (m, 2 H), 1.71 (m, 2 H), 1.42 (s, 9 H), 0.42 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  451 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>3-{6-Chloro-5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol 76.</b> A mixture of <b>75</b> (145 mg, 0.323 mmol), <i>N</i>-(<i>tert</i>-butoxycarbonyl)-<i>N</i>-(3-chlorophenyl)-2-amino-6-chloropyrazine <b>68</b> (120 mg, 0.353 mmol), dichlorobis(triphenylphosphine)palladium (23 mg, 0.033 mmol), and LiCl (55 mg, 1.3 mmol) in anhydrous toluene (4 mL) was stirred at 110 °C for 32 h under nitrogen. After the solvent was removed under reduced pressure, the residue was purified by flash chromatography (EtOAc/hexane as solvent) to give 28 mg (15%) of the coupling compound as a yellow solid. A solution of the yellow solid (28 mg, 0.047 mmol), TFA (1 mL), and CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was stirred at room temperature for 1.5 h and then concentrated. A saturated NH<sub>4</sub>OH solution was added to the residue until the mixture became basic, followed by the addition of water. The precipitated solid was collected through filtration, washed with water, and dried under a vacuum. The product was purified by flash chromatography on silica gel (EtOAc/CH<sub>2</sub>Cl<sub>2</sub> as solvent) to provide 13 mg (70%) of <b>76</b> as a yellow solid:  <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.89 (s, 1 H), 8.26 (s, 2 H), 8.07 (s, 1 H), 7.86 (d, <i>J</i> = 2.9 Hz, 1 H), 7.57 (d, <i>J</i> = 8.3 Hz, 1 H), 7.32 (t, <i>J</i> = 8.1 Hz, 1 H), 7.20 (d, <i>J</i> = 2.9 Hz, 1 H), 6.99 (d, <i>J</i> = 6.0 Hz, 1 H), 6.26 (t, <i>J</i> = 5.2 Hz, 1 H), 4.50 (brs, 1 H), 3.50 (m, 2 H), 3.15 (m, 2 H), 1.72 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  390 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>18</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>5</sub>O 390.0888, found 390.0901. </div><div class="NLM_p"><b>(6-Amino-5-trimethylstannanyl-pyridin-3-yl)-[3-(</b><b><i>tert</i></b><b>-butyl-diphenyl-silanyloxy)-propyl]-ca</b><b>rbamic Acid Benzyl Ester 77.</b> A mixture of compound <b>65</b> (1.25 g, 2.02 mmol), bis(trimethyltin) (1.00 g, 3.05 mmol), tetrakis(triphenylphosphine) palladium (240 mg, 0.208 mmol), LiCl (260 mg, 6.13 mmol), and 2,6-di-<i>tert</i>-butyl-4-methylphenol (20 mg, 0.091 mmol) in anhydrous 1,4-dioxane (25 mL) was refluxed at 100 °C for 3 h under nitrogen. After the solvent was removed under reduced pressure, the residue was purified by flash chromatography (EtOAc/hexane as solvent) to give 1.05 g (74%) of <b>77</b> as a yellow oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.86 (brs, 1 H), 7.61−7.58 (m, 5 H), 7.43−7.28 (m, 11 H), 5.11 (brs, 2 H), 4.40 (s, 2 H), 3.75 (t, <i>J</i> = 7.6 Hz, 2 H), 3.66 (t, <i>J</i> = 6.0 Hz, 2 H), 1.85−1.76 (m, 2 H), 0.99 (s, 9 H), 0.34 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  704 (M + H<sup>+</sup>). </div><div class="NLM_p"><b>[6-(2-Amino-5-{benzyloxycarbonyl-[3-(</b><b><i>tert</i></b><b>-butyl-diphenyl-silanyloxy)-propyl]-amino}-pyri</b><b>din-3-yl)-pyrazin-2-yl]-(3-chloro-phenyl)-carbamic Acid </b><b><i>tert</i></b><b>-Butyl Ester 78.</b> A mixture of compound <b>77</b> (1.05 g, 1.50 mmol), <i>N</i>-(<i>tert</i>-butoxycarbonyl)-<i>N</i>-(3-chlorophenyl)-2-amino-6-chloropyrazine <b>68</b> (510 mg, 1.50 mmol), dichlorobis(triphenylphosphine)palladium (105 mg, 0.150 mmol), and LiCl (190 mg, 4.48 mmol) in anhydrous toluene (30 mL) was stirred at 100 °C for 2.5 h under nitrogen. After the solvent was removed under reduced pressure, the residue was purified by flash chromatography (EtOAc/hexane as solvent) to give 830 mg (66%) of <b>78 </b>as a yellow oil:  <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.00 (s, 1 H), 8.52 (brs, 1 H), 7.93 (s, 1 H), 7.66 (brs, 1 H), 7.59−7.55 (m, 5 H), 7.41−7.27 (m, 13 H), 7.14 (m, 1 H), 5.89 (s, 2 H), 5.11 (brs, 2 H), 3.77 (t, <i>J</i> = 7.4 Hz, 2 H), 3.65 (t, <i>J</i> = 5.9 Hz, 2 H), 1.84−1.75 (m, 2 H), 1.48 (s, 9 H), 0.97 (s, 9 H); MS (ES) <i>m</i>/<i>z</i>:  843 (M + H<sup>+</sup>). Anal. (C<sub>47</sub>H<sub>51</sub>ClN<sub>6</sub>O<sub>5</sub>Si<b>.</b>1.70 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>3-{6-Amino-5-[6-(3-chloro-phenylamino)-pyrazin-2-yl]-pyridin-3-ylamino}-propan-1-ol 79.</b> A solution of compound <b>78</b> (70 mg, 0.083 mmol), CF<sub>3</sub>SO<sub>3</sub>H (0.4 mL), and CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was stirred at room temperature for 1.5 h and then concentrated. A saturated NH<sub>4</sub>OH solution was added to the residue at 4 °C until the mixture was made basic followed by the addition of water. The aqueous solution was discarded. The gummy material left in the reaction flask was washed with <a name="jm004801504907" id="jm004801504907"></a> water, dried under a vacuum, and purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH as solvent) to provide 37 mg (76%) of <b>79</b> as a dark yellow oil:  <sup>1</sup>H NMR (300 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.31 (s, 1 H), 8.07 (s, 1 H), 7.71 (s, 1 H), 7.61 (d, <i>J</i> = 2.5 Hz, 1 H), 7.47 (m, 2 H), 7.29 (t, <i>J</i> = 8.0 Hz, 1 H), 7.01 (d, <i>J</i> = 6.6 Hz, 1 H), 3.71 (t, <i>J</i> = 6.2 Hz, 2 H), 3.19 (t, <i>J</i> = 6.9 Hz, 2 H), 1.85 (m, 2 H); MS (ES) <i>m</i>/<i>z</i>:  371 (M + H<sup>+</sup>); FAB-HRMS (M + H<sup>+</sup>) calcd. for C<sub>18</sub>H<sub>19</sub>ClN<sub>6</sub>O 371.1387, found 371.1391. </div><div class="NLM_p"><b>Biology. Kinase Activity Assays.</b> A kinase reaction mixture was prepared in 50 mM Tris-Cl (pH 8), 10 mM MgCl<sub>2</sub>, 0.1 mM Na<sub>3</sub>VO<sub>4,</sub> 1 mM DTT, 1% DMSO, 0.25 μM biotinylated peptide substrate, 0.2−0.8 μCi per well <sup>33</sup>P-γ-ATP [2000−3000 Ci/mmol] and 5 μM ATP in the presence or absence of test compound and incubated at 30 °C for 1 h in a streptavidin coated FlashPlate (Perkin-Elmer, Boston, MA). Biotinylated peptide substrates were described as follows:<sup>38</sup> VEGF-R2 (biotin-KHKKLAEGSAYEEV-amide), calmodulin kinase 2 (biotin-KKALRRQETVDAL-amide), casein kinase-1 (biotin-KRRRALS(phospho)VASLPGL-amide), casein kinase-2 (biotin-RREEETEEE-amide), CDK1 (biotin-KTPKKAKKPKTPKKAKKL-amide), CDK4 (GST-retinoblastoma protein construct), EGFR (biotin-DRVYIHPF-amide), FGFR-2 (biotin-poly(GT) 4:1), GSK-3 (biotin-KRREILSRRP(phospho)SYR-amide), insulin-R kinase (biotin-TRDIYETDYYRK-amide), MAPK (biotin-APRTPGGRR-amide), PDGF-R (biotin-KHKKLAEGSAYEEV-amide), PKA (biotin-GRTGRRNSI-amide), PKCβ2 (biotin-RFARKGSLRQKNV-amide), and PKCγ (biotin-RFARKGSLRQKNV-amide). Reaction conditions and components varied slightly depending on the protein kinase being assayed. The reaction was terminated by washing with PBS containing 100 mM EDTA, and plates were counted in a scintillation counter. Inhibition of the enzymatic activity due to the compound was measured by observing a reduced amount of <sup>33</sup>P-γ-ATP incorporated into the immobilized peptide relative to untreated controls. Linear regression analysis of the percent of inhibition by the test compound was used to calculate IC<sub>50</sub> values (GraphPad Prism 3, GraphPad Software, San Diego, CA). </div><div class="NLM_p"><b>Cell Culture.</b> HUVEC and HASMC cells were obtained from Cascade Biologicals (Portland, OR) and maintained in Media 200 containing low serum growth supplement (Cascade Biologicals). All other cells were obtained from the American Type Culture Collection (Manassas, VA). HeLa, A375, and HCT-116 cells were cultured in minimal essential medium (MEM) with 0.1 mM nonessential amino acids and 1 mM sodium pyruvate supplemented with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine and 10% FCS (Hyclone, Logan, UT). MRC5 were cultured in Eagle's MEM and A375 were cultured in Dulbecco's modified Eagle's medium with 4 mM <span class="smallcaps smallerCapital">l</span>-glutamine and 1.5 g/L sodium bicarbonate supplemented with 10% FCS. Cells were maintained at 37 °C plus 5% CO<sub>2</sub> as exponentially growing monolayers. </div><div class="NLM_p"><b>VEGF-Stimulated HUVEC Proliferation. </b>To evaluate inhibition of VEGF-stimulated proliferation, HUVEC cells were detached with trypsin and seeded into 96-well plates in F-12K medium (Invitrogen, Carlsbad, CA) containing 0.2% heat-inactivated fetal bovine serum. Cells were stimulated with 2 ng/well VEGF (R&D Systems) in the presence or absence of test compounds. BrdU was added 24 h after the addition of VEGF and incubated with cells for an additional 20−24 h. BrdU incorporation was quantified using cell proliferation ELISA, BrdU reagents (Roche Biochemicals, Indianapolis, IN). </div><div class="NLM_p"><b>Cell Proliferation Assay.</b> The ability of the test compound to inhibit the proliferation of cell growth was determined by measuring <sup>14</sup>C-thymidine incorporation into primary cells or cell lines derived from carcinomas originating from several tissues. Briefly, cells were trypsinized and seeded into 96-well CytoStar scintillating microplates (Amersham, Piscataway, NJ) in complete medium in a volume of 100 μL. Cells were incubated for 24 h at 37 °C in an atmosphere containing 5% CO<sub>2</sub>. The test compound was added, and cells were incubated for 24 more hours. Methyl <sup>14</sup>C-thymidine (Perkin-Elmer, Boston, MA) was diluted in complete medium, and 0.2 μCi was added to each well of the CytoStar plate in a volume of 20 μL. The plate was incubated for 24 additional hours in the presence of test compound. Plates were washed twice with 200 μL of PBS, and <sup>14</sup>C-thymidine incorporation was quantified on a Packard Top Count. IC<sub>50</sub> values reported as >10 indicate inhibition did not reach 50% of control at the highest dose tested. </div><div class="NLM_p"><b>In Vivo Antitumor Model. </b>The VEGFR-2 inhibitors have been submitted to Piedmont Research Center (PRC) for evaluation against the A375 human melanoma xenograft growing in nude mice. Female <i>nu/nu</i> mice, 8 weeks of age were fed ad libitum water and an autoclaved standard rodent diet consisting of 5% fat, 6% fiber, 8% ash, 10% moisture, and 3% minerals. Female nude mice were implanted subcutaneously with 1 mm<sup>3</sup> A375 melanoma fragments in the flank. Tumors were monitored twice weekly and then daily as the neoplasms reached the desired size range (about 75 mg). Animals were pair-matched on day 1 when their tumors were in the 62−126 mg range, and the group mean tumor sizes were 66−71 mg. Estimated tumor weight was calculated using the formula:  tumor weight (mg) = (<i>w</i><sup>2</sup><i>l</i>)/2, where <i>w</i> = width and <i>l</i> = length in millimeters of an A375 melanoma. The VEGFR-2 inhibitors were provided preformulated for i.p. administration in a vehicle consisting of 1.5% Pluronic F108. Control groups included a no treatment tumor growth control group (10 mice) and a vehicle control group (6 mice). Each of the VEGFR-2 inhibitors were administered as i.p. at 75 or 10 mg/kg on a qd × 30 schedule. DTIC was given i.p. at 90 mg/kg on a qd × 5 schedule. All therapies were initiated on day 1, and the experiment was terminated on day 60. The tumor growth delay method was used in this study. Each animal was euthanized when its A375 neoplasm reached a size of 2.0 g. Mean day of survival (MDS) values were calculated for all groups. The MDS values calculated for each group based on the calculated day of death of each mouse as given by the formula:<a class="ref internalNav" href="#jm058205be00002" aria-label=""></a><span class="NLM_disp-formula" id="jm058205be00002"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205be00002.gif" alt="" id="_i30" /></img></span> where time to exceed endpoint (observed) = number of days it takes for each tumor to grow past the endpoint (cutoff) size. This is the day the animal is euthanized as a cancer death. D<sub>2</sub> = day the animal is euthanized. D<sub>1</sub> = last day of caliper measurement before tumor reaches the endpoint. Wt<sub>2</sub> = tumor weight on D<sub>2</sub>. Wt<sub>1</sub> = tumor weight on D<sub>1</sub>. Endpoint weight = predetermined “cutoff” tumor size for the model being used. </div><div class="NLM_p">Animals were weighted twice weekly during the study. Mice were examined frequently for clinical signs of any adverse, drug-related side effects. Acceptable toxicity for cancer drugs in mice is defined by the NCI as no mean group weight loss of over 20% during the test and not more than one toxic death among 10 treated animals. The unpaired <i>t</i>-test and Mann−Whitney U test were used to determine the statistical significance of any difference in survival times between a treatment group and the control group. All statistical analyses were conducted at a <i>p</i> level of 0.05 (two-tailed). </div><div class="NLM_p"><b>Computational Details. </b>As previously described,<sup>25</sup> a model of VEGFR-2 in complex with <b>7</b> was developed, based on the X-ray structure of VEGFR-2<sup>41</sup> (PDB code:  <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VR2">1VR2</a>). This model was then used as the target structure for docking all the compounds reported here. The standard precision (SP) mode of the docking program Glide<sup>39</sup> was used to identify favorable binding poses. Glide allows the conformation and the position of a ligand be flexibly explored inside the binding pocket while holding the protein rigid during docking. The top 10 docking poses with the best Emodel scores<sup>40</sup> were saved for each compound, and the ones that led to the best QSAR model were eventually selected as the predicted binding poses. The selection procedure was conducted as follows. The top 1 pose with the best Emodel score was initially picked for each compound. After further geometry optimization, each complex structure was scored as in-place by GlideScore.<sup>40</sup> The value of each GlideScore component was extracted and used to build a QSAR model by linear regression, and its leave-one-out cross-<a name="jm004801504908" id="jm004801504908"></a> validated <i>q</i><sup>2</sup> value was calculated. Then, the compound with the worst cross-validation prediction was reexamined, and another one from its top 10 docking poses was selected. After repeating the above steps, another QSAR model was developed, and its <i>q</i><sup>2</sup> value was calculated. If the new <i>q</i><sup>2</sup> value became better than the old one, the new docking pose was kept to replace the old one for that particular compound; otherwise, the new pose selection was rejected, and another pose would be tried. This procedure was repeated until a QSAR model with a satisfying <i>q</i><sup>2</sup> value was obtained. </div><div class="NLM_p">Each ligand−receptor complex structure was optimized by energy minimization in the aqueous solution, treated by the implicit GB/SA water model.<sup>42</sup> To prevent the unrealistic movement that may be caused by using implicit water model, harmonic position constraints of 100 and 10 kj/(Å<sup>2</sup> mol) were applied to the residues that were more than 12 Å away or within 6 to 12 Å from any ligand atom, respectively, while the ligand and the residues that are less than 6 Å away from the ligand were treated without position constraints. </div><div class="NLM_p last">All the molecular mechanism calculations were done using the program MacroModel<sup>43</sup> with OPLS_AA force field.<sup>44</sup> The Polak-Ribiere conjugate gradient method was used for energy minimization and the derivative convergence criterion was set at 0.05 kj/(Å mol). The QSAR analysis was conducted using the program MOE.<sup>45</sup></div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm058205b/suppl_file/jm058205b_s.pdf">jm058205b_s.pdf (72.76 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm058205b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gee-Hong Kuo</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Prouty</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aihua Wang</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart Emanuel</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan DeAngelis</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Zhang</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fengbin Song</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence Beall</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Connolly</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prahba Karnachi</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Chen</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert H. Gruninger</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Sechler</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angel Fuentes-Pesquera</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven A. Middleton</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda Jolliffe</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William V. Murray</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Division, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, P.O. Box 300, Raritan, New Jersey 08869 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank High Output Synthesis team help to scale-up some of the compounds for biological evaluation. </p></div><div class="refs-header-label"><a name="jm004801504909" id="jm004801504909"></a></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="jm058205bb00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm058205bb00001_1"><span><span class="NLM_string-ref">Risau, W. Mechanism of angiogenesis. <i>  Nature</i><b>1997</b>, <i>386</i>, 671−674.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=1997&pages=674&author=W+Risau&title=Mechanism+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisau%26aufirst%3DW%26atitle%3DMechanism%2520of%2520angiogenesis%26jtitle%3DNature%26date%3D1997%26volume%3D386%26spage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm058205bb00002_1"><span><span class="NLM_string-ref">Ribatti, D.; Vacca, A.; Nico, B.; Roncali, L.; Dammacco, F. Postnatal angiogenesis. <i>  Mech. Dev.</i><b>2001</b>, <i>100</i>, 157−163.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2001&pages=163&author=D.+Ribatti&author=A.+Vacca&author=B.+Nico&author=L.+Roncali&author=F+Dammacco&title=Postnatal+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRibatti%26aufirst%3DD.%26atitle%3DPostnatal%2520angiogenesis%26jtitle%3DMech.%2520Dev.%26date%3D2001%26volume%3D100%26spage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm058205bb00003_1"><span><span class="NLM_string-ref">(a) Folkman, J. Anti-angiogenesis:  new concept for therapy of solid tumors. <i>  Ann. Surg</i>. <b>1972</b>, <i>175</i>, 409−416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1972&pages=416&author=J.+Folkman&author=+Anti&title=new+concept+for+therapy+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3Dnew%2520concept%2520for%2520therapy%2520of%2520solid%2520tumors%26jtitle%3DAnn.%2520Surg.%26date%3D1972%26volume%3D175%26spage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00003_2"><span><span class="NLM_string-ref">(b) Folkman, J. Tumor angiogenesis:  therapeutic implications. <i>  N. Engl. J. Med.</i><b>1971</b>, <i>285</i>, 1182−1186.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+Folkman%2C+J.+Tumor+angiogenesis%3A%E2%80%89+therapeutic+implications.+N.+Engl.+J.+Med.+1971%2C+285%2C+1182%E2%88%921186.+%28b%29+Folkman%2C+J.+Tumor+angiogenesis%3A%E2%80%89+therapeutic+implications.+N.+Engl.+J.+Med.1971%2C+285%2C+1182%E2%88%921186."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00003_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26jtitle%3D%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm058205bb00004_1"><span><span class="NLM_string-ref">Spranger, J.; Pfeiffer, A. F. New concepts in pathogenesis and treatment of diabetic retinopathy<i>. Exp. Clin. Endocrinol. Diabetes</i><b>2001</b>, <i>109</i> (Suppl. 2) S438−S450.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109+%28Suppl.+2&publication_year=2001&pages=S450&author=J.+Spranger&author=A.+F+Pfeiffer&title=New+concepts+in+pathogenesis+and+treatment+of+diabetic+retinopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DJ.%26atitle%3DNew%2520concepts%2520in%2520pathogenesis%2520and%2520treatment%2520of%2520diabetic%2520retinopathy%26jtitle%3DExp.%2520Clin.%2520Endocrinol.%2520Diabetes%26date%3D2001%26volume%3D109%2520%2528Suppl.%25202%26spage%3DS450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm058205bb00005_1"><span><span class="NLM_string-ref">Walsh, D. A.; Haywood, L. Angiogenesis:  a therapeutic target in arthritis. <i>  Curr. Opin. Invest. Drugs </i><b>2001</b>, <i>2</i>, 1054−1063.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=1063&author=D.+A.+Walsh&author=L.+Haywood&author=+Angiogenesis&title=a+therapeutic+target+in+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3Da%2520therapeutic%2520target%2520in%2520arthritis%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D2%26spage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm058205bb00006_1"><span><span class="NLM_string-ref">McLaren, J.; Prentice, A.; Charnock-Jones, D. S.; Millican, S. A.; Muller, K. H.; Sharkey, A. M.; Smith, S. K. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids<i>. J. Clin. Invest</i>. <b>1996</b>, <i>98</i>, 482−489.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1996&pages=489&author=J.+McLaren&author=A.+Prentice&author=D.+S.+Charnock-Jones&author=S.+A.+Millican&author=K.+H.+Muller&author=A.+M.+Sharkey&author=S.+K+Smith&title=Vascular+endothelial+growth+factor+is+produced+by+peritoneal+fluid+macrophages+in+endometriosis+and+is+regulated+by+ovarian+steroids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaren%26aufirst%3DJ.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520is%2520produced%2520by%2520peritoneal%2520fluid%2520macrophages%2520in%2520endometriosis%2520and%2520is%2520regulated%2520by%2520ovarian%2520steroids%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1996%26volume%3D98%26spage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm058205bb00007_1"><span><span class="NLM_string-ref">Detmar, M. The role of VEGF and thrombospondin in skin angiogenesis. <i>  Dermatol. Sci.</i><b>2000</b>, <i>24</i>, S78−S84.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=S84&author=M+Detmar&title=The+role+of+VEGF+and+thrombospondin+in+skin+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDetmar%26aufirst%3DM%26atitle%3DThe%2520role%2520of%2520VEGF%2520and%2520thrombospondin%2520in%2520skin%2520angiogenesis%26jtitle%3DDermatol.%2520Sci.%26date%3D2000%26volume%3D24%26spage%3DS84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm058205bb00008_1"><span><span class="NLM_string-ref">Folkman, J. What is the evidence that tumors are angiogenesis dependment? <i>J. Natl. Cancer Inst.</i><b>1990</b>, <i>82</i>, 4−6.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=6&author=J+Folkman&title=What+is+the+evidence+that+tumors+are+angiogenesis+dependment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DWhat%2520is%2520the%2520evidence%2520that%2520tumors%2520are%2520angiogenesis%2520dependment%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm058205bb00009_1"><span><span class="NLM_string-ref">Liotta, L. A.; Steeg, P. S.; Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis:  an imbalance of positive and negative regulation. <i>  Cell</i><b>1991</b>, 64, 327−336.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=336&author=L.+A.+Liotta&author=P.+S.+Steeg&author=W.+G+Stetler-Stevenson&title=Cancer+metastasis+and+angiogenesis%3A%E2%80%89+an+imbalance+of+positive+and+negative+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26atitle%3DCancer%2520metastasis%2520and%2520angiogenesis%253A%25E2%2580%2589%2520an%2520imbalance%2520of%2520positive%2520and%2520negative%2520regulation%26jtitle%3DCell%26date%3D1991%26volume%3D64%26spage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00010"><div class="reference"><div class="NLM_citation" id="jm058205bb00010_1"><span><span class="NLM_string-ref">(a) Nugent, M. A.; Iozzo, R. V. Fibroblast growth factor-2<i>. Int. J. Biochem. </i><i>Cell. Biol</i>. <b>2000</b>, <i>32</i>, 115−120.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2000&pages=120&author=M.+A.+Nugent&author=R.+V+Iozzo&title=Fibroblast+growth+factor-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNugent%26aufirst%3DM.%2BA.%26atitle%3DFibroblast%2520growth%2520factor-2%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D32%26spage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00010_2"><span><span class="NLM_string-ref">(b) Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. <i>  Nat. Med</i>. <b>2000</b>, <i>6</i>, 389−395.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=395&author=P+Carmeliet&title=Mechanisms+of+angiogenesis+and+arteriogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP%26atitle%3DMechanisms%2520of%2520angiogenesis%2520and%2520arteriogenesis%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00010_3"><span><span class="NLM_string-ref">(c) Davis, S.; Yancopoulos, G. D. The angiopoietins:  yin and yang in angiogenesis. <i>  Curr. </i><i>Top. Microbiol. Immunol.</i><b>1999</b>, <i>237</i>, 173−185.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1999&pages=185&author=S.+Davis&author=G.+D+Yancopoulos&title=The+angiopoietins%3A%E2%80%89+yin+and+yang+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DS.%26atitle%3DThe%2520angiopoietins%253A%25E2%2580%2589%2520yin%2520and%2520yang%2520in%2520angiogenesis%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D1999%26volume%3D237%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00010_4"><span><span class="NLM_string-ref">(d) Lindahl, P.; Bostrom, H.; Karlsson, L.; Hellstrom, M.; Kalen, M.; Betsholtz, C. Role of platelet-derived growth factors in angiogenesis and alveogenesis. <i>  Curr. </i><i>Top. Pathol</i>. <b>1999</b>, <i>93</i>, 27−33.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=33&author=P.+Lindahl&author=H.+Bostrom&author=L.+Karlsson&author=M.+Hellstrom&author=M.+Kalen&author=C+Betsholtz&title=Role+of+platelet-derived+growth+factors+in+angiogenesis+and+alveogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindahl%26aufirst%3DP.%26atitle%3DRole%2520of%2520platelet-derived%2520growth%2520factors%2520in%2520angiogenesis%2520and%2520alveogenesis%26jtitle%3DCurr.%2520Top.%2520Pathol.%26date%3D1999%26volume%3D93%26spage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm058205bb00011_1"><span><span class="NLM_string-ref">(a) Cross, M. J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis:  signaling pathways, biological responses, and therapeutic inhibition. <i>  Trends Pharm. Sci</i>. <b>2001</b>, <i>22</i>, 201−207.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=207&author=M.+J.+Cross&author=L+Claesson-Welsh&title=FGF+and+VEGF+function+in+angiogenesis%3A%E2%80%89+signaling+pathways%2C+biological+responses%2C+and+therapeutic+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DM.%2BJ.%26atitle%3DFGF%2520and%2520VEGF%2520function%2520in%2520angiogenesis%253A%25E2%2580%2589%2520signaling%2520pathways%252C%2520biological%2520responses%252C%2520and%2520therapeutic%2520inhibition%26jtitle%3DTrends%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D22%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00011_2"><span><span class="NLM_string-ref">(b) McMahon, G. VEGF receptor signaling in tumor angiogenesis. <i>  Oncologist</i><b>2000</b>, <i>5 </i>(Suppl. 1), 3−10.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5+%28Suppl.+1&publication_year=2000&pages=10&author=G+McMahon&title=VEGF+receptor+signaling+in+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DG%26atitle%3DVEGF%2520receptor%2520signaling%2520in%2520tumor%2520angiogenesis%26jtitle%3DOncologist%26date%3D2000%26volume%3D5%2520%2528Suppl.%25201%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00011_3"><span><span class="NLM_string-ref">(c) Ferrara, N.; Davis-Smyth, T. The biology of vascular endothelial growth factor. <i>  Endocrinol. Rev</i>. <b>1997</b>, <i>18</i>, 4−25.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=25&author=N.+Ferrara&author=T+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00011_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocrinol.%2520Rev.%26date%3D1997%26volume%3D18%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm058205bb00012_1"><span><span class="NLM_string-ref">De Vries, C.; Escobedo, J. A.; Ueno, H.; Houck, K.; Ferrara, N.; Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. <i>  Science</i><b>1992</b>, <i>255</i>, 989−991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1992&pages=991&author=C.+De+Vries&author=J.+A.+Escobedo&author=H.+Ueno&author=K.+Houck&author=N.+Ferrara&author=L.+T+Williams&title=The+fms-like+tyrosine+kinase%2C+a+receptor+for+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVries%26aufirst%3DC.%26atitle%3DThe%2520fms-like%2520tyrosine%2520kinase%252C%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DScience%26date%3D1992%26volume%3D255%26spage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm058205bb00013_1"><span><span class="NLM_string-ref">Shalaby, F.; Rossant, J.; Yamaguchl, T. P.; Gertsenstein, M.; Wu, X.-F.; Breltman, M. L.; Schuh, A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. <i>  Nature</i><b>1995</b>, <i>376</i>, 62−66.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=66&author=F.+Shalaby&author=J.+Rossant&author=T.+P.+Yamaguchl&author=M.+Gertsenstein&author=X.-F.+Wu&author=M.+L.+Breltman&author=A.+C+Schuh&title=Failure+of+blood-island+formation+and+vasculogenesis+in+Flk-1-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShalaby%26aufirst%3DF.%26atitle%3DFailure%2520of%2520blood-island%2520formation%2520and%2520vasculogenesis%2520in%2520Flk-1-deficient%2520mice%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm058205bb00014_1"><span><span class="NLM_string-ref">Ferrara, N.; Gerber, H.-P.; LeCouter, J. The biology of VEGF and its receptors. <i>  Nat. Med.</i><b>2003</b>, <i>9</i>, 669−676.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=676&author=N.+Ferrara&author=H.-P.+Gerber&author=J+LeCouter&title=The+biology+of+VEGF+and+its+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DThe%2520biology%2520of%2520VEGF%2520and%2520its%2520receptors%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm058205bb00015_1"><span><span class="NLM_string-ref">Kerbel, R. S. A cancer therapy resistant to resistance. <i>  Nature</i><b>1997</b>, <i>390</i>, 335−336.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=1997&pages=336&author=R.+S+Kerbel&title=A+cancer+therapy+resistant+to+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKerbel%26aufirst%3DR.%2BS%26atitle%3DA%2520cancer%2520therapy%2520resistant%2520to%2520resistance%26jtitle%3DNature%26date%3D1997%26volume%3D390%26spage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm058205bb00016_1"><span><span class="NLM_string-ref">Yang, J. C.; Haworth, L.; Sherry, R. M.; Hwu, P.; Schwartzentruber, D. J.; Topalian, S. L.; Steinberg, S. M.; Chen, H. X.; Rosenberg, S. A. A randomized trial of bevacizumab (anti-VEGF antibody) in metastatic renal cancer. <i>  N. Eng. J. Med</i>. <b>2003</b>, <i>349</i>, 427−434.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=434&author=J.+C.+Yang&author=L.+Haworth&author=R.+M.+Sherry&author=P.+Hwu&author=D.+J.+Schwartzentruber&author=S.+L.+Topalian&author=S.+M.+Steinberg&author=H.+X.+Chen&author=S.+A+Rosenberg&title=A+randomized+trial+of+bevacizumab+%28anti-VEGF+antibody%29+in+metastatic+renal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%2BC.%26atitle%3DA%2520randomized%2520trial%2520of%2520bevacizumab%2520%2528anti-VEGF%2520antibody%2529%2520in%2520metastatic%2520renal%2520cancer%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm058205bb00017_1"><span><span class="NLM_string-ref">Prewett, M.; Huber, J.; Li, Y.; Santiago, A.; O'Connor, W.; King, K.; Overholser, J.; Hooper, A.; Pytowski, B.; Witte, L.; Bohlen, P.; Hicklin, D. J. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis<i>. Cancer Res</i>. <b>1999</b>, <i>59</i>, 5209−5218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5218&author=M.+Prewett&author=J.+Huber&author=Y.+Li&author=A.+Santiago&author=W.+O%27Connor&author=K.+King&author=J.+Overholser&author=A.+Hooper&author=B.+Pytowski&author=L.+Witte&author=P.+Bohlen&author=D.+J+Hicklin&title=Antivascular+endothelial+growth+factor+receptor+%28fetal+liver+kinase+1%29+monoclonal+antibody+inhibits+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrewett%26aufirst%3DM.%26atitle%3DAntivascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528fetal%2520liver%2520kinase%25201%2529%2520monoclonal%2520antibody%2520inhibits%2520tumor%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm058205bb00018_1"><span><span class="NLM_string-ref">Holash, J.; Davis, S.; Papadopoulos, N.; Croll, S. D.; Ho, L.; Russell, M.; Boland, P.; Leidich, R.; Hylton, D.; Burova, E.; Ioffe, E.; Huang, T.; Radziejewski, C.; Baily, K.; Fandl, J. P.; Daly, T.; Wiegand, S. J.; Yancopoulos, G. D.; Rudge, J. S. VEGF-Trap:  a VEGF blocker with potent antitumor effects. <i>  Proc. Natl. Acad. Sci., U.S.A.</i><b>2002</b>, <i>99</i>, 11393−11398.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11398&author=J.+Holash&author=S.+Davis&author=N.+Papadopoulos&author=S.+D.+Croll&author=L.+Ho&author=M.+Russell&author=P.+Boland&author=R.+Leidich&author=D.+Hylton&author=E.+Burova&author=E.+Ioffe&author=T.+Huang&author=C.+Radziejewski&author=K.+Baily&author=J.+P.+Fandl&author=T.+Daly&author=S.+J.+Wiegand&author=G.+D.+Yancopoulos&author=J.+S.+Rudge&author=+Trap&title=VEGF+blocker+with+potent+antitumor+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolash%26aufirst%3DJ.%26atitle%3DVEGF%2520blocker%2520with%2520potent%2520antitumor%2520effects%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%252C%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D11398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm058205bb00019_1"><span><span class="NLM_string-ref">(a) Drevs, J.; Müller-Driver, R.; Wittig, C.; Fuxius, S.; Esser, N.; Hugenschmidt, H.; Konerding, M. A.; Allegrini, P. R.; Wood, J.; Hennig, J.; Unger, C.; Marmé, D. PTK787/ZK222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, effects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. <i>  Cancer Res</i>. <b>2002</b>, <i>62</i>, 4015−4022.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4022&author=J.+Drevs&author=R.+M%C3%BCller-Driver&author=C.+Wittig&author=S.+Fuxius&author=N.+Esser&author=H.+Hugenschmidt&author=M.+A.+Konerding&author=P.+R.+Allegrini&author=J.+Wood&author=J.+Hennig&author=C.+Unger&author=D.+Marm%C3%A9&title=a+specific+vascular+endothelial+growth+factor-receptor+tyrosine+kinase+inhibitor%2C+effects+the+anatomy+of+the+tumor+vascular+bed+and+the+functional+vascular+properties+as+detected+by+dynamic+enhanced+magnetic+resonance+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrevs%26aufirst%3DJ.%26atitle%3Da%2520specific%2520vascular%2520endothelial%2520growth%2520factor-receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520effects%2520the%2520anatomy%2520of%2520the%2520tumor%2520vascular%2520bed%2520and%2520the%2520functional%2520vascular%2520properties%2520as%2520detected%2520by%2520dynamic%2520enhanced%2520magnetic%2520resonance%2520imaging%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00019_2"><span><span class="NLM_string-ref">(b) Bold, G.; Altman, K.-H.; Frei, J.; Lang, M.; Manley, P. W.; Traxler, P.; Wietfeld, B.; Brüggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; Martiny-Baron, G.; Mestan, J.; Rösel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Lässer, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J. M. New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinase useful as antagonists of tumor-driven angiogenesis. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 2310−2323.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2323&author=G.+Bold&author=K.-H.+Altman&author=J.+Frei&author=M.+Lang&author=P.+W.+Manley&author=P.+Traxler&author=B.+Wietfeld&author=J.+Br%C3%BCggen&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=P.+Furet&author=F.+Hofmann&author=G.+Martiny-Baron&author=J.+Mestan&author=J.+R%C3%B6sel&author=M.+Sills&author=D.+Stover&author=F.+Acemoglu&author=E.+Boss&author=R.+Emmenegger&author=L.+L%C3%A4sser&author=E.+Masso&author=R.+Roth&author=C.+Schlachter&author=W.+Vetterli&author=D.+Wyss&author=J.+M+Wood&title=New+anilinophthalazines+as+potent+and+orally+well+absorbed+inhibitors+of+the+VEGF+receptor+tyrosine+kinase+useful+as+antagonists+of+tumor-driven+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00019_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DNew%2520anilinophthalazines%2520as%2520potent%2520and%2520orally%2520well%2520absorbed%2520inhibitors%2520of%2520the%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520useful%2520as%2520antagonists%2520of%2520tumor-driven%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00020"><div class="reference"><div class="NLM_citation" id="jm058205bb00020_1"><span><span class="NLM_string-ref">(a) Mendel, D. B.; Laird, A. D.; Xin, X.; Louie, S. G.; Christensen, J. G.; Li, G.; Schreck, R. E.; Abrams, T. J.; Ngai, T. J.; Lee, L. B.; Murray, L. J.; Carver, J.; Chan, E.; Moss, K. G.; Haznedar, J. O.; Sukbuntherng, J.; Blake, R. A.; Sun, L.; Tang, C.; Miller, T.; Shirazian, S.; McMahon, G.; Cherrington, J. M. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors:  determination of a pharmacokinetic/pharmacodynamic relationship. <i>  Clin. Cancer Res</i>. <b>2003</b>, <i>9</i>(1), 327−337.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=337&issue=1&author=D.+B.+Mendel&author=A.+D.+Laird&author=X.+Xin&author=S.+G.+Louie&author=J.+G.+Christensen&author=G.+Li&author=R.+E.+Schreck&author=T.+J.+Abrams&author=T.+J.+Ngai&author=L.+B.+Lee&author=L.+J.+Murray&author=J.+Carver&author=E.+Chan&author=K.+G.+Moss&author=J.+O.+Haznedar&author=J.+Sukbuntherng&author=R.+A.+Blake&author=L.+Sun&author=C.+Tang&author=T.+Miller&author=S.+Shirazian&author=G.+McMahon&author=J.+M+Cherrington&title=In+vivo+antitumor+activity+of+SU11248%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+receptors%3A%E2%80%89+determination+of+a+pharmacokinetic%2Fpharmacodynamic+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520SU11248%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520receptors%253A%25E2%2580%2589%2520determination%2520of%2520a%2520pharmacokinetic%252Fpharmacodynamic%2520relationship%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26issue%3D1%26spage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00020_2"><span><span class="NLM_string-ref">(b) Sepp-Lorenzino, L.; Thomas, K. A. <i>  Expert Opin. Invest</i>. <i>Drugs</i><b>2002</b>, <i>11</i>, 1−18.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+Sepp-Lorenzino%2C+L.%3B+Thomas%2C+K.+A.+Expert+Opin.+Invest.+Drugs+2002%2C+11%2C+1%E2%88%9218.+%28b%29+Sepp-Lorenzino%2C+L.%3B+Thomas%2C+K.+A.+Expert+Opin.+Invest.+Drugs2002%2C+11%2C+1%E2%88%9218."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00020_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm058205bb00021_1"><span><span class="NLM_string-ref">Abdollahi, A.; Lipson, K. E.; Han, X.; Krempien, R.; Trinh, T.; Weber, K. J.; Hahnfeldt, P.; Hlatky, L.; Debus, J.; Howlett, A. R.; Huber, P. E. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. <i>  Cancer Res</i>. <b>2003</b>, <i>63</i>, 3755−3763.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=3763&author=A.+Abdollahi&author=K.+E.+Lipson&author=X.+Han&author=R.+Krempien&author=T.+Trinh&author=K.+J.+Weber&author=P.+Hahnfeldt&author=L.+Hlatky&author=J.+Debus&author=A.+R.+Howlett&author=P.+E.+Huber&title=attenuate+the+angiogenic+effects+of+radiation-induced+tumor+cell+growth+factor+production+and+amplify+the+direct+anti-endothelial+action+of+radiation+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdollahi%26aufirst%3DA.%26atitle%3Dattenuate%2520the%2520angiogenic%2520effects%2520of%2520radiation-induced%2520tumor%2520cell%2520growth%2520factor%2520production%2520and%2520amplify%2520the%2520direct%2520anti-endothelial%2520action%2520of%2520radiation%2520in%2520vitro%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D3763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm058205bb00022_1"><span><span class="NLM_string-ref">(a) Ciardiello, F.; Caputo, R.; Damiano, V.; Caputo, R.; Troiani, T.; Vitagliano, D.; Carlomagno, F.; Veneziani, B. M.; Fontanini, G.; Bianco, A. R.; Tortora, G. Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. <i>  Clin. </i><i>Cancer Res.</i><b>2003</b>, <i>9</i>, 1546−1556.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1556&author=F.+Ciardiello&author=R.+Caputo&author=V.+Damiano&author=R.+Caputo&author=T.+Troiani&author=D.+Vitagliano&author=F.+Carlomagno&author=B.+M.+Veneziani&author=G.+Fontanini&author=A.+R.+Bianco&author=G+Tortora&title=Antitumor+effects+of+ZD6474%2C+a+small+molecule+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+with+additional+activity+against+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DAntitumor%2520effects%2520of%2520ZD6474%252C%2520a%2520small%2520molecule%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520with%2520additional%2520activity%2520against%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00022_2"><span><span class="NLM_string-ref">(b) Hennequin, L. F.; Stokes, E. S.; Thomas, A. P.; Johnstone, C.; Plé, P. A.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J.; Curwen, J. O. Novel 4-anilinoquinazolines with C-7 basic side chains:  design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. </i><i>Chem</i>. <b>2002</b>, <i>45</i>, 1300−1312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1312&author=L.+F.+Hennequin&author=E.+S.+Stokes&author=A.+P.+Thomas&author=C.+Johnstone&author=P.+A.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&author=J.+O.+Curwen&author=+Novel&title=basic+side+chains%3A%E2%80%89+design+and+structure+activity+relationship+of+a+series+of+potent%2C+orally+active%2C+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00022_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3Dbasic%2520side%2520chains%253A%25E2%2580%2589%2520design%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520series%2520of%2520potent%252C%2520orally%2520active%252C%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm058205bb00023_1"><span><span class="NLM_string-ref">Kabbinavar, F.; Hurwitz, H. I.; Fehrenbacher, L.; Meropol, N. J.; Novotny, W. F.; Lieberman, G.; Griffing, S.; Bergsland, E. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. <i>  J. Clin. Oncol</i>. <b>2003</b>, <i>21</i>, 60−65.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=65&author=F.+Kabbinavar&author=H.+I.+Hurwitz&author=L.+Fehrenbacher&author=N.+J.+Meropol&author=W.+F.+Novotny&author=G.+Lieberman&author=S.+Griffing&author=E+Bergsland&title=Phase+II%2C+randomized+trial+comparing+bevacizumab+plus+fluorouracil+%28FU%29%2Fleucovorin+%28LV%29+with+FU%2FLV+alone+in+patients+with+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKabbinavar%26aufirst%3DF.%26atitle%3DPhase%2520II%252C%2520randomized%2520trial%2520comparing%2520bevacizumab%2520plus%2520fluorouracil%2520%2528FU%2529%252Fleucovorin%2520%2528LV%2529%2520with%2520FU%252FLV%2520alone%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26spage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm058205bb00024_1"><span><span class="NLM_string-ref">(a) Gingrich, D. E.; Reddy, D. R.; Iqbal, M. A.; Singh, J.; Almone, L. D.; Angeles, T. S.; Albom, M.; Yang, S.; Ator, M. A.; Meyer, S. L.; Robinson, C.; Ruggeri, B. A.; Dionne, C. A.; Vaught, J. L.; Mallamo, J. P.; Hudkins, R. L. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors:  structure−activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2, 1-<i>a</i>]pyrrolo[3, 4-<i>c</i>]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055. <i>  J. Med. Chem</i>. <b>2003</b>, <i>46</i>, 5375−5388.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5388&author=D.+E.+Gingrich&author=D.+R.+Reddy&author=M.+A.+Iqbal&author=J.+Singh&author=L.+D.+Almone&author=T.+S.+Angeles&author=M.+Albom&author=S.+Yang&author=M.+A.+Ator&author=S.+L.+Meyer&author=C.+Robinson&author=B.+A.+Ruggeri&author=C.+A.+Dionne&author=J.+L.+Vaught&author=J.+P.+Mallamo&author=R.+L+Hudkins&title=A+new+class+of+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+structure%E2%88%92activity+relationships+for+a+series+of+9-alkoxymethyl-12-%283-hydroxypropyl%29indeno%5B2%2C+1-a%5Dpyrrolo%5B3%2C+4-c%5Dcarbazole-5-ones+and+the+identification+of+CEP-5214+and+its+dimethylglycine+ester+prodrug+clinical+candidate+CEP-7055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520structure%25E2%2588%2592activity%2520relationships%2520for%2520a%2520series%2520of%25209-alkoxymethyl-12-%25283-hydroxypropyl%2529indeno%255B2%252C%25201-a%255Dpyrrolo%255B3%252C%25204-c%255Dcarbazole-5-ones%2520and%2520the%2520identification%2520of%2520CEP-5214%2520and%2520its%2520dimethylglycine%2520ester%2520prodrug%2520clinical%2520candidate%2520CEP-7055%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00024_2"><span><span class="NLM_string-ref">(b) Boyer, S. J. Small molecule inhibitors of KDR (VEGFR-2) kinase:  an overview of structure activity relationships. <i>  Curr. </i><i>Top. Med. Chem</i>. <b>2002</b>, <i>2</i>, 973−1000.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=1000&author=S.+J+Boyer&title=Small+molecule+inhibitors+of+KDR+%28VEGFR-2%29+kinase%3A%E2%80%89+an+overview+of+structure+activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00024_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DS.%2BJ%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520KDR%2520%2528VEGFR-2%2529%2520kinase%253A%25E2%2580%2589%2520an%2520overview%2520of%2520structure%2520activity%2520relationships%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00024_3"><span><span class="NLM_string-ref">(c) Connell, R. D. Patent focus on cancer chemotherapeutics V. Angiogenesis agents:  September 2001-August 2002. <i>  Expert Opin. Ther. Pat.</i><b>2002</b>, <i>12</i>, 1763−1782.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1782&author=R.+D+Connell&title=Patent+focus+on+cancer+chemotherapeutics+V.+Angiogenesis+agents%3A%E2%80%89+September+2001-August+2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00024_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConnell%26aufirst%3DR.%2BD%26atitle%3DPatent%2520focus%2520on%2520cancer%2520chemotherapeutics%2520V.%2520Angiogenesis%2520agents%253A%25E2%2580%2589%2520September%25202001-August%25202002%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2002%26volume%3D12%26spage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm058205bb00025_1"><span><span class="NLM_string-ref">Kuo, G.-H.; Wang, A.; Emanuel, S.; DeAngelis, A.; Zhang, R.; Connolly, P. J.; Murray, W. V.; Gruninger, R. H.; Sechler, J.; Fuentes-Pesquera, A.; Johnson, D.; Middleton, S. A.; Jolliffe, L.; Chen, X. Synthesis and Discovery of Pyrazine-Pyridine Biheteroaryl as a Novel Series of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors <i>J. Med. Chem</i>. <b>2005</b>, <i>48</i>, 1886−1900.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1900&author=G.-H.+Kuo&author=A.+Wang&author=S.+Emanuel&author=A.+DeAngelis&author=R.+Zhang&author=P.+J.+Connolly&author=W.+V.+Murray&author=R.+H.+Gruninger&author=J.+Sechler&author=A.+Fuentes-Pesquera&author=D.+Johnson&author=S.+A.+Middleton&author=L.+Jolliffe&author=X+Chen&title=Synthesis+and+Discovery+of+Pyrazine-Pyridine+Biheteroaryl+as+a+Novel+Series+of+Potent+Vascular+Endothelial+Growth+Factor+Receptor-2+Inhibitors+J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DG.-H.%26atitle%3DSynthesis%2520and%2520Discovery%2520of%2520Pyrazine-Pyridine%2520Biheteroaryl%2520as%2520a%2520Novel%2520Series%2520of%2520Potent%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520Inhibitors%2520J%26jtitle%3DMed.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm058205bb00026_1"><span><span class="NLM_string-ref">Farina, V.; Krishnan, B. Large rate accelerations in the Stille reaction with tri-2-furylphosphine and triphenylarsine as palladium ligands:  mechanistic and synthetic implications. <i>  J. Am. Chem. Soc.</i><b>1991</b>, <i>113</i>, 9585−9595.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=9595&author=V.+Farina&author=B+Krishnan&title=Large+rate+accelerations+in+the+Stille+reaction+with+tri-2-furylphosphine+and+triphenylarsine+as+palladium+ligands%3A%E2%80%89+mechanistic+and+synthetic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarina%26aufirst%3DV.%26atitle%3DLarge%2520rate%2520accelerations%2520in%2520the%2520Stille%2520reaction%2520with%2520tri-2-furylphosphine%2520and%2520triphenylarsine%2520as%2520palladium%2520ligands%253A%25E2%2580%2589%2520mechanistic%2520and%2520synthetic%2520implications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D9595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm058205bb00027_1"><span><span class="NLM_string-ref">(a) Wolfe, J. P.; Buchwald, S. L. Palladium-catalyzed amination of aryl triflates. <i>  J. Org. Chem</i>. <b>1997</b>, <i>62</i>, 1264−1267.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=1267&author=J.+P.+Wolfe&author=S.+L+Buchwald&title=Palladium-catalyzed+amination+of+aryl+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520triflates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00027_2"><span><span class="NLM_string-ref">(b) Aranyos, A.; Old, D. W.; Kiyomori, A.; Wolfe, J. P.; Sadighi, J. P.; Buchwald, S. L. Novel electron-rich bulky phosphine ligands facilitate the palladium-catalyzed preparation of diaryl ethers. <i>  J. Am. Chem. Soc</i>. <b>1999</b>, <i>121</i>, 4369−4378.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=4378&author=A.+Aranyos&author=D.+W.+Old&author=A.+Kiyomori&author=J.+P.+Wolfe&author=J.+P.+Sadighi&author=S.+L+Buchwald&title=Novel+electron-rich+bulky+phosphine+ligands+facilitate+the+palladium-catalyzed+preparation+of+diaryl+ethers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00027_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAranyos%26aufirst%3DA.%26atitle%3DNovel%2520electron-rich%2520bulky%2520phosphine%2520ligands%2520facilitate%2520the%2520palladium-catalyzed%2520preparation%2520of%2520diaryl%2520ethers%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D4378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm058205bb00028_1"><span><span class="NLM_string-ref">Reisch, J.; Dziemba, P.; Mura, M. L.; Rao, A. R. R. Natural product chemistry. Part 159 [1]. Two methods for the synthesis of 4-azaacronycine as a potential antitumor agent.<i> J. Heterocycl. Chem</i>. <b>1993</b>, <i>30</i>, 981−983.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=983&author=J.+Reisch&author=P.+Dziemba&author=M.+L.+Mura&author=A.+R.+R+Rao&title=Natural+product+chemistry.+Part+159+%5B1%5D.+Two+methods+for+the+synthesis+of+4-azaacronycine+as+a+potential+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReisch%26aufirst%3DJ.%26atitle%3DNatural%2520product%2520chemistry.%2520Part%2520159%2520%255B1%255D.%2520Two%2520methods%2520for%2520the%2520synthesis%2520of%25204-azaacronycine%2520as%2520a%2520potential%2520antitumor%2520agent%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm058205bb00029_1"><span><span class="NLM_string-ref">Fujita, M.; Oka, H.; Ogura, K. Palladium(0)/LiCl promoted cross-coupling reaction of (4-pyridyl)stannanes and aromatic bromides:  easy access to poly(4-pyridyl)-substituted aromatics. <i>  Tetrahedron Lett.</i><b>1995</b>, <i>36</i>, 5247−5250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=5250&author=M.+Fujita&author=H.+Oka&author=K.+Ogura&author=+Palladium&title=promoted+cross-coupling+reaction+of+%284-pyridyl%29stannanes+and+aromatic+bromides%3A%E2%80%89+easy+access+to+poly%284-pyridyl%29-substituted+aromatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DM.%26atitle%3Dpromoted%2520cross-coupling%2520reaction%2520of%2520%25284-pyridyl%2529stannanes%2520and%2520aromatic%2520bromides%253A%25E2%2580%2589%2520easy%2520access%2520to%2520poly%25284-pyridyl%2529-substituted%2520aromatics%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D5250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00030"><div class="reference"><div class="NLM_citation" id="jm058205bb00030_1"><span><span class="NLM_string-ref">Brown, A. D.; Dickinson, R. P.; Wythes, M. J. Indole derivatives as 5-HT-like agonists. WO 93/21178.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Brown%2C+A.+D.%3B+Dickinson%2C+R.+P.%3B+Wythes%2C+M.+J.+Indole+derivatives+as+5-HT-like+agonists.+WO+93%2F21178.+Brown%2C+A.+D.%3B+Dickinson%2C+R.+P.%3B+Wythes%2C+M.+J.+Indole+derivatives+as+5-HT-like+agonists.+WO+93%2F21178."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm058205bb00031_1"><span><span class="NLM_string-ref">Mann, G.; Hartwig, J. F.; Driver, M. S.; Fernández-Rivas, C. Palladium-catalyzed C-N(sp<sup>2</sup>) bond formation:  <i>N</i>-arylation of aromatic and unsaturated nitrogen and the reductive elimination chemistry of palladium azolyl and methyleneamido complexes<i>. J. Am. Chem. Soc.</i><b>1998</b>, <i>120</i>, 827−828.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=828&author=G.+Mann&author=J.+F.+Hartwig&author=M.+S.+Driver&author=C.+Fern%C3%A1ndez-Rivas&author=+Palladium&title=N-arylation+of+aromatic+and+unsaturated+nitrogen+and+the+reductive+elimination+chemistry+of+palladium+azolyl+and+methyleneamido+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DG.%26atitle%3DN-arylation%2520of%2520aromatic%2520and%2520unsaturated%2520nitrogen%2520and%2520the%2520reductive%2520elimination%2520chemistry%2520of%2520palladium%2520azolyl%2520and%2520methyleneamido%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm058205bb00032_1"><span><span class="NLM_string-ref">Brogi, E.; Wu, T.; Namiki, A.; Isner, J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. <i>  Circulation</i><b>1994</b>, <i>90</i>, 649−652.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1994&pages=652&author=E.+Brogi&author=T.+Wu&author=A.+Namiki&author=J.+M+Isner&title=Indirect+angiogenic+cytokines+upregulate+VEGF+and+bFGF+gene+expression+in+vascular+smooth+muscle+cells%2C+whereas+hypoxia+upregulates+VEGF+expression+only"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrogi%26aufirst%3DE.%26atitle%3DIndirect%2520angiogenic%2520cytokines%2520upregulate%2520VEGF%2520and%2520bFGF%2520gene%2520expression%2520in%2520vascular%2520smooth%2520muscle%2520cells%252C%2520whereas%2520hypoxia%2520upregulates%2520VEGF%2520expression%2520only%26jtitle%3DCirculation%26date%3D1994%26volume%3D90%26spage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm058205bb00033_1"><span><span class="NLM_string-ref">Kilic, T.; Alberta, J. A.; Zdunek, P. R.; Acar, M.; Iannarelli, P.; O'Reilly, T.; Buchdunger, E.; Black, P. M.; Stiles, C. D. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. <i>  Cancer Res</i>. <b>2000</b>, <i>60</i>, 5143−5150.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5150&author=T.+Kilic&author=J.+A.+Alberta&author=P.+R.+Zdunek&author=M.+Acar&author=P.+Iannarelli&author=T.+O%27Reilly&author=E.+Buchdunger&author=P.+M.+Black&author=C.+D+Stiles&title=Intracranial+inhibition+of+platelet-derived+growth+factor-mediated+glioblastoma+cell+growth+by+an+orally+active+kinase+inhibitor+of+the+2-phenylaminopyrimidine+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKilic%26aufirst%3DT.%26atitle%3DIntracranial%2520inhibition%2520of%2520platelet-derived%2520growth%2520factor-mediated%2520glioblastoma%2520cell%2520growth%2520by%2520an%2520orally%2520active%2520kinase%2520inhibitor%2520of%2520the%25202-phenylaminopyrimidine%2520class%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm058205bb00034_1"><span><span class="NLM_string-ref">(a) Compounds <b>56</b>, <b>57</b>, and <b>58</b> were not evaluated further because of the strong inhibition of CYP450 enzymes were observed in human liver microsomal studies. Compounds <b>39</b> and <b>41</b> demonstrated low oral bioavailability (<i>F</i> < 10%) and therefore were administered through i.p. route for the in vivo studies.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Compounds+56%2C+57%2C+and+58+were+not+evaluated+further+because+of+the+strong+inhibition+of+CYP450+enzymes+were+observed+in+human+liver+microsomal+studies.+Compounds+39+and+41+demonstrated+low+oral+bioavailability+%28F+%3C+10%25%29+and+therefore+were+administered+through+i.p.+route+for+the+in+vivo+studies.+%28a%29+Compounds+56%2C+57%2C+and+58+were+not+evaluated+further+because+of+the+strong+inhibition+of+CYP450+enzymes+were+observed+in+human+liver+microsomal+studies.+Compounds+39+and+41+demonstrated+low+oral+bioavailability+%28F+%3C+10%25%29+and+therefore+were+administered+through+i.p.+route+for+the+in+vivo+studies."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00034_2"><span><span class="NLM_string-ref">(b) The A375 melanoma is considered to be a good target for VEGFR-2 inhibitors because it has good vascularization, which supports its rapid growth kinetics.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+The+A375+melanoma+is+considered+to+be+a+good+target+for+VEGFR-2+inhibitors+because+it+has+good+vascularization%2C+which+supports+its+rapid+growth+kinetics.+%28b%29+The+A375+melanoma+is+considered+to+be+a+good+target+for+VEGFR-2+inhibitors+because+it+has+good+vascularization%2C+which+supports+its+rapid+growth+kinetics."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00034_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm058205bb00034_3"><span><span class="NLM_string-ref">(c) Serrone, L.; Zeuli, M.; Sega, F. M.; Cognetti, F. Dacarbazine-based chemotherapy for metastatic melanoma:  thirty year experience overview. <i>  J. Exp. Clin</i>. <i>Cancer</i><i>Res</i>. <b>2000</b>, <i>19</i>, 21−34.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=34&author=L.+Serrone&author=M.+Zeuli&author=F.+M.+Sega&author=F+Cognetti&title=Dacarbazine-based+chemotherapy+for+metastatic+melanoma%3A%E2%80%89+thirty+year+experience+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00034_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerrone%26aufirst%3DL.%26atitle%3DDacarbazine-based%2520chemotherapy%2520for%2520metastatic%2520melanoma%253A%25E2%2580%2589%2520thirty%2520year%2520experience%2520overview%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D19%26spage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm058205bb00035_1"><span><span class="NLM_string-ref">Eisch, J. J.; Gopal, H.; Russo, D. A. Preparation and aluminum chloride induced rearrangement of cyclopropylpyridines. <i>  J. Org. Chem</i>. <b>1974</b>, <i>39</i>, 3110−3114.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1974&pages=3114&author=J.+J.+Eisch&author=H.+Gopal&author=D.+A+Russo&title=Preparation+and+aluminum+chloride+induced+rearrangement+of+cyclopropylpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisch%26aufirst%3DJ.%2BJ.%26atitle%3DPreparation%2520and%2520aluminum%2520chloride%2520induced%2520rearrangement%2520of%2520cyclopropylpyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1974%26volume%3D39%26spage%3D3114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00036"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00036'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="jm058205bb00036_1"><span><span class="NLM_string-ref">Caldwell, W. S.; Bencherif, M.; Dull, G. M.; Crooks, P. A.; Lippiello, P. M.; Bhatti, B. S.; Deo, N. M.; Ravard, A. 3-Pyridyl-1-azabicycloalkane derivatives for prevention and treatment of CNS disorders. WO9900385, CAN 130:105302.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Caldwell%2C+W.+S.%3B+Bencherif%2C+M.%3B+Dull%2C+G.+M.%3B+Crooks%2C+P.+A.%3B+Lippiello%2C+P.+M.%3B+Bhatti%2C+B.+S.%3B+Deo%2C+N.+M.%3B+Ravard%2C+A.+3-Pyridyl-1-azabicycloalkane+derivatives+for+prevention+and+treatment+of+CNS+disorders.+WO9900385%2C+CAN+130%3A105302.+Caldwell%2C+W.+S.%3B+Bencherif%2C+M.%3B+Dull%2C+G.+M.%3B+Crooks%2C+P.+A.%3B+Lippiello%2C+P.+M.%3B+Bhatti%2C+B.+S.%3B+Deo%2C+N.+M.%3B+Ravard%2C+A.+3-Pyridyl-1-azabicycloalkane+derivatives+for+prevention+and+treatment+of+CNS+disorders.+WO9900385%2C+CAN+130%3A105302."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00037"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00037'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="jm058205bb00037_1"><span><span class="NLM_string-ref">Chung, J. Y. L.; Zhao, D.; Hughes, D. L.; Grabowski, E. J. J. A practical synthesis of fibrinogen receptor antagonist MK-383. Selective functionalization of (S)-tyrosine. <i>  Tetrahedron</i><b>1993</b>, <i>49</i>, 5767−5776.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=5776&author=J.+Y.+L.+Chung&author=D.+Zhao&author=D.+L.+Hughes&author=E.+J.+J+Grabowski&title=A+practical+synthesis+of+fibrinogen+receptor+antagonist+MK-383.+Selective+functionalization+of+%28S%29-tyrosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DJ.%2BY.%2BL.%26atitle%3DA%2520practical%2520synthesis%2520of%2520fibrinogen%2520receptor%2520antagonist%2520MK-383.%2520Selective%2520functionalization%2520of%2520%2528S%2529-tyrosine%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D5776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00038"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00038'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="jm058205bb00038_1"><span><span class="NLM_string-ref">Emanuel, S.; Gruninger, R. H.; Fuentes-Pesquera, A.; Connolly, P. J.; Seamon, J. A.; Hazel, S.; Tominovich, R.; Hollister, B.; Napier, C.; Reuman, M.; Bignan, G.; Tuman, R.; Johnson, D.; Moffatt, D.; Batchelor, M.; Foley, A.; O'Connell, J.; Allen, R.; Perry, M.; Jolliffe, L.; Middleton, S. A. A VEGF-R2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models. <i>  Mol. Pharm</i>. <b>2004</b>, <i>66</i>, 635−647.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=647&author=S.+Emanuel&author=R.+H.+Gruninger&author=A.+Fuentes-Pesquera&author=P.+J.+Connolly&author=J.+A.+Seamon&author=S.+Hazel&author=R.+Tominovich&author=B.+Hollister&author=C.+Napier&author=M.+Reuman&author=G.+Bignan&author=R.+Tuman&author=D.+Johnson&author=D.+Moffatt&author=M.+Batchelor&author=A.+Foley&author=J.+O%27Connell&author=R.+Allen&author=M.+Perry&author=L.+Jolliffe&author=S.+A+Middleton&title=A+VEGF-R2+kinase+inhibitor+potentiates+the+activity+of+the+conventional+chemotherapeutic+agents+paclitaxel+and+doxorubicin+in+tumor+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmanuel%26aufirst%3DS.%26atitle%3DA%2520VEGF-R2%2520kinase%2520inhibitor%2520potentiates%2520the%2520activity%2520of%2520the%2520conventional%2520chemotherapeutic%2520agents%2520paclitaxel%2520and%2520doxorubicin%2520in%2520tumor%2520xenograft%2520models%26jtitle%3DMol.%2520Pharm.%26date%3D2004%26volume%3D66%26spage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00039"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00039'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="jm058205bb00039_1"><span><span class="NLM_string-ref"><i>Glide</i>; Schrodinger:  Portland, OR.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Glide%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR.+Glide%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00040"><div class="reference"><div class="NLM_citation" id="jm058205bb00040_1"><span><span class="NLM_string-ref">Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide. A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. <i>  J. </i><i>Med. Chem</i>. <b>2004</b>, <i>47</i>, 1739−1749.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1749&author=R.+A.+Friesner&author=J.+L.+Banks&author=R.+B.+Murphy&author=T.+A.+Halgren&author=J.+J.+Klicic&author=D.+T.+Mainz&author=M.+P.+Repasky&author=E.+H.+Knoll&author=M.+Shelley&author=J.+K.+Perry&author=D.+E.+Shaw&author=P.+Francis&author=P.+S.+Shenkin&author=+Glide&title=A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00041"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00041'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="jm058205bb00041_1"><span><span class="NLM_string-ref">McTigue, M. A.; Wickersham, J. A.; Pinko, C.; Showalter, R. E.; Parast, C. V.; Tempczyk-Russell, A.; Gehring, M. R.; Mroczkowski, B.; Kan, C.-C.; Villafranca, J. E.; Appelt, K. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2:  a key enzyme in angiogenesis. <i>  Structure</i><b>1999</b>, <i>7</i>, 319−330.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=330&author=M.+A.+McTigue&author=J.+A.+Wickersham&author=C.+Pinko&author=R.+E.+Showalter&author=C.+V.+Parast&author=A.+Tempczyk-Russell&author=M.+R.+Gehring&author=B.+Mroczkowski&author=C.-C.+Kan&author=J.+E.+Villafranca&author=K+Appelt&title=Crystal+structure+of+the+kinase+domain+of+human+vascular+endothelial+growth+factor+receptor+2%3A%E2%80%89+a+key+enzyme+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520kinase%2520domain%2520of%2520human%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25202%253A%25E2%2580%2589%2520a%2520key%2520enzyme%2520in%2520angiogenesis%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00042"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00042'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="jm058205bb00042_1"><span><span class="NLM_string-ref">Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical treatment of salvation for molecular mechanics and dynamics. <i>  J. Am. </i><i>Chem. Soc</i>. <b>1990</b>, <i>112</i>, 6127−6129.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1990&pages=6129&author=W.+C.+Still&author=A.+Tempczyk&author=R.+C.+Hawley&author=T+Hendrickson&title=Semianalytical+treatment+of+salvation+for+molecular+mechanics+and+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DSemianalytical%2520treatment%2520of%2520salvation%2520for%2520molecular%2520mechanics%2520and%2520dynamics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1990%26volume%3D112%26spage%3D6129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00043"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00043'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="jm058205bb00043_1"><span><span class="NLM_string-ref"><i>MacroModel</i>; Schrodinger:  Portland, OR.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MacroModel%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR.+MacroModel%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00044"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00044'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="jm058205bb00044_1"><span><span class="NLM_string-ref">Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. <i>  J. Am. Chem. Soc</i>. <b>1996</b>, <i>118</i>, 11225−11235.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11235&author=W.+L.+Jorgensen&author=D.+S.+Maxwell&author=J+Tirado-Rives&title=Development+and+testing+of+the+OPLS+all-atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS%2520all-atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D11235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm058205bb00045"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm058205bb00045'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="jm058205bb00045_1"><span><span class="NLM_string-ref"><i>MOE</i>; Chemical Computing Group, Inc.:  Montreal, Quebec, Canada.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MOE%3B+Chemical+Computing+Group%2C+Inc.%3A%E2%80%89+Montreal%2C+Quebec%2C+Canada.+MOE%3B+Chemical+Computing+Group%2C+Inc.%3A%E2%80%89+Montreal%2C+Quebec%2C+Canada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm058205bb00001':['jm058205bb00001_1'],'jm058205bb00002':['jm058205bb00002_1'],'jm058205bb00003':['jm058205bb00003_1','jm058205bb00003_2'],'jm058205bb00004':['jm058205bb00004_1'],'jm058205bb00005':['jm058205bb00005_1'],'jm058205bb00006':['jm058205bb00006_1'],'jm058205bb00007':['jm058205bb00007_1'],'jm058205bb00008':['jm058205bb00008_1'],'jm058205bb00009':['jm058205bb00009_1'],'jm058205bb00010':['jm058205bb00010_1','jm058205bb00010_2','jm058205bb00010_3','jm058205bb00010_4'],'jm058205bb00011':['jm058205bb00011_1','jm058205bb00011_2','jm058205bb00011_3'],'jm058205bb00012':['jm058205bb00012_1'],'jm058205bb00013':['jm058205bb00013_1'],'jm058205bb00014':['jm058205bb00014_1'],'jm058205bb00015':['jm058205bb00015_1'],'jm058205bb00016':['jm058205bb00016_1'],'jm058205bb00017':['jm058205bb00017_1'],'jm058205bb00018':['jm058205bb00018_1'],'jm058205bb00019':['jm058205bb00019_1','jm058205bb00019_2'],'jm058205bb00020':['jm058205bb00020_1','jm058205bb00020_2'],'jm058205bb00021':['jm058205bb00021_1'],'jm058205bb00022':['jm058205bb00022_1','jm058205bb00022_2'],'jm058205bb00023':['jm058205bb00023_1'],'jm058205bb00024':['jm058205bb00024_1','jm058205bb00024_2','jm058205bb00024_3'],'jm058205bb00025':['jm058205bb00025_1'],'jm058205bb00026':['jm058205bb00026_1'],'jm058205bb00027':['jm058205bb00027_1','jm058205bb00027_2'],'jm058205bb00028':['jm058205bb00028_1'],'jm058205bb00029':['jm058205bb00029_1'],'jm058205bb00030':['jm058205bb00030_1'],'jm058205bb00031':['jm058205bb00031_1'],'jm058205bb00032':['jm058205bb00032_1'],'jm058205bb00033':['jm058205bb00033_1'],'jm058205bb00034':['jm058205bb00034_1','jm058205bb00034_2','jm058205bb00034_3'],'jm058205bb00035':['jm058205bb00035_1'],'jm058205bb00036':['jm058205bb00036_1'],'jm058205bb00037':['jm058205bb00037_1'],'jm058205bb00038':['jm058205bb00038_1'],'jm058205bb00039':['jm058205bb00039_1'],'jm058205bb00040':['jm058205bb00040_1'],'jm058205bb00041':['jm058205bb00041_1'],'jm058205bb00042':['jm058205bb00042_1'],'jm058205bb00043':['jm058205bb00043_1'],'jm058205bb00044':['jm058205bb00044_1'],'jm058205bb00045':['jm058205bb00045_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Röver</span>, <span class="hlFld-ContribAuthor ">Mirjana  Andjelkovic</span>, <span class="hlFld-ContribAuthor ">Agnès  Bénardeau</span>, <span class="hlFld-ContribAuthor ">Evelyne  Chaput</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Guba</span>, <span class="hlFld-ContribAuthor ">Paul  Hebeisen</span>, <span class="hlFld-ContribAuthor ">Susanne  Mohr</span>, <span class="hlFld-ContribAuthor ">Matthias  Nettekoven</span>, <span class="hlFld-ContribAuthor ">Ulrike  Obst</span>, <span class="hlFld-ContribAuthor ">Wolfgang F.  Richter</span>, <span class="hlFld-ContribAuthor ">Christoph  Ullmer</span>, <span class="hlFld-ContribAuthor ">Pius  Waldmeier</span>, and <span class="hlFld-ContribAuthor ">Matthew B.  Wright</span>  . </span><span class="cited-content_cbyCitation_article-title">6-Alkoxy-5-aryl-3-pyridinecarboxamides, a New Series of Bioavailable Cannabinoid Receptor Type 1 (CB1) Antagonists Including Peripherally Selective Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (24)
                                     , 9874-9896. <a href="https://doi.org/10.1021/jm4010708" title="DOI URL">https://doi.org/10.1021/jm4010708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4010708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4010708%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Alkoxy-5-aryl-3-pyridinecarboxamides%25252C%252Ba%252BNew%252BSeries%252Bof%252BBioavailable%252BCannabinoid%252BReceptor%252BType%252B1%252B%252528CB1%252529%252BAntagonists%252BIncluding%252BPeripherally%252BSelective%252BCompounds%26aulast%3DR%25C3%25B6ver%26aufirst%3DStephan%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D16072013%26date%3D20112013%26date%3D27122013%26date%3D31102013%26volume%3D56%26issue%3D24%26spage%3D9874%26epage%3D9896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zixian  Chen</span>, <span class="hlFld-ContribAuthor ">Jiangtao  Zhu</span>, <span class="hlFld-ContribAuthor ">Haibo  Xie</span>, <span class="hlFld-ContribAuthor ">Shan  Li</span>, <span class="hlFld-ContribAuthor ">Yongming  Wu</span>, and <span class="hlFld-ContribAuthor ">Yuefa  Gong</span>  . </span><span class="cited-content_cbyCitation_article-title">A New Strategy for the Synthesis of Poly-Substituted 3-H, 3-Fluoro, or 3-Trifluoromethyl Pyridines via the Tandem C−F Bond Cleavage Protocol. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2010,</strong> <em>12 </em>
                                    (19)
                                     , 4376-4379. <a href="https://doi.org/10.1021/ol101859p" title="DOI URL">https://doi.org/10.1021/ol101859p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol101859p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol101859p%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BNew%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252BPoly-Substituted%252B3-H%25252C%252B3-Fluoro%25252C%252Bor%252B3-Trifluoromethyl%252BPyridines%252Bvia%252Bthe%252BTandem%252BC%2525E2%252588%252592F%252BBond%252BCleavage%252BProtocol%26aulast%3DChen%26aufirst%3DZixian%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D9%252008%25202010%26date%3D02092010%26date%3D01102010%26volume%3D12%26issue%3D19%26spage%3D4376%26epage%3D4379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roya  Shahnaei</span>, <span class="hlFld-ContribAuthor ">Hassan  Kabirifard</span>, <span class="hlFld-ContribAuthor ">Parinaz  Fathololoomi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of pyrazine‐2,3‐dicarbonitriles via the one‐pot three‐component reaction of 4‐benzoyl‐5‐phenylamino‐2,3‐dihydrothiophene‐2,3‐dione, diaminomaleonitrile, and functionalized alcohols in acetonitrile. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (2)
                                     , 550-555. <a href="https://doi.org/10.1002/jhet.3761" title="DOI URL">https://doi.org/10.1002/jhet.3761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3761%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bpyrazine%2525E2%252580%2525902%25252C3%2525E2%252580%252590dicarbonitriles%252Bvia%252Bthe%252Bone%2525E2%252580%252590pot%252Bthree%2525E2%252580%252590component%252Breaction%252Bof%252B4%2525E2%252580%252590benzoyl%2525E2%252580%2525905%2525E2%252580%252590phenylamino%2525E2%252580%2525902%25252C3%2525E2%252580%252590dihydrothiophene%2525E2%252580%2525902%25252C3%2525E2%252580%252590dione%25252C%252Bdiaminomaleonitrile%25252C%252Band%252Bfunctionalized%252Balcohols%252Bin%252Bacetonitrile%26aulast%3DShahnaei%26aufirst%3DRoya%26date%3D2020%26date%3D2019%26volume%3D57%26issue%3D2%26spage%3D550%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">En  Liang</span>, <span class="hlFld-ContribAuthor ">Yinrong  Wu</span>, <span class="hlFld-ContribAuthor ">Jiewen  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Xiong</span>, <span class="hlFld-ContribAuthor ">Jinwu  Zhao</span>, <span class="hlFld-ContribAuthor ">Xingang  Yao</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed aerobic oxidative cyclization protocol for the synthesis of quinazolines via amination of C(sp3)-H bonds of methylazaarenes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (52)
                                     , 130783. <a href="https://doi.org/10.1016/j.tet.2019.130783" title="DOI URL">https://doi.org/10.1016/j.tet.2019.130783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.130783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.130783%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCopper-catalyzed%252Baerobic%252Boxidative%252Bcyclization%252Bprotocol%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bquinazolines%252Bvia%252Bamination%252Bof%252BC%252528sp3%252529-H%252Bbonds%252Bof%252Bmethylazaarenes%26aulast%3DLiang%26aufirst%3DEn%26date%3D2019%26volume%3D75%26issue%3D52%26spage%3D130783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Moloudi</span>, <span class="hlFld-ContribAuthor ">Hassan  Kabirifard</span>, <span class="hlFld-ContribAuthor ">Sohila  Piri</span>, <span class="hlFld-ContribAuthor ">Elham  Naghizadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2,3-dicyanopyrazine and ethyl 5-amino-4,6-dicyanobiphenyl-3-carboxylate derivatives from ethyl aroylpyruvates. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2018,</strong> <em>24 </em>
                                    (2)
                                     , 99-102. <a href="https://doi.org/10.1515/hc-2017-0190" title="DOI URL">https://doi.org/10.1515/hc-2017-0190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2017-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2017-0190%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DSynthesis%252Bof%252B2%25252C3-dicyanopyrazine%252Band%252Bethyl%252B5-amino-4%25252C6-dicyanobiphenyl-3-carboxylate%252Bderivatives%252Bfrom%252Bethyl%252Baroylpyruvates%26aulast%3DMoloudi%26aufirst%3DMaryam%26date%3D2018%26volume%3D24%26issue%3D2%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Moloudi</span>, <span class="hlFld-ContribAuthor ">Hassan  Kabirifard</span>, <span class="hlFld-ContribAuthor ">Raihaneh  Kabirifard</span>, <span class="hlFld-ContribAuthor ">Mona  Mahdikhani</span>. </span><span class="cited-content_cbyCitation_article-title">Reactions of 4-benzoyl-5-phenylamino-2,3-dihydrothiophene-2,3-dione and diaminomaleonitrile in the presence of alcohols as reactant and solvent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Sulfur Chemistry</span><span> <strong>2017,</strong> <em>42 </em>, 1-10. <a href="https://doi.org/10.1080/17415993.2017.1307983" title="DOI URL">https://doi.org/10.1080/17415993.2017.1307983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17415993.2017.1307983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17415993.2017.1307983%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Sulfur%2520Chemistry%26atitle%3DReactions%252Bof%252B4-benzoyl-5-phenylamino-2%25252C3-dihydrothiophene-2%25252C3-dione%252Band%252Bdiaminomaleonitrile%252Bin%252Bthe%252Bpresence%252Bof%252Balcohols%252Bas%252Breactant%252Band%252Bsolvent%26aulast%3DMoloudi%26aufirst%3DMaryam%26date%3D2017%26date%3D2017%26volume%3D42%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-hui  Deng</span>, <span class="hlFld-ContribAuthor ">Zhong-hui  Yan</span>, <span class="hlFld-ContribAuthor ">Ji-ping  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Li-ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimidinylacetamide-based 2-pyridylureas as Angiogenesis Inhibitors: Design, Synthesis and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Archives of Medical Research</span><span> <strong>2017,</strong> <em>48 </em>
                                    (4)
                                     , 333-342. <a href="https://doi.org/10.1016/j.arcmed.2017.08.004" title="DOI URL">https://doi.org/10.1016/j.arcmed.2017.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arcmed.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arcmed.2017.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Medical%2520Research%26atitle%3DPyrimidinylacetamide-based%252B2-pyridylureas%252Bas%252BAngiogenesis%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%26aulast%3DDeng%26aufirst%3DYa-hui%26date%3D2017%26volume%3D48%26issue%3D4%26spage%3D333%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Chang</span>, <span class="hlFld-ContribAuthor ">Zhongjie  Wu</span>, <span class="hlFld-ContribAuthor ">Lu  Yu</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Peipei  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-light-mediated C3-azolylation of imidazo[1,2-a]pyridines with 2-bromoazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (25)
                                     , 5318-5324. <a href="https://doi.org/10.1039/C7OB00883J" title="DOI URL">https://doi.org/10.1039/C7OB00883J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00883J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00883J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DVisible-light-mediated%252BC3-azolylation%252Bof%252Bimidazo%25255B1%25252C2-a%25255Dpyridines%252Bwith%252B2-bromoazoles%26aulast%3DChang%26aufirst%3DQing%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D25%26spage%3D5318%26epage%3D5324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W.  Sun</span>, <span class="hlFld-ContribAuthor ">Z.  Ma</span>, <span class="hlFld-ContribAuthor ">H.  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation of 4-aryl-1,4-dihydropyridines as VEGFR-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2016,</strong> <em>86 </em>
                                    (12)
                                     , 2891-2899. <a href="https://doi.org/10.1134/S1070363216120574" title="DOI URL">https://doi.org/10.1134/S1070363216120574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363216120574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363216120574%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DBiological%252Bevaluation%252Bof%252B4-aryl-1%25252C4-dihydropyridines%252Bas%252BVEGFR-2%252Bkinase%252Binhibitors%26aulast%3DSun%26aufirst%3DW.%26date%3D2016%26date%3D2017%26volume%3D86%26issue%3D12%26spage%3D2891%26epage%3D2899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Hui  Deng</span>, <span class="hlFld-ContribAuthor ">Ji-Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Yi-Juan  Cheng</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Diarylureas and Diarylamides with Oxazolo[5,4-
              d
              ]pyrimidine Scaffold as Angiogenesis Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2016,</strong> <em>13 </em>
                                    (9)
                                     , 1230-1239. <a href="https://doi.org/10.1002/cbdv.201600035" title="DOI URL">https://doi.org/10.1002/cbdv.201600035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201600035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201600035%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDiarylureas%252Band%252BDiarylamides%252Bwith%252BOxazolo%25255B5%25252C4-%252Bd%252B%25255Dpyrimidine%252BScaffold%252Bas%252BAngiogenesis%252BInhibitors%26aulast%3DDeng%26aufirst%3DYa-Hui%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D9%26spage%3D1230%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Sharif</span>, <span class="hlFld-ContribAuthor ">Khurram  Shoaib</span>, <span class="hlFld-ContribAuthor ">Shahzad  Ahmed</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Zharylkasyn A.  Abilov</span>, <span class="hlFld-ContribAuthor ">Anke  Spannenberg</span>, <span class="hlFld-ContribAuthor ">Peter  Langer</span>. </span><span class="cited-content_cbyCitation_article-title">Suzuki–Miyaura reactions of 3,5-dichloro-2,4,6-trifluoropyridine. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (29)
                                     , 3060-3062. <a href="https://doi.org/10.1016/j.tetlet.2016.05.041" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.05.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.05.041%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSuzuki%2525E2%252580%252593Miyaura%252Breactions%252Bof%252B3%25252C5-dichloro-2%25252C4%25252C6-trifluoropyridine%26aulast%3DSharif%26aufirst%3DMuhammad%26date%3D2016%26volume%3D57%26issue%3D29%26spage%3D3060%26epage%3D3062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Maftei</span>, <span class="hlFld-ContribAuthor ">Catalin V.  Maftei</span>, <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>, <span class="hlFld-ContribAuthor ">Matthias  Freytag</span>, <span class="hlFld-ContribAuthor ">M. Heiko  Franz</span>, <span class="hlFld-ContribAuthor ">Gerhard  Kelter</span>, <span class="hlFld-ContribAuthor ">Heinz-Herbert  Fiebig</span>, <span class="hlFld-ContribAuthor ">Matthias  Tamm</span>, <span class="hlFld-ContribAuthor ">Ion  Neda</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoromethylpyridine-Substituted
              N
              -Heterocyclic Carbenes Related to Natural Products: Synthesis, Structure, and Potential Antitumor Activity of some Corresponding Gold(I), Rhodium(I), and Iridium(I) Complexes. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2016,</strong> <em>99 </em>
                                    (6)
                                     , 469-481. <a href="https://doi.org/10.1002/hlca.201500529" title="DOI URL">https://doi.org/10.1002/hlca.201500529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201500529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201500529%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DTrifluoromethylpyridine-Substituted%252BN%252B-Heterocyclic%252BCarbenes%252BRelated%252Bto%252BNatural%252BProducts%25253A%252BSynthesis%25252C%252BStructure%25252C%252Band%252BPotential%252BAntitumor%252BActivity%252Bof%252Bsome%252BCorresponding%252BGold%252528I%252529%25252C%252BRhodium%252528I%252529%25252C%252Band%252BIridium%252528I%252529%252BComplexes%26aulast%3DMaftei%26aufirst%3DElena%26date%3D2016%26date%3D2016%26volume%3D99%26issue%3D6%26spage%3D469%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catalin V.  Maftei</span>, <span class="hlFld-ContribAuthor ">Elena  Fodor</span>, <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>, <span class="hlFld-ContribAuthor ">Constantin G.  Daniliuc</span>, <span class="hlFld-ContribAuthor ">M. Heiko  Franz</span>, <span class="hlFld-ContribAuthor ">Gerhard  Kelter</span>, <span class="hlFld-ContribAuthor ">Heinz-Herbert  Fiebig</span>, <span class="hlFld-ContribAuthor ">Matthias  Tamm</span>, <span class="hlFld-ContribAuthor ">Ion  Neda</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 1,2,4-oxadiazoles and trifluoromethylpyridines related to natural products: synthesis, structural analysis and investigation of their antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (9)
                                     , 1185-1199. <a href="https://doi.org/10.1016/j.tet.2016.01.011" title="DOI URL">https://doi.org/10.1016/j.tet.2016.01.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.01.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DNovel%252B1%25252C2%25252C4-oxadiazoles%252Band%252Btrifluoromethylpyridines%252Brelated%252Bto%252Bnatural%252Bproducts%25253A%252Bsynthesis%25252C%252Bstructural%252Banalysis%252Band%252Binvestigation%252Bof%252Btheir%252Bantitumor%252Bactivity%26aulast%3DMaftei%26aufirst%3DCatalin%2BV.%26date%3D2016%26volume%3D72%26issue%3D9%26spage%3D1185%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Hui  Deng</span>, <span class="hlFld-ContribAuthor ">Dan  Xu</span>, <span class="hlFld-ContribAuthor ">Ye-Xiang  Su</span>, <span class="hlFld-ContribAuthor ">Yi-Juan  Cheng</span>, <span class="hlFld-ContribAuthor ">Yan-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Xiu-Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Oxazolo[5,4-
              d
              ]pyrimidines as Potent VEGFR-2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2015,</strong> <em>12 </em>
                                    (4)
                                     , 528-537. <a href="https://doi.org/10.1002/cbdv.201400270" title="DOI URL">https://doi.org/10.1002/cbdv.201400270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201400270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201400270%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BOxazolo%25255B5%25252C4-%252Bd%252B%25255Dpyrimidines%252Bas%252BPotent%252BVEGFR-2%252BInhibitors%26aulast%3DDeng%26aufirst%3DYa-Hui%26date%3D2015%26date%3D2015%26volume%3D12%26issue%3D4%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zixian  Chen</span>, <span class="hlFld-ContribAuthor ">Jiangtao  Zhu</span>, <span class="hlFld-ContribAuthor ">Haibo  Xie</span>, <span class="hlFld-ContribAuthor ">Shan  Li</span>, <span class="hlFld-ContribAuthor ">Yongming  Wu</span>, <span class="hlFld-ContribAuthor ">Yuefa  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective synthesis of poly-substituted fluorine-containing pyridines and dihydropyrimidines via cascade C–F bond cleavage protocol. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2011,</strong> <em>9 </em>
                                    (16)
                                     , 5682. <a href="https://doi.org/10.1039/c1ob05371j" title="DOI URL">https://doi.org/10.1039/c1ob05371j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1ob05371j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1ob05371j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSelective%252Bsynthesis%252Bof%252Bpoly-substituted%252Bfluorine-containing%252Bpyridines%252Band%252Bdihydropyrimidines%252Bvia%252Bcascade%252BC%2525E2%252580%252593F%252Bbond%252Bcleavage%252Bprotocol%26aulast%3DChen%26aufirst%3DZixian%26date%3D2011%26volume%3D9%26issue%3D16%26spage%3D5682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Devi Prasad  Sahu</span>. </span><span class="cited-content_cbyCitation_article-title">Friedel-Crafts heteroarylation of (hetero)arenes: A facile entry to 4-(hetero)aryl quinazolines and quinolines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2009,</strong> <em>46 </em>
                                    (4)
                                     , 748-755. <a href="https://doi.org/10.1002/jhet.144" title="DOI URL">https://doi.org/10.1002/jhet.144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.144%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DFriedel-Crafts%252Bheteroarylation%252Bof%252B%252528hetero%252529arenes%25253A%252BA%252Bfacile%252Bentry%252Bto%252B4-%252528hetero%252529aryl%252Bquinazolines%252Band%252Bquinolines%26aulast%3DKumar%26aufirst%3DShailesh%26date%3D2009%26volume%3D46%26issue%3D4%26spage%3D748%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy E.  Smith</span>, <span class="hlFld-ContribAuthor ">Kate M.  Clapham</span>, <span class="hlFld-ContribAuthor ">Andrei S.  Batsanov</span>, <span class="hlFld-ContribAuthor ">Martin R.  Bryce</span>, <span class="hlFld-ContribAuthor ">Brian  Tarbit</span>. </span><span class="cited-content_cbyCitation_article-title">(Dimethoxy- and Dihalopyridyl)boronic Acids and Highly Functionalized Heteroarylpyridines by Suzuki Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2008,</strong> <em>2008 </em>
                                    (8)
                                     , 1458-1463. <a href="https://doi.org/10.1002/ejoc.200701156" title="DOI URL">https://doi.org/10.1002/ejoc.200701156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.200701156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.200701156%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%252528Dimethoxy-%252Band%252BDihalopyridyl%252529boronic%252BAcids%252Band%252BHighly%252BFunctionalized%252BHeteroarylpyridines%252Bby%252BSuzuki%252BCross-Coupling%252BReactions%26aulast%3DSmith%26aufirst%3DAmy%2BE.%26date%3D2008%26volume%3D2008%26issue%3D8%26spage%3D1458%26epage%3D1463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiazhong  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Qin</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, <span class="hlFld-ContribAuthor ">Mancang  Liu</span>, <span class="hlFld-ContribAuthor ">Zhide  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Prediction of Inhibition Activity of Pyrazine–Pyridine Biheteroaryls as VEGFR-2 Inhibitors Based on Least Squares Support Vector Machines. </span><span class="cited-content_cbyCitation_journal-name">QSAR & Combinatorial Science</span><span> <strong>2008,</strong> <em>27 </em>
                                    (2)
                                     , 157-164. <a href="https://doi.org/10.1002/qsar.200630154" title="DOI URL">https://doi.org/10.1002/qsar.200630154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qsar.200630154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqsar.200630154%26sid%3Dliteratum%253Aachs%26jtitle%3DQSAR%2520%2526%2520Combinatorial%2520Science%26atitle%3DIn%252BSilico%252BPrediction%252Bof%252BInhibition%252BActivity%252Bof%252BPyrazine%2525E2%252580%252593Pyridine%252BBiheteroaryls%252Bas%252BVEGFR-2%252BInhibitors%252BBased%252Bon%252BLeast%252BSquares%252BSupport%252BVector%252BMachines%26aulast%3DLi%26aufirst%3DJiazhong%26date%3D2008%26volume%3D27%26issue%3D2%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joe A.  Tran</span>, <span class="hlFld-ContribAuthor ">Caroline W.  Chen</span>, <span class="hlFld-ContribAuthor ">Fabio C.  Tucci</span>, <span class="hlFld-ContribAuthor ">Wanlong  Jiang</span>, <span class="hlFld-ContribAuthor ">Beth A.  Fleck</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses of tetrahydrothiophenes and tetrahydrofurans and studies of their derivatives as melanocortin-4 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (3)
                                     , 1124-1130. <a href="https://doi.org/10.1016/j.bmcl.2007.11.128" title="DOI URL">https://doi.org/10.1016/j.bmcl.2007.11.128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2007.11.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2007.11.128%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSyntheses%252Bof%252Btetrahydrothiophenes%252Band%252Btetrahydrofurans%252Band%252Bstudies%252Bof%252Btheir%252Bderivatives%252Bas%252Bmelanocortin-4%252Breceptor%252Bligands%26aulast%3DTran%26aufirst%3DJoe%2BA.%26date%3D2008%26volume%3D18%26issue%3D3%26spage%3D1124%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael P.  Groziak</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6.2 (2005) Six-membered ring systems: diazines and benzo derivatives (2005). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 353-382. <a href="https://doi.org/10.1016/S0959-6380(08)80015-3" title="DOI URL">https://doi.org/10.1016/S0959-6380(08)80015-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(08)80015-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2808%2980015-3%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6.2%252B%2525282005%252529%252BSix-membered%252Bring%252Bsystems%25253A%252Bdiazines%252Band%252Bbenzo%252Bderivatives%252B%2525282005%252529%26aulast%3DGroziak%26aufirst%3DMichael%2BP.%26date%3D2008%26spage%3D353%26epage%3D382%26pub%3DElsevier%26atitle%3DA%252Bcritical%252Breview%252Bof%252Bthe%252B2006%252Bliterature%252Bpreceded%252Bby%252Btwo%252Bchapters%252Bon%252Bcurrent%252Bheterocyclic%252Btopics%26date%3D2008%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Liu  Yang</span>, <span class="hlFld-ContribAuthor ">Xuan  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel pyridine acid esters of podophyllotoxin and esters of 4′-demethylepipodophyllotoxin. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2007,</strong> <em>16 </em>
                                    (7-9)
                                     , 319-330. <a href="https://doi.org/10.1007/s00044-007-9010-2" title="DOI URL">https://doi.org/10.1007/s00044-007-9010-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-007-9010-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-007-9010-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyridine%252Bacid%252Besters%252Bof%252Bpodophyllotoxin%252Band%252Besters%252Bof%252B4%2525E2%252580%2525B2-demethylepipodophyllotoxin%26aulast%3DLiu%26aufirst%3DYing-Qian%26date%3D2007%26date%3D2008%26volume%3D16%26issue%3D7-9%26spage%3D319%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 4 Pyridines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2007,</strong>,, 189-249. <a href="https://doi.org/10.1016/S1460-1567(07)80053-5" title="DOI URL">https://doi.org/10.1016/S1460-1567(07)80053-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1460-1567(07)80053-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1460-1567%2807%2980053-5%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B4%252BPyridines%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2007%26spage%3D189%26epage%3D249%26pub%3DElsevier%26atitle%3DPalladium%252Bin%252BHeterocyclic%252BChemistry%252B-%252BA%252BGuide%252Bfor%252Bthe%252BSynthetic%252BChemist%26date%3D2007%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Yu</span>, <span class="hlFld-ContribAuthor ">M.  Wu</span>, <span class="hlFld-ContribAuthor ">S.  Lin</span>, <span class="hlFld-ContribAuthor ">Prue  Talbot</span>. </span><span class="cited-content_cbyCitation_article-title">Cigarette Smoke Toxicants Alter Growth and Survival of Cultured Mammalian Cells. </span><span class="cited-content_cbyCitation_journal-name">Toxicological Sciences</span><span> <strong>2006,</strong> <em>93 </em>
                                    (1)
                                     , 82-95. <a href="https://doi.org/10.1093/toxsci/kfl047" title="DOI URL">https://doi.org/10.1093/toxsci/kfl047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/toxsci/kfl047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ftoxsci%2Fkfl047%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicological%2520Sciences%26atitle%3DCigarette%252BSmoke%252BToxicants%252BAlter%252BGrowth%252Band%252BSurvival%252Bof%252BCultured%252BMammalian%252BCells%26aulast%3DYu%26aufirst%3DRichard%26date%3D2006%26date%3D2006%26volume%3D93%26issue%3D1%26spage%3D82%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed A.  Ismail</span>, <span class="hlFld-ContribAuthor ">David W.  Boykin</span>, <span class="hlFld-ContribAuthor ">Chad E.  Stephens</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of 5,5′-diaryl-2,2′-bichalcophenes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2006,</strong> <em>47 </em>
                                    (5)
                                     , 795-797. <a href="https://doi.org/10.1016/j.tetlet.2005.11.091" title="DOI URL">https://doi.org/10.1016/j.tetlet.2005.11.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2005.11.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2005.11.091%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252B5%25252C5%2525E2%252580%2525B2-diaryl-2%25252C2%2525E2%252580%2525B2-bichalcophenes%26aulast%3DIsmail%26aufirst%3DMohamed%2BA.%26date%3D2006%26volume%3D47%26issue%3D5%26spage%3D795%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bn00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bn00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bh00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Scheme 1  </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bh00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00002.jpeg" id="rightTab-_i8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) [(<i>n</i>-Bu)<sub>3</sub>Sn]<sub>2</sub>, Pd(OAc)<sub>2</sub>, P(<i>o</i>-Tol)<sub>3</sub>, 100 °C; (ii) 2,6-dichloropyrazine, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, LiCl, 100 °C; (iii) substituted aniline, Pd<sub>2</sub>(dba)<sub>3</sub>, DPPF, Cs<sub>2</sub>CO<sub>3</sub>, 110 °C; (iv) (a) Boc<sub>2</sub>O, DMAP, (b) NaOH, 0−20 °C; (v) DPPA, Et<sub>3</sub>N, <i>t-</i>BuOH, 65−100 °C; (vi) (a) X(CH<sub>2</sub>)<i><sub>n</sub></i>R<sup>1</sup>, Cs<sub>2</sub>CO<sub>3</sub>, 70 °C, (b) TFA.  </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bh00003" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00003.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) Benzylamine (or 3-chlorophenol), Pd<sub>2</sub>(dba)<sub>3</sub>, DPPF, Cs<sub>2</sub>CO<sub>3</sub>, 110 °C; (ii) (a) Boc<sub>2</sub>O, DMAP, (b) NaOH, 0−20 °C (or NaOH, 0−20 °C); (iii) DPPA, Et<sub>3</sub>N, <i>t-</i>BuOH, 65−100 °C; (iv) (a) Br(CH<sub>2</sub>)<sub>3</sub>OTBS, Cs<sub>2</sub>CO<sub>3</sub>, 70 °C, (b) TFA.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bh00004" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00004.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (a) NH<sub>2</sub>(CH<sub>2</sub>)<i><sub>n</sub></i>R, DIPA, HATU, 20 °C, (b) TFA; (ii) (a) 60% NaH, R<sup>1</sup>COCl, 20 °C, (b) TFA.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bh00005" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00005.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (a) Br<sub>2</sub>, H<sub>2</sub>O, (b) DPPA, Et<sub>3</sub>N, PhCH<sub>2</sub>OH; (ii) Br(CH<sub>2</sub>)<sub>3</sub>OTBDPS, Cs<sub>2</sub>CO<sub>3</sub>; (iii) NOBF<sub>4</sub>; (iv) Pd(PPh<sub>3</sub>)<sub>4</sub>, Me<sub>6</sub>Sn<sub>2</sub>, LiCl, BHT; (v) <b>68</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, LiCl; (vi) (a) H<sub>2</sub>, 10%Pd/C, (b) TFA, CH<sub>3</sub>SO<sub>3</sub>H.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bh00006" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bh00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00006.jpeg" id="rightTab-_i17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) (a) Br<sub>2</sub>, H<sub>2</sub>O, (b) POCl<sub>3</sub>, quinoline; (ii) DPPA, Et<sub>3</sub>N, <i>t</i>-BuOH; (iii) Br(CH<sub>2</sub>)<sub>3</sub>OH, Cs<sub>2</sub>CO<sub>3</sub>; (iv) Pd(PPh<sub>3</sub>)<sub>4</sub>, Me<sub>6</sub>Sn<sub>2</sub>, LiCl, BHT; (v) <b>68</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, LiCl.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bh00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bh00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bf00001" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bf00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00001.jpeg" id="rightTab-_i24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 (a) Illustration of the alignment of 32 compounds in the ATP-binding site of VEGFR-2. The ligands and the key residues that act as their hydorgen-bond partners are represented in the tube model, while the protein is represented in the carton model. The hydrogen bonds are indicated by the yellow dotted lines. The connolly water-accessible surface of binding site is represented as meshes. (Atom color scheme:  hydrogen in white; oxygen in red; nitrogen in blue; chlorine in dark green; carbon on ligands in orange; and carbon on proteins in gray.) (b) Correlation plot of the calculated pIC<sub>50</sub> values from eq 1 versus the experimental pIC<sub>50</sub> values. The dotted line represents the best fitting line between them.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bf00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm058205bf00002" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/medium/jm058205bf00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00002.jpeg" id="rightTab-_i25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Compounds <b>39</b> and <b>41</b> delay tumor growth and increase survival in an A375 melanoma tumor xenograft model. Compounds were administered to nude mice IP at 75 mg/kg, and tumor growth was measured. Percent remaining refers to the number of animals remaining in the study with a tumor size under 2 g. Animals with a tumor size over 2 g were removed from the study but do not represent treatment-related deaths. Control animals were treated with vehicle alone (▪). Dacarbazine (DTIC) was administered at 90 mg/kg on a qd × 5 schedule (red solid circles). Compound <b>39</b> (blue open triangles) and compound <b>41</b> (green open squares) were administered on a QD x 30 schedule, and the experiment was ended on day 60.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2005/jmcmar.2005.48.issue-15/jm058205b/production/images/large/jm058205bf00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm058205b&amp;id=jm058205bf00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004801504909" id="jm004801504909"></a></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm058205bb00001"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00001_1"><span><span class="NLM_string-ref">Risau, W. Mechanism of angiogenesis. <i>  Nature</i><b>1997</b>, <i>386</i>, 671−674.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=1997&pages=674&author=W+Risau&title=Mechanism+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisau%26aufirst%3DW%26atitle%3DMechanism%2520of%2520angiogenesis%26jtitle%3DNature%26date%3D1997%26volume%3D386%26spage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00002"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00002_1"><span><span class="NLM_string-ref">Ribatti, D.; Vacca, A.; Nico, B.; Roncali, L.; Dammacco, F. Postnatal angiogenesis. <i>  Mech. Dev.</i><b>2001</b>, <i>100</i>, 157−163.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2001&pages=163&author=D.+Ribatti&author=A.+Vacca&author=B.+Nico&author=L.+Roncali&author=F+Dammacco&title=Postnatal+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRibatti%26aufirst%3DD.%26atitle%3DPostnatal%2520angiogenesis%26jtitle%3DMech.%2520Dev.%26date%3D2001%26volume%3D100%26spage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00003"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00003_1"><span><span class="NLM_string-ref">(a) Folkman, J. Anti-angiogenesis:  new concept for therapy of solid tumors. <i>  Ann. Surg</i>. <b>1972</b>, <i>175</i>, 409−416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1972&pages=416&author=J.+Folkman&author=+Anti&title=new+concept+for+therapy+of+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3Dnew%2520concept%2520for%2520therapy%2520of%2520solid%2520tumors%26jtitle%3DAnn.%2520Surg.%26date%3D1972%26volume%3D175%26spage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00003_2"><span><span class="NLM_string-ref">(b) Folkman, J. Tumor angiogenesis:  therapeutic implications. <i>  N. Engl. J. Med.</i><b>1971</b>, <i>285</i>, 1182−1186.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+Folkman%2C+J.+Tumor+angiogenesis%3A%E2%80%89+therapeutic+implications.+N.+Engl.+J.+Med.+1971%2C+285%2C+1182%E2%88%921186.+%28b%29+Folkman%2C+J.+Tumor+angiogenesis%3A%E2%80%89+therapeutic+implications.+N.+Engl.+J.+Med.1971%2C+285%2C+1182%E2%88%921186."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00003_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26jtitle%3D%2520Engl.%2520J.%2520Med.%26date%3D1971%26volume%3D285%26spage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00004"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00004_1"><span><span class="NLM_string-ref">Spranger, J.; Pfeiffer, A. F. New concepts in pathogenesis and treatment of diabetic retinopathy<i>. Exp. Clin. Endocrinol. Diabetes</i><b>2001</b>, <i>109</i> (Suppl. 2) S438−S450.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109+%28Suppl.+2&publication_year=2001&pages=S450&author=J.+Spranger&author=A.+F+Pfeiffer&title=New+concepts+in+pathogenesis+and+treatment+of+diabetic+retinopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DJ.%26atitle%3DNew%2520concepts%2520in%2520pathogenesis%2520and%2520treatment%2520of%2520diabetic%2520retinopathy%26jtitle%3DExp.%2520Clin.%2520Endocrinol.%2520Diabetes%26date%3D2001%26volume%3D109%2520%2528Suppl.%25202%26spage%3DS450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00005"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00005_1"><span><span class="NLM_string-ref">Walsh, D. A.; Haywood, L. Angiogenesis:  a therapeutic target in arthritis. <i>  Curr. Opin. Invest. Drugs </i><b>2001</b>, <i>2</i>, 1054−1063.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=1063&author=D.+A.+Walsh&author=L.+Haywood&author=+Angiogenesis&title=a+therapeutic+target+in+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3Da%2520therapeutic%2520target%2520in%2520arthritis%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D2%26spage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00006"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00006_1"><span><span class="NLM_string-ref">McLaren, J.; Prentice, A.; Charnock-Jones, D. S.; Millican, S. A.; Muller, K. H.; Sharkey, A. M.; Smith, S. K. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids<i>. J. Clin. Invest</i>. <b>1996</b>, <i>98</i>, 482−489.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1996&pages=489&author=J.+McLaren&author=A.+Prentice&author=D.+S.+Charnock-Jones&author=S.+A.+Millican&author=K.+H.+Muller&author=A.+M.+Sharkey&author=S.+K+Smith&title=Vascular+endothelial+growth+factor+is+produced+by+peritoneal+fluid+macrophages+in+endometriosis+and+is+regulated+by+ovarian+steroids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaren%26aufirst%3DJ.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520is%2520produced%2520by%2520peritoneal%2520fluid%2520macrophages%2520in%2520endometriosis%2520and%2520is%2520regulated%2520by%2520ovarian%2520steroids%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1996%26volume%3D98%26spage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00007"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00007_1"><span><span class="NLM_string-ref">Detmar, M. The role of VEGF and thrombospondin in skin angiogenesis. <i>  Dermatol. Sci.</i><b>2000</b>, <i>24</i>, S78−S84.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=S84&author=M+Detmar&title=The+role+of+VEGF+and+thrombospondin+in+skin+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDetmar%26aufirst%3DM%26atitle%3DThe%2520role%2520of%2520VEGF%2520and%2520thrombospondin%2520in%2520skin%2520angiogenesis%26jtitle%3DDermatol.%2520Sci.%26date%3D2000%26volume%3D24%26spage%3DS84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00008"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00008_1"><span><span class="NLM_string-ref">Folkman, J. What is the evidence that tumors are angiogenesis dependment? <i>J. Natl. Cancer Inst.</i><b>1990</b>, <i>82</i>, 4−6.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=6&author=J+Folkman&title=What+is+the+evidence+that+tumors+are+angiogenesis+dependment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DWhat%2520is%2520the%2520evidence%2520that%2520tumors%2520are%2520angiogenesis%2520dependment%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00009"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00009_1"><span><span class="NLM_string-ref">Liotta, L. A.; Steeg, P. S.; Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis:  an imbalance of positive and negative regulation. <i>  Cell</i><b>1991</b>, 64, 327−336.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=336&author=L.+A.+Liotta&author=P.+S.+Steeg&author=W.+G+Stetler-Stevenson&title=Cancer+metastasis+and+angiogenesis%3A%E2%80%89+an+imbalance+of+positive+and+negative+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26atitle%3DCancer%2520metastasis%2520and%2520angiogenesis%253A%25E2%2580%2589%2520an%2520imbalance%2520of%2520positive%2520and%2520negative%2520regulation%26jtitle%3DCell%26date%3D1991%26volume%3D64%26spage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm058205bb00010_1"><span><span class="NLM_string-ref">(a) Nugent, M. A.; Iozzo, R. V. Fibroblast growth factor-2<i>. Int. J. Biochem. </i><i>Cell. Biol</i>. <b>2000</b>, <i>32</i>, 115−120.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2000&pages=120&author=M.+A.+Nugent&author=R.+V+Iozzo&title=Fibroblast+growth+factor-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNugent%26aufirst%3DM.%2BA.%26atitle%3DFibroblast%2520growth%2520factor-2%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D32%26spage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00010_2"><span><span class="NLM_string-ref">(b) Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. <i>  Nat. Med</i>. <b>2000</b>, <i>6</i>, 389−395.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=395&author=P+Carmeliet&title=Mechanisms+of+angiogenesis+and+arteriogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP%26atitle%3DMechanisms%2520of%2520angiogenesis%2520and%2520arteriogenesis%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26spage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00010_3"><span><span class="NLM_string-ref">(c) Davis, S.; Yancopoulos, G. D. The angiopoietins:  yin and yang in angiogenesis. <i>  Curr. </i><i>Top. Microbiol. Immunol.</i><b>1999</b>, <i>237</i>, 173−185.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=1999&pages=185&author=S.+Davis&author=G.+D+Yancopoulos&title=The+angiopoietins%3A%E2%80%89+yin+and+yang+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DS.%26atitle%3DThe%2520angiopoietins%253A%25E2%2580%2589%2520yin%2520and%2520yang%2520in%2520angiogenesis%26jtitle%3DCurr.%2520Top.%2520Microbiol.%2520Immunol.%26date%3D1999%26volume%3D237%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00010_4"><span><span class="NLM_string-ref">(d) Lindahl, P.; Bostrom, H.; Karlsson, L.; Hellstrom, M.; Kalen, M.; Betsholtz, C. Role of platelet-derived growth factors in angiogenesis and alveogenesis. <i>  Curr. </i><i>Top. Pathol</i>. <b>1999</b>, <i>93</i>, 27−33.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=33&author=P.+Lindahl&author=H.+Bostrom&author=L.+Karlsson&author=M.+Hellstrom&author=M.+Kalen&author=C+Betsholtz&title=Role+of+platelet-derived+growth+factors+in+angiogenesis+and+alveogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00010_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindahl%26aufirst%3DP.%26atitle%3DRole%2520of%2520platelet-derived%2520growth%2520factors%2520in%2520angiogenesis%2520and%2520alveogenesis%26jtitle%3DCurr.%2520Top.%2520Pathol.%26date%3D1999%26volume%3D93%26spage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00011"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00011_1"><span><span class="NLM_string-ref">(a) Cross, M. J.; Claesson-Welsh, L. FGF and VEGF function in angiogenesis:  signaling pathways, biological responses, and therapeutic inhibition. <i>  Trends Pharm. Sci</i>. <b>2001</b>, <i>22</i>, 201−207.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=207&author=M.+J.+Cross&author=L+Claesson-Welsh&title=FGF+and+VEGF+function+in+angiogenesis%3A%E2%80%89+signaling+pathways%2C+biological+responses%2C+and+therapeutic+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DM.%2BJ.%26atitle%3DFGF%2520and%2520VEGF%2520function%2520in%2520angiogenesis%253A%25E2%2580%2589%2520signaling%2520pathways%252C%2520biological%2520responses%252C%2520and%2520therapeutic%2520inhibition%26jtitle%3DTrends%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D22%26spage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00011_2"><span><span class="NLM_string-ref">(b) McMahon, G. VEGF receptor signaling in tumor angiogenesis. <i>  Oncologist</i><b>2000</b>, <i>5 </i>(Suppl. 1), 3−10.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5+%28Suppl.+1&publication_year=2000&pages=10&author=G+McMahon&title=VEGF+receptor+signaling+in+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcMahon%26aufirst%3DG%26atitle%3DVEGF%2520receptor%2520signaling%2520in%2520tumor%2520angiogenesis%26jtitle%3DOncologist%26date%3D2000%26volume%3D5%2520%2528Suppl.%25201%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00011_3"><span><span class="NLM_string-ref">(c) Ferrara, N.; Davis-Smyth, T. The biology of vascular endothelial growth factor. <i>  Endocrinol. Rev</i>. <b>1997</b>, <i>18</i>, 4−25.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=25&author=N.+Ferrara&author=T+Davis-Smyth&title=The+biology+of+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00011_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DThe%2520biology%2520of%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DEndocrinol.%2520Rev.%26date%3D1997%26volume%3D18%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00012"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00012_1"><span><span class="NLM_string-ref">De Vries, C.; Escobedo, J. A.; Ueno, H.; Houck, K.; Ferrara, N.; Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. <i>  Science</i><b>1992</b>, <i>255</i>, 989−991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1992&pages=991&author=C.+De+Vries&author=J.+A.+Escobedo&author=H.+Ueno&author=K.+Houck&author=N.+Ferrara&author=L.+T+Williams&title=The+fms-like+tyrosine+kinase%2C+a+receptor+for+vascular+endothelial+growth+factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BVries%26aufirst%3DC.%26atitle%3DThe%2520fms-like%2520tyrosine%2520kinase%252C%2520a%2520receptor%2520for%2520vascular%2520endothelial%2520growth%2520factor%26jtitle%3DScience%26date%3D1992%26volume%3D255%26spage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00013"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00013_1"><span><span class="NLM_string-ref">Shalaby, F.; Rossant, J.; Yamaguchl, T. P.; Gertsenstein, M.; Wu, X.-F.; Breltman, M. L.; Schuh, A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. <i>  Nature</i><b>1995</b>, <i>376</i>, 62−66.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=1995&pages=66&author=F.+Shalaby&author=J.+Rossant&author=T.+P.+Yamaguchl&author=M.+Gertsenstein&author=X.-F.+Wu&author=M.+L.+Breltman&author=A.+C+Schuh&title=Failure+of+blood-island+formation+and+vasculogenesis+in+Flk-1-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShalaby%26aufirst%3DF.%26atitle%3DFailure%2520of%2520blood-island%2520formation%2520and%2520vasculogenesis%2520in%2520Flk-1-deficient%2520mice%26jtitle%3DNature%26date%3D1995%26volume%3D376%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00014"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00014_1"><span><span class="NLM_string-ref">Ferrara, N.; Gerber, H.-P.; LeCouter, J. The biology of VEGF and its receptors. <i>  Nat. Med.</i><b>2003</b>, <i>9</i>, 669−676.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=676&author=N.+Ferrara&author=H.-P.+Gerber&author=J+LeCouter&title=The+biology+of+VEGF+and+its+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DThe%2520biology%2520of%2520VEGF%2520and%2520its%2520receptors%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00015"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00015_1"><span><span class="NLM_string-ref">Kerbel, R. S. A cancer therapy resistant to resistance. <i>  Nature</i><b>1997</b>, <i>390</i>, 335−336.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=1997&pages=336&author=R.+S+Kerbel&title=A+cancer+therapy+resistant+to+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKerbel%26aufirst%3DR.%2BS%26atitle%3DA%2520cancer%2520therapy%2520resistant%2520to%2520resistance%26jtitle%3DNature%26date%3D1997%26volume%3D390%26spage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00016"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00016_1"><span><span class="NLM_string-ref">Yang, J. C.; Haworth, L.; Sherry, R. M.; Hwu, P.; Schwartzentruber, D. J.; Topalian, S. L.; Steinberg, S. M.; Chen, H. X.; Rosenberg, S. A. A randomized trial of bevacizumab (anti-VEGF antibody) in metastatic renal cancer. <i>  N. Eng. J. Med</i>. <b>2003</b>, <i>349</i>, 427−434.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2003&pages=434&author=J.+C.+Yang&author=L.+Haworth&author=R.+M.+Sherry&author=P.+Hwu&author=D.+J.+Schwartzentruber&author=S.+L.+Topalian&author=S.+M.+Steinberg&author=H.+X.+Chen&author=S.+A+Rosenberg&title=A+randomized+trial+of+bevacizumab+%28anti-VEGF+antibody%29+in+metastatic+renal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%2BC.%26atitle%3DA%2520randomized%2520trial%2520of%2520bevacizumab%2520%2528anti-VEGF%2520antibody%2529%2520in%2520metastatic%2520renal%2520cancer%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2003%26volume%3D349%26spage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00017"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00017_1"><span><span class="NLM_string-ref">Prewett, M.; Huber, J.; Li, Y.; Santiago, A.; O'Connor, W.; King, K.; Overholser, J.; Hooper, A.; Pytowski, B.; Witte, L.; Bohlen, P.; Hicklin, D. J. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis<i>. Cancer Res</i>. <b>1999</b>, <i>59</i>, 5209−5218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5218&author=M.+Prewett&author=J.+Huber&author=Y.+Li&author=A.+Santiago&author=W.+O%27Connor&author=K.+King&author=J.+Overholser&author=A.+Hooper&author=B.+Pytowski&author=L.+Witte&author=P.+Bohlen&author=D.+J+Hicklin&title=Antivascular+endothelial+growth+factor+receptor+%28fetal+liver+kinase+1%29+monoclonal+antibody+inhibits+tumor+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrewett%26aufirst%3DM.%26atitle%3DAntivascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528fetal%2520liver%2520kinase%25201%2529%2520monoclonal%2520antibody%2520inhibits%2520tumor%2520angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00018"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00018_1"><span><span class="NLM_string-ref">Holash, J.; Davis, S.; Papadopoulos, N.; Croll, S. D.; Ho, L.; Russell, M.; Boland, P.; Leidich, R.; Hylton, D.; Burova, E.; Ioffe, E.; Huang, T.; Radziejewski, C.; Baily, K.; Fandl, J. P.; Daly, T.; Wiegand, S. J.; Yancopoulos, G. D.; Rudge, J. S. VEGF-Trap:  a VEGF blocker with potent antitumor effects. <i>  Proc. Natl. Acad. Sci., U.S.A.</i><b>2002</b>, <i>99</i>, 11393−11398.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11398&author=J.+Holash&author=S.+Davis&author=N.+Papadopoulos&author=S.+D.+Croll&author=L.+Ho&author=M.+Russell&author=P.+Boland&author=R.+Leidich&author=D.+Hylton&author=E.+Burova&author=E.+Ioffe&author=T.+Huang&author=C.+Radziejewski&author=K.+Baily&author=J.+P.+Fandl&author=T.+Daly&author=S.+J.+Wiegand&author=G.+D.+Yancopoulos&author=J.+S.+Rudge&author=+Trap&title=VEGF+blocker+with+potent+antitumor+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolash%26aufirst%3DJ.%26atitle%3DVEGF%2520blocker%2520with%2520potent%2520antitumor%2520effects%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%252C%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D11398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00019"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00019_1"><span><span class="NLM_string-ref">(a) Drevs, J.; Müller-Driver, R.; Wittig, C.; Fuxius, S.; Esser, N.; Hugenschmidt, H.; Konerding, M. A.; Allegrini, P. R.; Wood, J.; Hennig, J.; Unger, C.; Marmé, D. PTK787/ZK222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, effects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. <i>  Cancer Res</i>. <b>2002</b>, <i>62</i>, 4015−4022.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4022&author=J.+Drevs&author=R.+M%C3%BCller-Driver&author=C.+Wittig&author=S.+Fuxius&author=N.+Esser&author=H.+Hugenschmidt&author=M.+A.+Konerding&author=P.+R.+Allegrini&author=J.+Wood&author=J.+Hennig&author=C.+Unger&author=D.+Marm%C3%A9&title=a+specific+vascular+endothelial+growth+factor-receptor+tyrosine+kinase+inhibitor%2C+effects+the+anatomy+of+the+tumor+vascular+bed+and+the+functional+vascular+properties+as+detected+by+dynamic+enhanced+magnetic+resonance+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDrevs%26aufirst%3DJ.%26atitle%3Da%2520specific%2520vascular%2520endothelial%2520growth%2520factor-receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520effects%2520the%2520anatomy%2520of%2520the%2520tumor%2520vascular%2520bed%2520and%2520the%2520functional%2520vascular%2520properties%2520as%2520detected%2520by%2520dynamic%2520enhanced%2520magnetic%2520resonance%2520imaging%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00019_2"><span><span class="NLM_string-ref">(b) Bold, G.; Altman, K.-H.; Frei, J.; Lang, M.; Manley, P. W.; Traxler, P.; Wietfeld, B.; Brüggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; Martiny-Baron, G.; Mestan, J.; Rösel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Lässer, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J. M. New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinase useful as antagonists of tumor-driven angiogenesis. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 2310−2323.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2323&author=G.+Bold&author=K.-H.+Altman&author=J.+Frei&author=M.+Lang&author=P.+W.+Manley&author=P.+Traxler&author=B.+Wietfeld&author=J.+Br%C3%BCggen&author=E.+Buchdunger&author=R.+Cozens&author=S.+Ferrari&author=P.+Furet&author=F.+Hofmann&author=G.+Martiny-Baron&author=J.+Mestan&author=J.+R%C3%B6sel&author=M.+Sills&author=D.+Stover&author=F.+Acemoglu&author=E.+Boss&author=R.+Emmenegger&author=L.+L%C3%A4sser&author=E.+Masso&author=R.+Roth&author=C.+Schlachter&author=W.+Vetterli&author=D.+Wyss&author=J.+M+Wood&title=New+anilinophthalazines+as+potent+and+orally+well+absorbed+inhibitors+of+the+VEGF+receptor+tyrosine+kinase+useful+as+antagonists+of+tumor-driven+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00019_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DNew%2520anilinophthalazines%2520as%2520potent%2520and%2520orally%2520well%2520absorbed%2520inhibitors%2520of%2520the%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520useful%2520as%2520antagonists%2520of%2520tumor-driven%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm058205bb00020_1"><span><span class="NLM_string-ref">(a) Mendel, D. B.; Laird, A. D.; Xin, X.; Louie, S. G.; Christensen, J. G.; Li, G.; Schreck, R. E.; Abrams, T. J.; Ngai, T. J.; Lee, L. B.; Murray, L. J.; Carver, J.; Chan, E.; Moss, K. G.; Haznedar, J. O.; Sukbuntherng, J.; Blake, R. A.; Sun, L.; Tang, C.; Miller, T.; Shirazian, S.; McMahon, G.; Cherrington, J. M. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors:  determination of a pharmacokinetic/pharmacodynamic relationship. <i>  Clin. Cancer Res</i>. <b>2003</b>, <i>9</i>(1), 327−337.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=337&issue=1&author=D.+B.+Mendel&author=A.+D.+Laird&author=X.+Xin&author=S.+G.+Louie&author=J.+G.+Christensen&author=G.+Li&author=R.+E.+Schreck&author=T.+J.+Abrams&author=T.+J.+Ngai&author=L.+B.+Lee&author=L.+J.+Murray&author=J.+Carver&author=E.+Chan&author=K.+G.+Moss&author=J.+O.+Haznedar&author=J.+Sukbuntherng&author=R.+A.+Blake&author=L.+Sun&author=C.+Tang&author=T.+Miller&author=S.+Shirazian&author=G.+McMahon&author=J.+M+Cherrington&title=In+vivo+antitumor+activity+of+SU11248%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+growth+factor+and+platelet-derived+growth+factor+receptors%3A%E2%80%89+determination+of+a+pharmacokinetic%2Fpharmacodynamic+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendel%26aufirst%3DD.%2BB.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520SU11248%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520platelet-derived%2520growth%2520factor%2520receptors%253A%25E2%2580%2589%2520determination%2520of%2520a%2520pharmacokinetic%252Fpharmacodynamic%2520relationship%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26issue%3D1%26spage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00020_2"><span><span class="NLM_string-ref">(b) Sepp-Lorenzino, L.; Thomas, K. A. <i>  Expert Opin. Invest</i>. <i>Drugs</i><b>2002</b>, <i>11</i>, 1−18.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+Sepp-Lorenzino%2C+L.%3B+Thomas%2C+K.+A.+Expert+Opin.+Invest.+Drugs+2002%2C+11%2C+1%E2%88%9218.+%28b%29+Sepp-Lorenzino%2C+L.%3B+Thomas%2C+K.+A.+Expert+Opin.+Invest.+Drugs2002%2C+11%2C+1%E2%88%9218."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00020_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00021"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00021_1"><span><span class="NLM_string-ref">Abdollahi, A.; Lipson, K. E.; Han, X.; Krempien, R.; Trinh, T.; Weber, K. J.; Hahnfeldt, P.; Hlatky, L.; Debus, J.; Howlett, A. R.; Huber, P. E. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. <i>  Cancer Res</i>. <b>2003</b>, <i>63</i>, 3755−3763.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=3763&author=A.+Abdollahi&author=K.+E.+Lipson&author=X.+Han&author=R.+Krempien&author=T.+Trinh&author=K.+J.+Weber&author=P.+Hahnfeldt&author=L.+Hlatky&author=J.+Debus&author=A.+R.+Howlett&author=P.+E.+Huber&title=attenuate+the+angiogenic+effects+of+radiation-induced+tumor+cell+growth+factor+production+and+amplify+the+direct+anti-endothelial+action+of+radiation+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdollahi%26aufirst%3DA.%26atitle%3Dattenuate%2520the%2520angiogenic%2520effects%2520of%2520radiation-induced%2520tumor%2520cell%2520growth%2520factor%2520production%2520and%2520amplify%2520the%2520direct%2520anti-endothelial%2520action%2520of%2520radiation%2520in%2520vitro%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D3763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00022"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00022_1"><span><span class="NLM_string-ref">(a) Ciardiello, F.; Caputo, R.; Damiano, V.; Caputo, R.; Troiani, T.; Vitagliano, D.; Carlomagno, F.; Veneziani, B. M.; Fontanini, G.; Bianco, A. R.; Tortora, G. Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. <i>  Clin. </i><i>Cancer Res.</i><b>2003</b>, <i>9</i>, 1546−1556.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1556&author=F.+Ciardiello&author=R.+Caputo&author=V.+Damiano&author=R.+Caputo&author=T.+Troiani&author=D.+Vitagliano&author=F.+Carlomagno&author=B.+M.+Veneziani&author=G.+Fontanini&author=A.+R.+Bianco&author=G+Tortora&title=Antitumor+effects+of+ZD6474%2C+a+small+molecule+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor%2C+with+additional+activity+against+epidermal+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiardiello%26aufirst%3DF.%26atitle%3DAntitumor%2520effects%2520of%2520ZD6474%252C%2520a%2520small%2520molecule%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%252C%2520with%2520additional%2520activity%2520against%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2003%26volume%3D9%26spage%3D1556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00022_2"><span><span class="NLM_string-ref">(b) Hennequin, L. F.; Stokes, E. S.; Thomas, A. P.; Johnstone, C.; Plé, P. A.; Ogilvie, D. J.; Dukes, M.; Wedge, S. R.; Kendrew, J.; Curwen, J. O. Novel 4-anilinoquinazolines with C-7 basic side chains:  design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. <i>  J. Med. </i><i>Chem</i>. <b>2002</b>, <i>45</i>, 1300−1312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1312&author=L.+F.+Hennequin&author=E.+S.+Stokes&author=A.+P.+Thomas&author=C.+Johnstone&author=P.+A.+Pl%C3%A9&author=D.+J.+Ogilvie&author=M.+Dukes&author=S.+R.+Wedge&author=J.+Kendrew&author=J.+O.+Curwen&author=+Novel&title=basic+side+chains%3A%E2%80%89+design+and+structure+activity+relationship+of+a+series+of+potent%2C+orally+active%2C+VEGF+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00022_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3Dbasic%2520side%2520chains%253A%25E2%2580%2589%2520design%2520and%2520structure%2520activity%2520relationship%2520of%2520a%2520series%2520of%2520potent%252C%2520orally%2520active%252C%2520VEGF%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00023"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00023_1"><span><span class="NLM_string-ref">Kabbinavar, F.; Hurwitz, H. I.; Fehrenbacher, L.; Meropol, N. J.; Novotny, W. F.; Lieberman, G.; Griffing, S.; Bergsland, E. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. <i>  J. Clin. Oncol</i>. <b>2003</b>, <i>21</i>, 60−65.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=65&author=F.+Kabbinavar&author=H.+I.+Hurwitz&author=L.+Fehrenbacher&author=N.+J.+Meropol&author=W.+F.+Novotny&author=G.+Lieberman&author=S.+Griffing&author=E+Bergsland&title=Phase+II%2C+randomized+trial+comparing+bevacizumab+plus+fluorouracil+%28FU%29%2Fleucovorin+%28LV%29+with+FU%2FLV+alone+in+patients+with+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKabbinavar%26aufirst%3DF.%26atitle%3DPhase%2520II%252C%2520randomized%2520trial%2520comparing%2520bevacizumab%2520plus%2520fluorouracil%2520%2528FU%2529%252Fleucovorin%2520%2528LV%2529%2520with%2520FU%252FLV%2520alone%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26spage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00024"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00024_1"><span><span class="NLM_string-ref">(a) Gingrich, D. E.; Reddy, D. R.; Iqbal, M. A.; Singh, J.; Almone, L. D.; Angeles, T. S.; Albom, M.; Yang, S.; Ator, M. A.; Meyer, S. L.; Robinson, C.; Ruggeri, B. A.; Dionne, C. A.; Vaught, J. L.; Mallamo, J. P.; Hudkins, R. L. A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors:  structure−activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2, 1-<i>a</i>]pyrrolo[3, 4-<i>c</i>]carbazole-5-ones and the identification of CEP-5214 and its dimethylglycine ester prodrug clinical candidate CEP-7055. <i>  J. Med. Chem</i>. <b>2003</b>, <i>46</i>, 5375−5388.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5388&author=D.+E.+Gingrich&author=D.+R.+Reddy&author=M.+A.+Iqbal&author=J.+Singh&author=L.+D.+Almone&author=T.+S.+Angeles&author=M.+Albom&author=S.+Yang&author=M.+A.+Ator&author=S.+L.+Meyer&author=C.+Robinson&author=B.+A.+Ruggeri&author=C.+A.+Dionne&author=J.+L.+Vaught&author=J.+P.+Mallamo&author=R.+L+Hudkins&title=A+new+class+of+potent+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitors%3A%E2%80%89+structure%E2%88%92activity+relationships+for+a+series+of+9-alkoxymethyl-12-%283-hydroxypropyl%29indeno%5B2%2C+1-a%5Dpyrrolo%5B3%2C+4-c%5Dcarbazole-5-ones+and+the+identification+of+CEP-5214+and+its+dimethylglycine+ester+prodrug+clinical+candidate+CEP-7055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitors%253A%25E2%2580%2589%2520structure%25E2%2588%2592activity%2520relationships%2520for%2520a%2520series%2520of%25209-alkoxymethyl-12-%25283-hydroxypropyl%2529indeno%255B2%252C%25201-a%255Dpyrrolo%255B3%252C%25204-c%255Dcarbazole-5-ones%2520and%2520the%2520identification%2520of%2520CEP-5214%2520and%2520its%2520dimethylglycine%2520ester%2520prodrug%2520clinical%2520candidate%2520CEP-7055%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00024_2"><span><span class="NLM_string-ref">(b) Boyer, S. J. Small molecule inhibitors of KDR (VEGFR-2) kinase:  an overview of structure activity relationships. <i>  Curr. </i><i>Top. Med. Chem</i>. <b>2002</b>, <i>2</i>, 973−1000.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=1000&author=S.+J+Boyer&title=Small+molecule+inhibitors+of+KDR+%28VEGFR-2%29+kinase%3A%E2%80%89+an+overview+of+structure+activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00024_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DS.%2BJ%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520KDR%2520%2528VEGFR-2%2529%2520kinase%253A%25E2%2580%2589%2520an%2520overview%2520of%2520structure%2520activity%2520relationships%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00024_3"><span><span class="NLM_string-ref">(c) Connell, R. D. Patent focus on cancer chemotherapeutics V. Angiogenesis agents:  September 2001-August 2002. <i>  Expert Opin. Ther. Pat.</i><b>2002</b>, <i>12</i>, 1763−1782.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1782&author=R.+D+Connell&title=Patent+focus+on+cancer+chemotherapeutics+V.+Angiogenesis+agents%3A%E2%80%89+September+2001-August+2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00024_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConnell%26aufirst%3DR.%2BD%26atitle%3DPatent%2520focus%2520on%2520cancer%2520chemotherapeutics%2520V.%2520Angiogenesis%2520agents%253A%25E2%2580%2589%2520September%25202001-August%25202002%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2002%26volume%3D12%26spage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00025"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00025_1"><span><span class="NLM_string-ref">Kuo, G.-H.; Wang, A.; Emanuel, S.; DeAngelis, A.; Zhang, R.; Connolly, P. J.; Murray, W. V.; Gruninger, R. H.; Sechler, J.; Fuentes-Pesquera, A.; Johnson, D.; Middleton, S. A.; Jolliffe, L.; Chen, X. Synthesis and Discovery of Pyrazine-Pyridine Biheteroaryl as a Novel Series of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors <i>J. Med. Chem</i>. <b>2005</b>, <i>48</i>, 1886−1900.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1900&author=G.-H.+Kuo&author=A.+Wang&author=S.+Emanuel&author=A.+DeAngelis&author=R.+Zhang&author=P.+J.+Connolly&author=W.+V.+Murray&author=R.+H.+Gruninger&author=J.+Sechler&author=A.+Fuentes-Pesquera&author=D.+Johnson&author=S.+A.+Middleton&author=L.+Jolliffe&author=X+Chen&title=Synthesis+and+Discovery+of+Pyrazine-Pyridine+Biheteroaryl+as+a+Novel+Series+of+Potent+Vascular+Endothelial+Growth+Factor+Receptor-2+Inhibitors+J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DG.-H.%26atitle%3DSynthesis%2520and%2520Discovery%2520of%2520Pyrazine-Pyridine%2520Biheteroaryl%2520as%2520a%2520Novel%2520Series%2520of%2520Potent%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520Inhibitors%2520J%26jtitle%3DMed.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00026"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00026_1"><span><span class="NLM_string-ref">Farina, V.; Krishnan, B. Large rate accelerations in the Stille reaction with tri-2-furylphosphine and triphenylarsine as palladium ligands:  mechanistic and synthetic implications. <i>  J. Am. Chem. Soc.</i><b>1991</b>, <i>113</i>, 9585−9595.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=9595&author=V.+Farina&author=B+Krishnan&title=Large+rate+accelerations+in+the+Stille+reaction+with+tri-2-furylphosphine+and+triphenylarsine+as+palladium+ligands%3A%E2%80%89+mechanistic+and+synthetic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarina%26aufirst%3DV.%26atitle%3DLarge%2520rate%2520accelerations%2520in%2520the%2520Stille%2520reaction%2520with%2520tri-2-furylphosphine%2520and%2520triphenylarsine%2520as%2520palladium%2520ligands%253A%25E2%2580%2589%2520mechanistic%2520and%2520synthetic%2520implications%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D9595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00027"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00027_1"><span><span class="NLM_string-ref">(a) Wolfe, J. P.; Buchwald, S. L. Palladium-catalyzed amination of aryl triflates. <i>  J. Org. Chem</i>. <b>1997</b>, <i>62</i>, 1264−1267.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=1267&author=J.+P.+Wolfe&author=S.+L+Buchwald&title=Palladium-catalyzed+amination+of+aryl+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520triflates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00027_2"><span><span class="NLM_string-ref">(b) Aranyos, A.; Old, D. W.; Kiyomori, A.; Wolfe, J. P.; Sadighi, J. P.; Buchwald, S. L. Novel electron-rich bulky phosphine ligands facilitate the palladium-catalyzed preparation of diaryl ethers. <i>  J. Am. Chem. Soc</i>. <b>1999</b>, <i>121</i>, 4369−4378.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=4378&author=A.+Aranyos&author=D.+W.+Old&author=A.+Kiyomori&author=J.+P.+Wolfe&author=J.+P.+Sadighi&author=S.+L+Buchwald&title=Novel+electron-rich+bulky+phosphine+ligands+facilitate+the+palladium-catalyzed+preparation+of+diaryl+ethers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00027_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAranyos%26aufirst%3DA.%26atitle%3DNovel%2520electron-rich%2520bulky%2520phosphine%2520ligands%2520facilitate%2520the%2520palladium-catalyzed%2520preparation%2520of%2520diaryl%2520ethers%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D4378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00028"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00028_1"><span><span class="NLM_string-ref">Reisch, J.; Dziemba, P.; Mura, M. L.; Rao, A. R. R. Natural product chemistry. Part 159 [1]. Two methods for the synthesis of 4-azaacronycine as a potential antitumor agent.<i> J. Heterocycl. Chem</i>. <b>1993</b>, <i>30</i>, 981−983.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=983&author=J.+Reisch&author=P.+Dziemba&author=M.+L.+Mura&author=A.+R.+R+Rao&title=Natural+product+chemistry.+Part+159+%5B1%5D.+Two+methods+for+the+synthesis+of+4-azaacronycine+as+a+potential+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReisch%26aufirst%3DJ.%26atitle%3DNatural%2520product%2520chemistry.%2520Part%2520159%2520%255B1%255D.%2520Two%2520methods%2520for%2520the%2520synthesis%2520of%25204-azaacronycine%2520as%2520a%2520potential%2520antitumor%2520agent%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1993%26volume%3D30%26spage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00029"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00029_1"><span><span class="NLM_string-ref">Fujita, M.; Oka, H.; Ogura, K. Palladium(0)/LiCl promoted cross-coupling reaction of (4-pyridyl)stannanes and aromatic bromides:  easy access to poly(4-pyridyl)-substituted aromatics. <i>  Tetrahedron Lett.</i><b>1995</b>, <i>36</i>, 5247−5250.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=5250&author=M.+Fujita&author=H.+Oka&author=K.+Ogura&author=+Palladium&title=promoted+cross-coupling+reaction+of+%284-pyridyl%29stannanes+and+aromatic+bromides%3A%E2%80%89+easy+access+to+poly%284-pyridyl%29-substituted+aromatics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DM.%26atitle%3Dpromoted%2520cross-coupling%2520reaction%2520of%2520%25284-pyridyl%2529stannanes%2520and%2520aromatic%2520bromides%253A%25E2%2580%2589%2520easy%2520access%2520to%2520poly%25284-pyridyl%2529-substituted%2520aromatics%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D5250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm058205bb00030_1"><span><span class="NLM_string-ref">Brown, A. D.; Dickinson, R. P.; Wythes, M. J. Indole derivatives as 5-HT-like agonists. WO 93/21178.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Brown%2C+A.+D.%3B+Dickinson%2C+R.+P.%3B+Wythes%2C+M.+J.+Indole+derivatives+as+5-HT-like+agonists.+WO+93%2F21178.+Brown%2C+A.+D.%3B+Dickinson%2C+R.+P.%3B+Wythes%2C+M.+J.+Indole+derivatives+as+5-HT-like+agonists.+WO+93%2F21178."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00031"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00031_1"><span><span class="NLM_string-ref">Mann, G.; Hartwig, J. F.; Driver, M. S.; Fernández-Rivas, C. Palladium-catalyzed C-N(sp<sup>2</sup>) bond formation:  <i>N</i>-arylation of aromatic and unsaturated nitrogen and the reductive elimination chemistry of palladium azolyl and methyleneamido complexes<i>. J. Am. Chem. Soc.</i><b>1998</b>, <i>120</i>, 827−828.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=828&author=G.+Mann&author=J.+F.+Hartwig&author=M.+S.+Driver&author=C.+Fern%C3%A1ndez-Rivas&author=+Palladium&title=N-arylation+of+aromatic+and+unsaturated+nitrogen+and+the+reductive+elimination+chemistry+of+palladium+azolyl+and+methyleneamido+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DG.%26atitle%3DN-arylation%2520of%2520aromatic%2520and%2520unsaturated%2520nitrogen%2520and%2520the%2520reductive%2520elimination%2520chemistry%2520of%2520palladium%2520azolyl%2520and%2520methyleneamido%2520complexes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00032"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00032_1"><span><span class="NLM_string-ref">Brogi, E.; Wu, T.; Namiki, A.; Isner, J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. <i>  Circulation</i><b>1994</b>, <i>90</i>, 649−652.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1994&pages=652&author=E.+Brogi&author=T.+Wu&author=A.+Namiki&author=J.+M+Isner&title=Indirect+angiogenic+cytokines+upregulate+VEGF+and+bFGF+gene+expression+in+vascular+smooth+muscle+cells%2C+whereas+hypoxia+upregulates+VEGF+expression+only"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrogi%26aufirst%3DE.%26atitle%3DIndirect%2520angiogenic%2520cytokines%2520upregulate%2520VEGF%2520and%2520bFGF%2520gene%2520expression%2520in%2520vascular%2520smooth%2520muscle%2520cells%252C%2520whereas%2520hypoxia%2520upregulates%2520VEGF%2520expression%2520only%26jtitle%3DCirculation%26date%3D1994%26volume%3D90%26spage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00033"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00033_1"><span><span class="NLM_string-ref">Kilic, T.; Alberta, J. A.; Zdunek, P. R.; Acar, M.; Iannarelli, P.; O'Reilly, T.; Buchdunger, E.; Black, P. M.; Stiles, C. D. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. <i>  Cancer Res</i>. <b>2000</b>, <i>60</i>, 5143−5150.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5150&author=T.+Kilic&author=J.+A.+Alberta&author=P.+R.+Zdunek&author=M.+Acar&author=P.+Iannarelli&author=T.+O%27Reilly&author=E.+Buchdunger&author=P.+M.+Black&author=C.+D+Stiles&title=Intracranial+inhibition+of+platelet-derived+growth+factor-mediated+glioblastoma+cell+growth+by+an+orally+active+kinase+inhibitor+of+the+2-phenylaminopyrimidine+class"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKilic%26aufirst%3DT.%26atitle%3DIntracranial%2520inhibition%2520of%2520platelet-derived%2520growth%2520factor-mediated%2520glioblastoma%2520cell%2520growth%2520by%2520an%2520orally%2520active%2520kinase%2520inhibitor%2520of%2520the%25202-phenylaminopyrimidine%2520class%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00034"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00034_1"><span><span class="NLM_string-ref">(a) Compounds <b>56</b>, <b>57</b>, and <b>58</b> were not evaluated further because of the strong inhibition of CYP450 enzymes were observed in human liver microsomal studies. Compounds <b>39</b> and <b>41</b> demonstrated low oral bioavailability (<i>F</i> < 10%) and therefore were administered through i.p. route for the in vivo studies.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28a%29+Compounds+56%2C+57%2C+and+58+were+not+evaluated+further+because+of+the+strong+inhibition+of+CYP450+enzymes+were+observed+in+human+liver+microsomal+studies.+Compounds+39+and+41+demonstrated+low+oral+bioavailability+%28F+%3C+10%25%29+and+therefore+were+administered+through+i.p.+route+for+the+in+vivo+studies.+%28a%29+Compounds+56%2C+57%2C+and+58+were+not+evaluated+further+because+of+the+strong+inhibition+of+CYP450+enzymes+were+observed+in+human+liver+microsomal+studies.+Compounds+39+and+41+demonstrated+low+oral+bioavailability+%28F+%3C+10%25%29+and+therefore+were+administered+through+i.p.+route+for+the+in+vivo+studies."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00034_2"><span><span class="NLM_string-ref">(b) The A375 melanoma is considered to be a good target for VEGFR-2 inhibitors because it has good vascularization, which supports its rapid growth kinetics.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+The+A375+melanoma+is+considered+to+be+a+good+target+for+VEGFR-2+inhibitors+because+it+has+good+vascularization%2C+which+supports+its+rapid+growth+kinetics.+%28b%29+The+A375+melanoma+is+considered+to+be+a+good+target+for+VEGFR-2+inhibitors+because+it+has+good+vascularization%2C+which+supports+its+rapid+growth+kinetics."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00034_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm058205bb00034_3"><span><span class="NLM_string-ref">(c) Serrone, L.; Zeuli, M.; Sega, F. M.; Cognetti, F. Dacarbazine-based chemotherapy for metastatic melanoma:  thirty year experience overview. <i>  J. Exp. Clin</i>. <i>Cancer</i><i>Res</i>. <b>2000</b>, <i>19</i>, 21−34.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=34&author=L.+Serrone&author=M.+Zeuli&author=F.+M.+Sega&author=F+Cognetti&title=Dacarbazine-based+chemotherapy+for+metastatic+melanoma%3A%E2%80%89+thirty+year+experience+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00034_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerrone%26aufirst%3DL.%26atitle%3DDacarbazine-based%2520chemotherapy%2520for%2520metastatic%2520melanoma%253A%25E2%2580%2589%2520thirty%2520year%2520experience%2520overview%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D19%26spage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00035"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00035_1"><span><span class="NLM_string-ref">Eisch, J. J.; Gopal, H.; Russo, D. A. Preparation and aluminum chloride induced rearrangement of cyclopropylpyridines. <i>  J. Org. Chem</i>. <b>1974</b>, <i>39</i>, 3110−3114.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1974&pages=3114&author=J.+J.+Eisch&author=H.+Gopal&author=D.+A+Russo&title=Preparation+and+aluminum+chloride+induced+rearrangement+of+cyclopropylpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEisch%26aufirst%3DJ.%2BJ.%26atitle%3DPreparation%2520and%2520aluminum%2520chloride%2520induced%2520rearrangement%2520of%2520cyclopropylpyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1974%26volume%3D39%26spage%3D3114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00036"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00036" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00036_1"><span><span class="NLM_string-ref">Caldwell, W. S.; Bencherif, M.; Dull, G. M.; Crooks, P. A.; Lippiello, P. M.; Bhatti, B. S.; Deo, N. M.; Ravard, A. 3-Pyridyl-1-azabicycloalkane derivatives for prevention and treatment of CNS disorders. WO9900385, CAN 130:105302.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Caldwell%2C+W.+S.%3B+Bencherif%2C+M.%3B+Dull%2C+G.+M.%3B+Crooks%2C+P.+A.%3B+Lippiello%2C+P.+M.%3B+Bhatti%2C+B.+S.%3B+Deo%2C+N.+M.%3B+Ravard%2C+A.+3-Pyridyl-1-azabicycloalkane+derivatives+for+prevention+and+treatment+of+CNS+disorders.+WO9900385%2C+CAN+130%3A105302.+Caldwell%2C+W.+S.%3B+Bencherif%2C+M.%3B+Dull%2C+G.+M.%3B+Crooks%2C+P.+A.%3B+Lippiello%2C+P.+M.%3B+Bhatti%2C+B.+S.%3B+Deo%2C+N.+M.%3B+Ravard%2C+A.+3-Pyridyl-1-azabicycloalkane+derivatives+for+prevention+and+treatment+of+CNS+disorders.+WO9900385%2C+CAN+130%3A105302."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00037"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00037" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00037_1"><span><span class="NLM_string-ref">Chung, J. Y. L.; Zhao, D.; Hughes, D. L.; Grabowski, E. J. J. A practical synthesis of fibrinogen receptor antagonist MK-383. Selective functionalization of (S)-tyrosine. <i>  Tetrahedron</i><b>1993</b>, <i>49</i>, 5767−5776.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=5776&author=J.+Y.+L.+Chung&author=D.+Zhao&author=D.+L.+Hughes&author=E.+J.+J+Grabowski&title=A+practical+synthesis+of+fibrinogen+receptor+antagonist+MK-383.+Selective+functionalization+of+%28S%29-tyrosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DJ.%2BY.%2BL.%26atitle%3DA%2520practical%2520synthesis%2520of%2520fibrinogen%2520receptor%2520antagonist%2520MK-383.%2520Selective%2520functionalization%2520of%2520%2528S%2529-tyrosine%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D5776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00038"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00038" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00038_1"><span><span class="NLM_string-ref">Emanuel, S.; Gruninger, R. H.; Fuentes-Pesquera, A.; Connolly, P. J.; Seamon, J. A.; Hazel, S.; Tominovich, R.; Hollister, B.; Napier, C.; Reuman, M.; Bignan, G.; Tuman, R.; Johnson, D.; Moffatt, D.; Batchelor, M.; Foley, A.; O'Connell, J.; Allen, R.; Perry, M.; Jolliffe, L.; Middleton, S. A. A VEGF-R2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models. <i>  Mol. Pharm</i>. <b>2004</b>, <i>66</i>, 635−647.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=647&author=S.+Emanuel&author=R.+H.+Gruninger&author=A.+Fuentes-Pesquera&author=P.+J.+Connolly&author=J.+A.+Seamon&author=S.+Hazel&author=R.+Tominovich&author=B.+Hollister&author=C.+Napier&author=M.+Reuman&author=G.+Bignan&author=R.+Tuman&author=D.+Johnson&author=D.+Moffatt&author=M.+Batchelor&author=A.+Foley&author=J.+O%27Connell&author=R.+Allen&author=M.+Perry&author=L.+Jolliffe&author=S.+A+Middleton&title=A+VEGF-R2+kinase+inhibitor+potentiates+the+activity+of+the+conventional+chemotherapeutic+agents+paclitaxel+and+doxorubicin+in+tumor+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmanuel%26aufirst%3DS.%26atitle%3DA%2520VEGF-R2%2520kinase%2520inhibitor%2520potentiates%2520the%2520activity%2520of%2520the%2520conventional%2520chemotherapeutic%2520agents%2520paclitaxel%2520and%2520doxorubicin%2520in%2520tumor%2520xenograft%2520models%26jtitle%3DMol.%2520Pharm.%26date%3D2004%26volume%3D66%26spage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00039"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00039" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00039_1"><span><span class="NLM_string-ref"><i>Glide</i>; Schrodinger:  Portland, OR.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Glide%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR.+Glide%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00040"><div class="reference"><div class="NLM_citation" id="rightTab-jm058205bb00040_1"><span><span class="NLM_string-ref">Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide. A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. <i>  J. </i><i>Med. Chem</i>. <b>2004</b>, <i>47</i>, 1739−1749.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1749&author=R.+A.+Friesner&author=J.+L.+Banks&author=R.+B.+Murphy&author=T.+A.+Halgren&author=J.+J.+Klicic&author=D.+T.+Mainz&author=M.+P.+Repasky&author=E.+H.+Knoll&author=M.+Shelley&author=J.+K.+Perry&author=D.+E.+Shaw&author=P.+Francis&author=P.+S.+Shenkin&author=+Glide&title=A+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DA%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00041"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00041" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00041_1"><span><span class="NLM_string-ref">McTigue, M. A.; Wickersham, J. A.; Pinko, C.; Showalter, R. E.; Parast, C. V.; Tempczyk-Russell, A.; Gehring, M. R.; Mroczkowski, B.; Kan, C.-C.; Villafranca, J. E.; Appelt, K. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2:  a key enzyme in angiogenesis. <i>  Structure</i><b>1999</b>, <i>7</i>, 319−330.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=330&author=M.+A.+McTigue&author=J.+A.+Wickersham&author=C.+Pinko&author=R.+E.+Showalter&author=C.+V.+Parast&author=A.+Tempczyk-Russell&author=M.+R.+Gehring&author=B.+Mroczkowski&author=C.-C.+Kan&author=J.+E.+Villafranca&author=K+Appelt&title=Crystal+structure+of+the+kinase+domain+of+human+vascular+endothelial+growth+factor+receptor+2%3A%E2%80%89+a+key+enzyme+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcTigue%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520kinase%2520domain%2520of%2520human%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25202%253A%25E2%2580%2589%2520a%2520key%2520enzyme%2520in%2520angiogenesis%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00042"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00042" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00042_1"><span><span class="NLM_string-ref">Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical treatment of salvation for molecular mechanics and dynamics. <i>  J. Am. </i><i>Chem. Soc</i>. <b>1990</b>, <i>112</i>, 6127−6129.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1990&pages=6129&author=W.+C.+Still&author=A.+Tempczyk&author=R.+C.+Hawley&author=T+Hendrickson&title=Semianalytical+treatment+of+salvation+for+molecular+mechanics+and+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DSemianalytical%2520treatment%2520of%2520salvation%2520for%2520molecular%2520mechanics%2520and%2520dynamics%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1990%26volume%3D112%26spage%3D6129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00043"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00043" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00043_1"><span><span class="NLM_string-ref"><i>MacroModel</i>; Schrodinger:  Portland, OR.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MacroModel%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR.+MacroModel%3B+Schrodinger%3A%E2%80%89+Portland%2C+OR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00044"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00044" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00044_1"><span><span class="NLM_string-ref">Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. <i>  J. Am. Chem. Soc</i>. <b>1996</b>, <i>118</i>, 11225−11235.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=11235&author=W.+L.+Jorgensen&author=D.+S.+Maxwell&author=J+Tirado-Rives&title=Development+and+testing+of+the+OPLS+all-atom+force+field+on+conformational+energetics+and+properties+of+organic+liquids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520the%2520OPLS%2520all-atom%2520force%2520field%2520on%2520conformational%2520energetics%2520and%2520properties%2520of%2520organic%2520liquids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26spage%3D11235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm058205bb00045"><div class="reference"><strong class="refLabel"><a href="#jm058205bb00045" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-jm058205bb00045_1"><span><span class="NLM_string-ref"><i>MOE</i>; Chemical Computing Group, Inc.:  Montreal, Quebec, Canada.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MOE%3B+Chemical+Computing+Group%2C+Inc.%3A%E2%80%89+Montreal%2C+Quebec%2C+Canada.+MOE%3B+Chemical+Computing+Group%2C+Inc.%3A%E2%80%89+Montreal%2C+Quebec%2C+Canada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm058205bb00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VR2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1VR2','PDB','1VR2'); return false;">PDB: 1VR2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021%2Fjm058205b">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Elemental analyses data are available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm058205b/suppl_file/jm058205b_s.pdf">jm058205b_s.pdf (72.76 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm058205b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2005.48.issue-15%3Barticle%3Aarticle%3A10.1021%2Fjm058205b%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm058205b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                484KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ae3097d0822f0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
